,BrainBankID,BrainBank,ArrivalDate,CaseID,BrainBankNetworkID ,ExpectedFFPERegions,ArrivedFFPERegions,ExpectedFrozenRegions,ArrivedFrozenRegions,RegionComments,Age,EthnicityID,Ethnicity,Sex,PostMortemDelayHours,BraakID,Braak,AD/CTRL,BraakDiagnosis,BraakDefinition,THALID,THAL ,THALDiagnosis,THALDefinition,CERADID,CERAD ,CERADDiagnosis,CERADDiagnosis1,APOEID,APOE,APOEDiagnosis,APOEDefinition,HistopathologicalDiagnosisID1,PrimaryHistopathologicalDefinition,HistopathologicalDiagnosisID2,SecondaryHistopathologicalDefinition,NeuropathComments,CauseOfDeath,KnownHypertension,Diabetic,Comments,ClinicalNotes,BiogenCohort,TREM2VariantID,TREM2Variant,TREM2Diagnosis,OtherGene,StudyID,Study,Study 2,Unnamed: 50,Unnamed: 51,CaseID (normalized),BrainBankNetworkID_normalized,BrainBankNetworkID_original,Sample_ID,Brain region,Enrichment,Sample_Name_normalized,Sample_Name_original,RNAseq/ATACseq
0,1.0,Bristol ,3/11/2021,1066,BBN006.30165,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",93.0,1.0,Missing,M,34.5,5.0,2,Control,Ndgen.BandBII,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,17.0,Ageing,,,No significant abnormalities apart from microinfarct in putamen,"Acute kidney injury, overdose of salicylate, chronic kidney disease",N,N,,,N,1.0,,,,3.0,MAP,,,,1066,BBN006_30165,BBN006.30165,IGF124263,PFC,,BBN006_30165,BBN006-30165-FC,
1,1.0,Bristol ,3/11/2021,1066,BBN006.30165,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",93.0,1.0,Missing,M,34.5,5.0,2,Control,Ndgen.BandBII,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,17.0,Ageing,,,No significant abnormalities apart from microinfarct in putamen,"Acute kidney injury, overdose of salicylate, chronic kidney disease",N,N,,,N,1.0,,,,3.0,MAP,,,,1066,BBN006_30165,BBN006.30165,IGF124277,MTEMP,,BBN006_30165,BBN006-30165-MTEMP,
2,1.0,Bristol ,3/11/2021,1066,BBN006.30165,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",93.0,1.0,Missing,M,34.5,5.0,2,Control,Ndgen.BandBII,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,17.0,Ageing,,,No significant abnormalities apart from microinfarct in putamen,"Acute kidney injury, overdose of salicylate, chronic kidney disease",N,N,,,N,1.0,,,,3.0,MAP,,,,1066,BBN006_30165,BBN006.30165,IGF123511,MTEMP,,BBN006_30165,BBN006-30165-MTEMP,
3,1.0,Bristol ,3/11/2021,1066,BBN006.30165,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",93.0,1.0,Missing,M,34.5,5.0,2,Control,Ndgen.BandBII,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,17.0,Ageing,,,No significant abnormalities apart from microinfarct in putamen,"Acute kidney injury, overdose of salicylate, chronic kidney disease",N,N,,,N,1.0,,,,3.0,MAP,,,,1066,BBN006_30165,BBN006.30165,IGF123544,PFC,,BBN006_30165,BBN006-30165-FC,
4,1.0,Bristol ,3/11/2021,1066,BBN006.30165,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",93.0,1.0,Missing,M,34.5,5.0,2,Control,Ndgen.BandBII,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,17.0,Ageing,,,No significant abnormalities apart from microinfarct in putamen,"Acute kidney injury, overdose of salicylate, chronic kidney disease",N,N,,,N,1.0,,,,3.0,MAP,,,,1066,BBN006_30165,BBN006.30165,IGF128409,PFC,,BBN006_30165,BBN006-30165-FC,RNAseq
5,1.0,Bristol ,3/11/2021,1066,BBN006.30165,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",93.0,1.0,Missing,M,34.5,5.0,2,Control,Ndgen.BandBII,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,17.0,Ageing,,,No significant abnormalities apart from microinfarct in putamen,"Acute kidney injury, overdose of salicylate, chronic kidney disease",N,N,,,N,1.0,,,,3.0,MAP,,,,1066,BBN006_30165,BBN006.30165,IGF128438,PFC,,BBN006_30165,BBN006-30165-FC_1,ATACseq
6,1.0,Bristol ,3/11/2021,1066,BBN006.30165,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",93.0,1.0,Missing,M,34.5,5.0,2,Control,Ndgen.BandBII,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,17.0,Ageing,,,No significant abnormalities apart from microinfarct in putamen,"Acute kidney injury, overdose of salicylate, chronic kidney disease",N,N,,,N,1.0,,,,3.0,MAP,,,,1066,BBN006_30165,BBN006.30165,IGF125070,MTG,,BBN006_30165,BBN006-30165-MTG_1,ATACseq
7,1.0,Bristol ,3/11/2021,1066,BBN006.30165,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",93.0,1.0,Missing,M,34.5,5.0,2,Control,Ndgen.BandBII,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,17.0,Ageing,,,No significant abnormalities apart from microinfarct in putamen,"Acute kidney injury, overdose of salicylate, chronic kidney disease",N,N,,,N,1.0,,,,3.0,MAP,,,,1066,BBN006_30165,BBN006.30165,IGF125042,MTG,,BBN006_30165,BBN006-30165-MTG,RNAseq
8,1.0,Bristol ,1/28/2021,1072,BBN006.30889,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",72.0,1.0,Missing,F,11.5,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,1.0,,,Not assesed,2.0,Alzheimer's Disease,19.0,hippocampal sclerosis of ag,Severe CAA,Advanced dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,1072,BBN006_30889,BBN006.30889,IGF124273,PFC,,BBN006_30889,BBN006-30889-FC,
9,1.0,Bristol ,1/28/2021,1072,BBN006.30889,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",72.0,1.0,Missing,F,11.5,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,1.0,,,Not assesed,2.0,Alzheimer's Disease,19.0,hippocampal sclerosis of ag,Severe CAA,Advanced dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,1072,BBN006_30889,BBN006.30889,IGF124265,MTEMP,,BBN006_30889,BBN006-30889-MTEMP,
10,1.0,Bristol ,1/28/2021,1072,BBN006.30889,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",72.0,1.0,Missing,F,11.5,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,1.0,,,Not assesed,2.0,Alzheimer's Disease,19.0,hippocampal sclerosis of ag,Severe CAA,Advanced dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,1072,BBN006_30889,BBN006.30889,IGF123515,MTEMP,,BBN006_30889,BBN006-30889-MTEMP,
11,1.0,Bristol ,1/28/2021,1072,BBN006.30889,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",72.0,1.0,Missing,F,11.5,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,1.0,,,Not assesed,2.0,Alzheimer's Disease,19.0,hippocampal sclerosis of ag,Severe CAA,Advanced dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,1072,BBN006_30889,BBN006.30889,IGF123527,PFC,,BBN006_30889,BBN006-30889-FC,
12,1.0,Bristol ,1/28/2021,1072,BBN006.30889,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",72.0,1.0,Missing,F,11.5,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,1.0,,,Not assesed,2.0,Alzheimer's Disease,19.0,hippocampal sclerosis of ag,Severe CAA,Advanced dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,1072,BBN006_30889,BBN006.30889,IGF128403,PFC,,BBN006_30889,BBN006-30889-FC,RNAseq
13,1.0,Bristol ,1/28/2021,1072,BBN006.30889,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",72.0,1.0,Missing,F,11.5,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,1.0,,,Not assesed,2.0,Alzheimer's Disease,19.0,hippocampal sclerosis of ag,Severe CAA,Advanced dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,1072,BBN006_30889,BBN006.30889,IGF128432,PFC,,BBN006_30889,BBN006-30889-FC_1,ATACseq
14,1.0,Bristol ,1/28/2021,1072,BBN006.30889,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",72.0,1.0,Missing,F,11.5,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,1.0,,,Not assesed,2.0,Alzheimer's Disease,19.0,hippocampal sclerosis of ag,Severe CAA,Advanced dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,1072,BBN006_30889,BBN006.30889,IGF125082,MTG,,BBN006_30889,BBN006-30889-MTG_1,ATACseq
15,1.0,Bristol ,1/28/2021,1072,BBN006.30889,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",72.0,1.0,Missing,F,11.5,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,1.0,,,Not assesed,2.0,Alzheimer's Disease,19.0,hippocampal sclerosis of ag,Severe CAA,Advanced dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,1072,BBN006_30889,BBN006.30889,IGF125054,MTG,,BBN006_30889,BBN006-30889-MTG,RNAseq
16,1.0,Bristol ,1/28/2021,1122,BBN006.34151,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",86.0,1.0,Missing,F,37.5,9.0,5,AD,Ndgen.BandBV,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,2.0,Alzheimer's Disease,,,,"AD, chronic lymphocytic leukaemia",N,N,,,N,1.0,,,,3.0,MAP,,,,1122,BBN006_34151,BBN006.34151,IGF124266,MTEMP,,BBN006_34151,BBN006-34151-MTEMP,
17,1.0,Bristol ,1/28/2021,1122,BBN006.34151,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",86.0,1.0,Missing,F,37.5,9.0,5,AD,Ndgen.BandBV,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,2.0,Alzheimer's Disease,,,,"AD, chronic lymphocytic leukaemia",N,N,,,N,1.0,,,,3.0,MAP,,,,1122,BBN006_34151,BBN006.34151,IGF123533,MTEMP,,BBN006_34151,BBN006-34151-MTEMP,
18,1.0,Bristol ,1/28/2021,1122,BBN006.34151,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",86.0,1.0,Missing,F,37.5,9.0,5,AD,Ndgen.BandBV,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,2.0,Alzheimer's Disease,,,,"AD, chronic lymphocytic leukaemia",N,N,,,N,1.0,,,,3.0,MAP,,,,1122,BBN006_34151,BBN006.34151,IGF123535,PFC,,BBN006_34151,BBN006-34151-FC,
19,1.0,Bristol ,1/28/2021,1122,BBN006.34151,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",86.0,1.0,Missing,F,37.5,9.0,5,AD,Ndgen.BandBV,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,2.0,Alzheimer's Disease,,,,"AD, chronic lymphocytic leukaemia",N,N,,,N,1.0,,,,3.0,MAP,,,,1122,BBN006_34151,BBN006.34151,IGF128391,PFC,,BBN006_34151,BBN006-34151-FC,RNAseq
20,1.0,Bristol ,1/28/2021,1122,BBN006.34151,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",86.0,1.0,Missing,F,37.5,9.0,5,AD,Ndgen.BandBV,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,2.0,Alzheimer's Disease,,,,"AD, chronic lymphocytic leukaemia",N,N,,,N,1.0,,,,3.0,MAP,,,,1122,BBN006_34151,BBN006.34151,IGF128420,PFC,,BBN006_34151,BBN006-34151-FC_1,ATACseq
21,1.0,Bristol ,1/28/2021,1122,BBN006.34151,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",86.0,1.0,Missing,F,37.5,9.0,5,AD,Ndgen.BandBV,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,2.0,Alzheimer's Disease,,,,"AD, chronic lymphocytic leukaemia",N,N,,,N,1.0,,,,3.0,MAP,,,,1122,BBN006_34151,BBN006.34151,IGF125083,MTG,,BBN006_34151,BBN006-34151-MTG_1,ATACseq
22,1.0,Bristol ,1/28/2021,1122,BBN006.34151,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",86.0,1.0,Missing,F,37.5,9.0,5,AD,Ndgen.BandBV,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,2.0,Alzheimer's Disease,,,,"AD, chronic lymphocytic leukaemia",N,N,,,N,1.0,,,,3.0,MAP,,,,1122,BBN006_34151,BBN006.34151,IGF125055,MTG,,BBN006_34151,BBN006-34151-MTG,RNAseq
23,1.0,Bristol ,1/28/2021,1149,BBN006.35417,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",83.0,1.0,Missing,M,41.75,6.0,3,AD,Ndgen.BandBIII,Moderate,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,2.0,Alzheimer's Disease,,,,Dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,1149,BBN006_35417,BBN006.35417,IGF123520,MTEMP,,BBN006_35417,BBN006-35417-MTEMP,
24,1.0,Bristol ,1/28/2021,1149,BBN006.35417,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",83.0,1.0,Missing,M,41.75,6.0,3,AD,Ndgen.BandBIII,Moderate,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,2.0,Alzheimer's Disease,,,,Dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,1149,BBN006_35417,BBN006.35417,IGF123524,PFC,,BBN006_35417,BBN006-35417-FC,
25,1.0,Bristol ,1/28/2021,1149,BBN006.35417,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",83.0,1.0,Missing,M,41.75,6.0,3,AD,Ndgen.BandBIII,Moderate,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,2.0,Alzheimer's Disease,,,,Dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,1149,BBN006_35417,BBN006.35417,IGF128398,EC,,BBN006_35417,BBN006-35417-EC,RNAseq
26,1.0,Bristol ,1/28/2021,1149,BBN006.35417,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",83.0,1.0,Missing,M,41.75,6.0,3,AD,Ndgen.BandBIII,Moderate,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,2.0,Alzheimer's Disease,,,,Dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,1149,BBN006_35417,BBN006.35417,IGF128413,PFC,,BBN006_35417,BBN006-35417-FC,RNAseq
27,1.0,Bristol ,1/28/2021,1149,BBN006.35417,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",83.0,1.0,Missing,M,41.75,6.0,3,AD,Ndgen.BandBIII,Moderate,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,2.0,Alzheimer's Disease,,,,Dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,1149,BBN006_35417,BBN006.35417,IGF128427,EC,,BBN006_35417,BBN006-35417-EC_1,ATACseq
28,1.0,Bristol ,1/28/2021,1149,BBN006.35417,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",83.0,1.0,Missing,M,41.75,6.0,3,AD,Ndgen.BandBIII,Moderate,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,2.0,Alzheimer's Disease,,,,Dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,1149,BBN006_35417,BBN006.35417,IGF128442,PFC,,BBN006_35417,BBN006-35417-FC_1,ATACseq
29,1.0,Bristol ,1/28/2021,1149,BBN006.35417,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",83.0,1.0,Missing,M,41.75,6.0,3,AD,Ndgen.BandBIII,Moderate,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,2.0,Alzheimer's Disease,,,,Dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,1149,BBN006_35417,BBN006.35417,IGF125073,MTG,,BBN006_35417,BBN006-35417-MTG_1,ATACseq
30,1.0,Bristol ,1/28/2021,1149,BBN006.35417,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",83.0,1.0,Missing,M,41.75,6.0,3,AD,Ndgen.BandBIII,Moderate,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,2.0,Alzheimer's Disease,,,,Dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,1149,BBN006_35417,BBN006.35417,IGF125045,MTG,,BBN006_35417,BBN006-35417-MTG,RNAseq
31,1.0,Bristol ,1/28/2021,1152,BBN006.35453,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",64.0,1.0,Missing,M,44.75,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,2.0,Alzheimer's Disease,,,,AD,N,N,,,N,1.0,,,,3.0,MAP,,,,1152,BBN006_35453,BBN006.35453,IGF124274,MTEMP,,BBN006_35453,BBN006-35453-MTEMP,
32,1.0,Bristol ,1/28/2021,1152,BBN006.35453,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",64.0,1.0,Missing,M,44.75,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,2.0,Alzheimer's Disease,,,,AD,N,N,,,N,1.0,,,,3.0,MAP,,,,1152,BBN006_35453,BBN006.35453,IGF123543,MTEMP,,BBN006_35453,BBN006-35453-MTEMP,
33,1.0,Bristol ,1/28/2021,1152,BBN006.35453,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",64.0,1.0,Missing,M,44.75,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,2.0,Alzheimer's Disease,,,,AD,N,N,,,N,1.0,,,,3.0,MAP,,,,1152,BBN006_35453,BBN006.35453,IGF123551,PFC,,BBN006_35453,BBN006-35453-FC,
34,1.0,Bristol ,1/28/2021,1152,BBN006.35453,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",64.0,1.0,Missing,M,44.75,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,2.0,Alzheimer's Disease,,,,AD,N,N,,,N,1.0,,,,3.0,MAP,,,,1152,BBN006_35453,BBN006.35453,IGF128392,PFC,,BBN006_35453,BBN006-35453-FC,RNAseq
35,1.0,Bristol ,1/28/2021,1152,BBN006.35453,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",64.0,1.0,Missing,M,44.75,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,2.0,Alzheimer's Disease,,,,AD,N,N,,,N,1.0,,,,3.0,MAP,,,,1152,BBN006_35453,BBN006.35453,IGF128421,PFC,,BBN006_35453,BBN006-35453-FC_1,ATACseq
36,1.0,Bristol ,1/28/2021,1152,BBN006.35453,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",64.0,1.0,Missing,M,44.75,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,2.0,Alzheimer's Disease,,,,AD,N,N,,,N,1.0,,,,3.0,MAP,,,,1152,BBN006_35453,BBN006.35453,IGF125067,MTG,,BBN006_35453,BBN006-35453-MTG_1,ATACseq
37,1.0,Bristol ,1/28/2021,1152,BBN006.35453,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",64.0,1.0,Missing,M,44.75,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,2.0,Alzheimer's Disease,,,,AD,N,N,,,N,1.0,,,,3.0,MAP,,,,1152,BBN006_35453,BBN006.35453,IGF125039,MTG,,BBN006_35453,BBN006-35453-MTG,RNAseq
38,1.0,Bristol ,1/28/2021,1160,BBN006.35513,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",90.0,1.0,Missing,M,61,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,2.0,Alzheimer's Disease,,,,"Inanition, AD",N,N,,,N,1.0,,,,3.0,MAP,,,,1160,BBN006_35513,BBN006.35513,IGF124267,MTEMP,,BBN006_35513,BBN006-35513-MTEMP,
39,1.0,Bristol ,1/28/2021,1160,BBN006.35513,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",90.0,1.0,Missing,M,61,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,2.0,Alzheimer's Disease,,,,"Inanition, AD",N,N,,,N,1.0,,,,3.0,MAP,,,,1160,BBN006_35513,BBN006.35513,IGF123522,PFC,,BBN006_35513,BBN006-35513-FC,
40,1.0,Bristol ,1/28/2021,1160,BBN006.35513,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",90.0,1.0,Missing,M,61,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,2.0,Alzheimer's Disease,,,,"Inanition, AD",N,N,,,N,1.0,,,,3.0,MAP,,,,1160,BBN006_35513,BBN006.35513,IGF123546,MTEMP,,BBN006_35513,BBN006-35513-MTEMP,
41,1.0,Bristol ,1/28/2021,1160,BBN006.35513,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",90.0,1.0,Missing,M,61,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,2.0,Alzheimer's Disease,,,,"Inanition, AD",N,N,,,N,1.0,,,,3.0,MAP,,,,1160,BBN006_35513,BBN006.35513,IGF128396,PFC,,BBN006_35513,BBN006-35513-FC,RNAseq
42,1.0,Bristol ,1/28/2021,1160,BBN006.35513,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",90.0,1.0,Missing,M,61,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,2.0,Alzheimer's Disease,,,,"Inanition, AD",N,N,,,N,1.0,,,,3.0,MAP,,,,1160,BBN006_35513,BBN006.35513,IGF128425,PFC,,BBN006_35513,BBN006-35513-FC_1,ATACseq
43,1.0,Bristol ,1/28/2021,1160,BBN006.35513,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",90.0,1.0,Missing,M,61,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,2.0,Alzheimer's Disease,,,,"Inanition, AD",N,N,,,N,1.0,,,,3.0,MAP,,,,1160,BBN006_35513,BBN006.35513,IGF125079,MTG,,BBN006_35513,BBN006-35513-MTG_1,ATACseq
44,1.0,Bristol ,1/28/2021,1160,BBN006.35513,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",90.0,1.0,Missing,M,61,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,2.0,Alzheimer's Disease,,,,"Inanition, AD",N,N,,,N,1.0,,,,3.0,MAP,,,,1160,BBN006_35513,BBN006.35513,IGF125051,MTG,,BBN006_35513,BBN006-35513-MTG,RNAseq
45,1.0,Bristol ,1/28/2021,1165,BBN006.35560,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",77.0,1.0,Missing,M,40.5,6.0,3,AD,Ndgen.BandBIII,Moderate,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,2.0,Alzheimer's Disease,,,"Argyrophilic grain disease, moderate CAA","Chest infection, dementia, heart failure",N,N,,,N,1.0,,,,3.0,MAP,,,,1165,BBN006_35560,BBN006.35560,IGF123530,PFC,,BBN006_35560,BBN006-35560-FC,
46,1.0,Bristol ,1/28/2021,1165,BBN006.35560,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",77.0,1.0,Missing,M,40.5,6.0,3,AD,Ndgen.BandBIII,Moderate,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,2.0,Alzheimer's Disease,,,"Argyrophilic grain disease, moderate CAA","Chest infection, dementia, heart failure",N,N,,,N,1.0,,,,3.0,MAP,,,,1165,BBN006_35560,BBN006.35560,IGF123552,MTEMP,,BBN006_35560,BBN006-35560-MTEMP,
47,1.0,Bristol ,1/28/2021,1165,BBN006.35560,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",77.0,1.0,Missing,M,40.5,6.0,3,AD,Ndgen.BandBIII,Moderate,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,2.0,Alzheimer's Disease,,,"Argyrophilic grain disease, moderate CAA","Chest infection, dementia, heart failure",N,N,,,N,1.0,,,,3.0,MAP,,,,1165,BBN006_35560,BBN006.35560,IGF128410,PFC,,BBN006_35560,BBN006-35560-FC,RNAseq
48,1.0,Bristol ,1/28/2021,1165,BBN006.35560,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",77.0,1.0,Missing,M,40.5,6.0,3,AD,Ndgen.BandBIII,Moderate,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,2.0,Alzheimer's Disease,,,"Argyrophilic grain disease, moderate CAA","Chest infection, dementia, heart failure",N,N,,,N,1.0,,,,3.0,MAP,,,,1165,BBN006_35560,BBN006.35560,IGF128439,PFC,,BBN006_35560,BBN006-35560-FC_1,ATACseq
49,1.0,Bristol ,1/28/2021,1165,BBN006.35560,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",77.0,1.0,Missing,M,40.5,6.0,3,AD,Ndgen.BandBIII,Moderate,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,2.0,Alzheimer's Disease,,,"Argyrophilic grain disease, moderate CAA","Chest infection, dementia, heart failure",N,N,,,N,1.0,,,,3.0,MAP,,,,1165,BBN006_35560,BBN006.35560,IGF125078,MTG,,BBN006_35560,BBN006-35560-MTG_1,ATACseq
50,1.0,Bristol ,1/28/2021,1165,BBN006.35560,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",77.0,1.0,Missing,M,40.5,6.0,3,AD,Ndgen.BandBIII,Moderate,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,2.0,Alzheimer's Disease,,,"Argyrophilic grain disease, moderate CAA","Chest infection, dementia, heart failure",N,N,,,N,1.0,,,,3.0,MAP,,,,1165,BBN006_35560,BBN006.35560,IGF125050,MTG,,BBN006_35560,BBN006-35560-MTG,RNAseq
51,1.0,Bristol ,1/28/2021,1190,BBN006.36102,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",75.0,1.0,Missing,M,46.5,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Minimal abnormalities (very mild primary age-related tauopathy (PART) and Alzheimer's disease changes; nothing significant to report to family),Multiple organ failure secondary to sepsis; Bacterial peritonitis; Cystectomy ,,,,,N,1.0,,,,3.0,MAP,,,,1190,BBN006_36102,BBN006.36102,IGF123504,MTEMP,,BBN006_36102,BBN006-36102-MTEMP,
52,1.0,Bristol ,1/28/2021,1190,BBN006.36102,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",75.0,1.0,Missing,M,46.5,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Minimal abnormalities (very mild primary age-related tauopathy (PART) and Alzheimer's disease changes; nothing significant to report to family),Multiple organ failure secondary to sepsis; Bacterial peritonitis; Cystectomy ,,,,,N,1.0,,,,3.0,MAP,,,,1190,BBN006_36102,BBN006.36102,IGF123521,PFC,,BBN006_36102,BBN006-36102-FC,
53,1.0,Bristol ,1/28/2021,1190,BBN006.36102,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",75.0,1.0,Missing,M,46.5,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Minimal abnormalities (very mild primary age-related tauopathy (PART) and Alzheimer's disease changes; nothing significant to report to family),Multiple organ failure secondary to sepsis; Bacterial peritonitis; Cystectomy ,,,,,N,1.0,,,,3.0,MAP,,,,1190,BBN006_36102,BBN006.36102,IGF128406,PFC,,BBN006_36102,BBN006-36102-FC,RNAseq
54,1.0,Bristol ,1/28/2021,1190,BBN006.36102,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",75.0,1.0,Missing,M,46.5,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Minimal abnormalities (very mild primary age-related tauopathy (PART) and Alzheimer's disease changes; nothing significant to report to family),Multiple organ failure secondary to sepsis; Bacterial peritonitis; Cystectomy ,,,,,N,1.0,,,,3.0,MAP,,,,1190,BBN006_36102,BBN006.36102,IGF128435,PFC,,BBN006_36102,BBN006-36102-FC_1,ATACseq
55,1.0,Bristol ,1/28/2021,1190,BBN006.36102,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",75.0,1.0,Missing,M,46.5,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Minimal abnormalities (very mild primary age-related tauopathy (PART) and Alzheimer's disease changes; nothing significant to report to family),Multiple organ failure secondary to sepsis; Bacterial peritonitis; Cystectomy ,,,,,N,1.0,,,,3.0,MAP,,,,1190,BBN006_36102,BBN006.36102,IGF125068,MTG,,BBN006_36102,BBN006-36102-MTG_1,ATACseq
56,1.0,Bristol ,1/28/2021,1190,BBN006.36102,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",75.0,1.0,Missing,M,46.5,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Minimal abnormalities (very mild primary age-related tauopathy (PART) and Alzheimer's disease changes; nothing significant to report to family),Multiple organ failure secondary to sepsis; Bacterial peritonitis; Cystectomy ,,,,,N,1.0,,,,3.0,MAP,,,,1190,BBN006_36102,BBN006.36102,IGF125040,MTG,,BBN006_36102,BBN006-36102-MTG,RNAseq
57,1.0,Bristol ,1/28/2021,1191,BBN006.36107,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",92.0,1.0,Missing,F,71,5.0,2,Control,Ndgen.BandBII,Control,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Minimal primary age-related tauopathy (PART)/Alzheimer's disease pathology (no significant abnormalities in report to family) ,"Community acquired pneumonia; Frailty of old age; Heart disease, diverticular disease and atrial fibrillation ",,,,,N,1.0,,,,3.0,MAP,,,,1191,BBN006_36107,BBN006.36107,IGF123519,MTEMP,,BBN006_36107,BBN006-36107-MTEMP,
58,1.0,Bristol ,1/28/2021,1191,BBN006.36107,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",92.0,1.0,Missing,F,71,5.0,2,Control,Ndgen.BandBII,Control,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Minimal primary age-related tauopathy (PART)/Alzheimer's disease pathology (no significant abnormalities in report to family) ,"Community acquired pneumonia; Frailty of old age; Heart disease, diverticular disease and atrial fibrillation ",,,,,N,1.0,,,,3.0,MAP,,,,1191,BBN006_36107,BBN006.36107,IGF123526,PFC,,BBN006_36107,BBN006-36107-FC,
59,1.0,Bristol ,1/28/2021,1191,BBN006.36107,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",92.0,1.0,Missing,F,71,5.0,2,Control,Ndgen.BandBII,Control,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Minimal primary age-related tauopathy (PART)/Alzheimer's disease pathology (no significant abnormalities in report to family) ,"Community acquired pneumonia; Frailty of old age; Heart disease, diverticular disease and atrial fibrillation ",,,,,N,1.0,,,,3.0,MAP,,,,1191,BBN006_36107,BBN006.36107,IGF128393,PFC,,BBN006_36107,BBN006-36107-FC,RNAseq
60,1.0,Bristol ,1/28/2021,1191,BBN006.36107,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",92.0,1.0,Missing,F,71,5.0,2,Control,Ndgen.BandBII,Control,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Minimal primary age-related tauopathy (PART)/Alzheimer's disease pathology (no significant abnormalities in report to family) ,"Community acquired pneumonia; Frailty of old age; Heart disease, diverticular disease and atrial fibrillation ",,,,,N,1.0,,,,3.0,MAP,,,,1191,BBN006_36107,BBN006.36107,IGF128422,PFC,,BBN006_36107,BBN006-36107-FC_1,ATACseq
61,1.0,Bristol ,1/28/2021,1191,BBN006.36107,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",92.0,1.0,Missing,F,71,5.0,2,Control,Ndgen.BandBII,Control,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Minimal primary age-related tauopathy (PART)/Alzheimer's disease pathology (no significant abnormalities in report to family) ,"Community acquired pneumonia; Frailty of old age; Heart disease, diverticular disease and atrial fibrillation ",,,,,N,1.0,,,,3.0,MAP,,,,1191,BBN006_36107,BBN006.36107,IGF125057,MTG,,BBN006_36107,BBN006-36107-MTG_1,ATACseq
62,1.0,Bristol ,1/28/2021,1191,BBN006.36107,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",92.0,1.0,Missing,F,71,5.0,2,Control,Ndgen.BandBII,Control,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Minimal primary age-related tauopathy (PART)/Alzheimer's disease pathology (no significant abnormalities in report to family) ,"Community acquired pneumonia; Frailty of old age; Heart disease, diverticular disease and atrial fibrillation ",,,,,N,1.0,,,,3.0,MAP,,,,1191,BBN006_36107,BBN006.36107,IGF125029,MTG,,BBN006_36107,BBN006-36107-MTG,RNAseq
63,1.0,Bristol ,1/28/2021,1194,BBN006.36170,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",87.0,1.0,Missing,F,29.5,5.0,2,Control,Ndgen.BandBII,Control,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Mild Alzheimer’s disease neuropathological changes,Pulmonary fibrosis,,,,,N,1.0,,,,3.0,MAP,,,,1194,BBN006_36170,BBN006.36170,IGF123538,PFC,,BBN006_36170,BBN006-36170-FC,
64,1.0,Bristol ,1/28/2021,1194,BBN006.36170,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",87.0,1.0,Missing,F,29.5,5.0,2,Control,Ndgen.BandBII,Control,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Mild Alzheimer’s disease neuropathological changes,Pulmonary fibrosis,,,,,N,1.0,,,,3.0,MAP,,,,1194,BBN006_36170,BBN006.36170,IGF123554,MTEMP,,BBN006_36170,BBN006-36170-MTEMP,
65,1.0,Bristol ,1/28/2021,1194,BBN006.36170,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",87.0,1.0,Missing,F,29.5,5.0,2,Control,Ndgen.BandBII,Control,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Mild Alzheimer’s disease neuropathological changes,Pulmonary fibrosis,,,,,N,1.0,,,,3.0,MAP,,,,1194,BBN006_36170,BBN006.36170,IGF128407,PFC,,BBN006_36170,BBN006-36170-FC,RNAseq
66,1.0,Bristol ,1/28/2021,1194,BBN006.36170,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",87.0,1.0,Missing,F,29.5,5.0,2,Control,Ndgen.BandBII,Control,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Mild Alzheimer’s disease neuropathological changes,Pulmonary fibrosis,,,,,N,1.0,,,,3.0,MAP,,,,1194,BBN006_36170,BBN006.36170,IGF128436,PFC,,BBN006_36170,BBN006-36170-FC_1,ATACseq
67,1.0,Bristol ,1/28/2021,1194,BBN006.36170,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",87.0,1.0,Missing,F,29.5,5.0,2,Control,Ndgen.BandBII,Control,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Mild Alzheimer’s disease neuropathological changes,Pulmonary fibrosis,,,,,N,1.0,,,,3.0,MAP,,,,1194,BBN006_36170,BBN006.36170,IGF125059,MTG,,BBN006_36170,BBN006-36170-MTG_1,ATACseq
68,1.0,Bristol ,1/28/2021,1194,BBN006.36170,2.0,2.0,10.0,8.0,"FROZEN: Frontal (BA9/BA46), Cingulate, EC, Putamen, Temporal, Trigone, Parietal, Calcarine. FFPE: Temporal, Frontal. 30 slides/region (22/Sep/22). ",87.0,1.0,Missing,F,29.5,5.0,2,Control,Ndgen.BandBII,Control,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,17.0,Ageing,,,Mild Alzheimer’s disease neuropathological changes,Pulmonary fibrosis,,,,,N,1.0,,,,3.0,MAP,,,,1194,BBN006_36170,BBN006.36170,IGF125031,MTG,,BBN006_36170,BBN006-36170-MTG,RNAseq
69,2.0,Newcastle,,19891053,BBN003.32184,,,,,"EC,MTEMP,SOM X",77.0,,,M,43,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19891053,BBN003_32184,BBN003.32184,IGF128092,MTG,GEN,BBN003_32184,BBN003-32184-MTG-NEG,RNAseq
70,2.0,Newcastle,,19910006,BBN003.32185,,,,,"EC,MTEMP,SOM ",67.0,,,F,8,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E4/E4,,Y,2.0,none,,,2.0,TREM2,,,,19910006,BBN003_32185,BBN003.32185,IGF128061,MTG,GEN,BBN003_32185,BBN003-32185-MTG-NEG,RNAseq
71,2.0,Newcastle,,19910006,BBN003.32185,,,,,"EC,MTEMP,SOM ",67.0,,,F,8,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E4/E4,,Y,2.0,none,,,2.0,TREM2,,,,19910006,BBN003_32185,BBN003.32185,IGF124025,SSC,GEN,BBN003_32185,BBN003-32185-SSC-ENR,RNAseq
72,2.0,Newcastle,,19910006,BBN003.32185,,,,,"EC,MTEMP,SOM ",67.0,,,F,8,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E4/E4,,Y,2.0,none,,,2.0,TREM2,,,,19910006,BBN003_32185,BBN003.32185,IGF124026,SSC,UNS,BBN003_32185,BBN003-32185-SSC-UNS,RNAseq
73,2.0,Newcastle,,19910334,BBN003.32196,,,,,"EC,MTEMP,SOM ",77.0,,,F,48,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3,,Y,2.0,none,,,2.0,TREM2,,,,19910334,BBN003_32196,BBN003.32196,IGF128064,MTG,GEN,BBN003_32196,BBN003-32196-MTG-NEG,RNAseq
74,2.0,Newcastle,,19910334,BBN003.32196,,,,,"EC,MTEMP,SOM ",77.0,,,F,48,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3,,Y,2.0,none,,,2.0,TREM2,,,,19910334,BBN003_32196,BBN003.32196,IGF124043,SSC,UNS,BBN003_32196,BBN003-32196-SSC-UNS,RNAseq
75,2.0,Newcastle,,19910334,BBN003.32196,,,,,"EC,MTEMP,SOM ",77.0,,,F,48,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3,,Y,2.0,none,,,2.0,TREM2,,,,19910334,BBN003_32196,BBN003.32196,IGF124044,SSC,GEN,BBN003_32196,BBN003-32196-SSC-ENR,RNAseq
76,2.0,Newcastle,,19920001,BBN_24610,,,,,"EC,MTEMP,SOM X",68.0,,,M,48,11.0,6,AD,Ndgen.BandBVI,Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19920001,BBN_24610,BBN_24610,IGF128090,MTG,GEN,BBN_24610,BBN-24610-MTG-NEG,RNAseq
77,2.0,Newcastle,,19920035,BBN003.32201,,,,,"EC,MTEMP,SOM ",79.0,,,F,24,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19920035,BBN003_32201,BBN003.32201,IGF124047,SSC,UNS,BBN003_32201,BBN003-32201-SSC-UNS,RNAseq
78,2.0,Newcastle,,19920035,BBN003.32201,,,,,"EC,MTEMP,SOM ",79.0,,,F,24,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19920035,BBN003_32201,BBN003.32201,IGF124048,SSC,GEN,BBN003_32201,BBN003-32201-SSC-ENR,RNAseq
79,2.0,Newcastle,,19920077,BBN003.32205,,,,,"EC,MTEMP,SOM ",76.0,,,M,30,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19920077,BBN003_32205,BBN003.32205,IGF128059,SSC,GEN,BBN003_32205,BBN003-32205-SSC-NEG,RNAseq
80,2.0,Newcastle,,19920077,BBN003.32205,,,,,"EC,MTEMP,SOM ",76.0,,,M,30,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19920077,BBN003_32205,BBN003.32205,IGF128070,MTG,GEN,BBN003_32205,BBN003-32205-MTG-NEG,RNAseq
81,2.0,Newcastle,,19920200,BBN003.32212,,,,,"EC,MTEMP,SOM ",64.0,,,M,10,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,prevously E3/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19920200,BBN003_32212,BBN003.32212,IGF128062,MTG,GEN,BBN003_32212,BBN003-32212-MTG-NEG,RNAseq
82,2.0,Newcastle,,19920200,BBN003.32212,,,,,"EC,MTEMP,SOM ",64.0,,,M,10,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,prevously E3/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19920200,BBN003_32212,BBN003.32212,IGF128077,SSC,GEN,BBN003_32212,BBN003-32212-SSC-NEG,RNAseq
83,2.0,Newcastle,,19930148,BBN003.32227,,,,,"EC,MTEMP,SOM ",66.0,,,M,41,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19930148,BBN003_32227,BBN003.32227,IGF128072,MTG,GEN,BBN003_32227,BBN003-32227-MTG-NEG,RNAseq
84,2.0,Newcastle,,19930154,BBN003.32228,,,,,"EC,MTEMP,SOM ",69.0,,,M,8,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19930154,BBN003_32228,BBN003.32228,IGF128073,MTG,GEN,BBN003_32228,BBN003-32228-MTG-NEG,RNAseq
85,2.0,Newcastle,,19930154,BBN003.32228,,,,,"EC,MTEMP,SOM ",69.0,,,M,8,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19930154,BBN003_32228,BBN003.32228,IGF124037,SSC,UNS,BBN003_32228,BBN003-32228-SSC-UNS,RNAseq
86,2.0,Newcastle,,19930154,BBN003.32228,,,,,"EC,MTEMP,SOM ",69.0,,,M,8,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19930154,BBN003_32228,BBN003.32228,IGF124038,SSC,GEN,BBN003_32228,BBN003-32228-SSC-ENR,RNAseq
87,2.0,Newcastle,,19930222,BBN003.32235,,,,,"EC,MTEMP,SOM ",67.0,,,M,48,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,previously E2/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19930222,BBN003_32235,BBN003.32235,IGF128068,MTG,GEN,BBN003_32235,BBN003-32235-MTG-NEG,RNAseq
88,2.0,Newcastle,,19930222,BBN003.32235,,,,,"EC,MTEMP,SOM ",67.0,,,M,48,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,previously E2/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19930222,BBN003_32235,BBN003.32235,IGF124049,SSC,UNS,BBN003_32235,BBN003-32235-SSC-UNS,RNAseq
89,2.0,Newcastle,,19930222,BBN003.32235,,,,,"EC,MTEMP,SOM ",67.0,,,M,48,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,previously E2/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19930222,BBN003_32235,BBN003.32235,IGF124050,SSC,GEN,BBN003_32235,BBN003-32235-SSC-ENR,RNAseq
90,2.0,Newcastle,,19960052,BBN003.26333,,,,,"EC,MTEMP,SOM ",88.0,,,F,9,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,19960052,BBN003_26333,BBN003.26333,IGF124053,SSC,UNS,BBN003_26333,BBN003-26333-SSC-UNS,RNAseq
91,2.0,Newcastle,,19960052,BBN003.26333,,,,,"EC,MTEMP,SOM ",88.0,,,F,9,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,19960052,BBN003_26333,BBN003.26333,IGF124054,SSC,GEN,BBN003_26333,BBN003-26333-SSC-ENR,RNAseq
92,2.0,Newcastle,,19980098,BBN003.32295,,,,,"EC,MTEMP,SOM ",75.0,,,F,27,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,19980098,BBN003_32295,BBN003.32295,IGF124029,SSC,UNS,BBN003_32295,BBN003-32295-SSC-UNS,RNAseq
93,2.0,Newcastle,,19980098,BBN003.32295,,,,,"EC,MTEMP,SOM ",75.0,,,F,27,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,19980098,BBN003_32295,BBN003.32295,IGF124030,SSC,GEN,BBN003_32295,BBN003-32295-SSC-ENR,RNAseq
94,2.0,Newcastle,,19980098,BBN003.32295,,,,,"EC,MTEMP,SOM ",75.0,,,F,27,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,19980098,BBN003_32295,BBN003.32295,IGF124051,MTG,GEN,BBN003_32295,BBN003-32295-MTG-ENR,RNAseq
95,2.0,Newcastle,,19980098,BBN003.32295,,,,,"EC,MTEMP,SOM ",75.0,,,F,27,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,19980098,BBN003_32295,BBN003.32295,IGF124052,MTG,UNS,BBN003_32295,BBN003-32295-MTG-UNS,RNAseq
96,2.0,Newcastle,,20050102,BBN_7115,,,,,"EC,MTEMP,SOM ",72.0,,,M,17,3.0,1,Control,Ndgen.BandBI,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20050102,BBN_7115,BBN_7115,IGF124061,MTG,UNS,BBN_7115,BBN-7115-MTG-UNS,RNAseq
97,2.0,Newcastle,,20050102,BBN_7115,,,,,"EC,MTEMP,SOM ",72.0,,,M,17,3.0,1,Control,Ndgen.BandBI,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20050102,BBN_7115,BBN_7115,IGF124062,MTG,GEN,BBN_7115,BBN-7115-MTG-ENR-,RNAseq
98,2.0,Newcastle,,20050102,BBN_7115,,,,,"EC,MTEMP,SOM ",72.0,,,M,17,3.0,1,Control,Ndgen.BandBI,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20050102,BBN_7115,BBN_7115,IGF124065,SSC,UNS,BBN_7115,BBN-7115-SSC-UNS,RNAseq
99,2.0,Newcastle,,20050102,BBN_7115,,,,,"EC,MTEMP,SOM ",72.0,,,M,17,3.0,1,Control,Ndgen.BandBI,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20050102,BBN_7115,BBN_7115,IGF124066,SSC,GEN,BBN_7115,BBN-7115-SSC-ENR,RNAseq
100,2.0,Newcastle,,20060093,BBN_7403,,,,,"EC,MTEMP,SOM ",78.0,,,F,23,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20060093,BBN_7403,BBN_7403,IGF124033,MTG,UNS,BBN_7403,BBN-7403-MTG-UNS,RNAseq
101,2.0,Newcastle,,20060093,BBN_7403,,,,,"EC,MTEMP,SOM ",78.0,,,F,23,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20060093,BBN_7403,BBN_7403,IGF124034,MTG,GEN,BBN_7403,BBN-7403-MTG-ENR,RNAseq
102,2.0,Newcastle,,20060093,BBN_7403,,,,,"EC,MTEMP,SOM ",78.0,,,F,23,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20060093,BBN_7403,BBN_7403,IGF124073,SSC,UNS,BBN_7403,BBN-7403-SSC-UNS,RNAseq
103,2.0,Newcastle,,20060093,BBN_7403,,,,,"EC,MTEMP,SOM ",78.0,,,F,23,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20060093,BBN_7403,BBN_7403,IGF124074,SSC,GEN,BBN_7403,BBN-7403-SSC-ENR,RNAseq
104,2.0,Newcastle,,20060099,BBN_7404,,,,,"EC,MTEMP,SOM ",89.0,,,F,24,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20060099,BBN_7404,BBN_7404,IGF124045,MTG,UNS,BBN_7404,BBN-7404-MTG-UNS,RNAseq
105,2.0,Newcastle,,20060099,BBN_7404,,,,,"EC,MTEMP,SOM ",89.0,,,F,24,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20060099,BBN_7404,BBN_7404,IGF124046,MTG,GEN,BBN_7404,BBN-7404-MTG-ENR,RNAseq
106,2.0,Newcastle,,20060099,BBN_7404,,,,,"EC,MTEMP,SOM ",89.0,,,F,24,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20060099,BBN_7404,BBN_7404,IGF124067,SSC,UNS,BBN_7404,BBN-7404-SSC-UNS,RNAseq
107,2.0,Newcastle,,20060099,BBN_7404,,,,,"EC,MTEMP,SOM ",89.0,,,F,24,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20060099,BBN_7404,BBN_7404,IGF124068,SSC,GEN,BBN_7404,BBN-7404-SSC-ENR,RNAseq
108,2.0,Newcastle,,20100742,BBN_7519,,,,,"EC,MTEMP,SOM ",67.0,,,M,22,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,,,,20100742,BBN_7519,BBN_7519,IGF128069,MTG,GEN,BBN_7519,BBN-7519-MTG-NEG,RNAseq
109,2.0,Newcastle,,20110137,BBN_7540,,,,,"EC,MTEMP,SOM ",75.0,,,F,33,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,20110137,BBN_7540,BBN_7540,IGF128058,SSC,GEN,BBN_7540,BBN-7540-SSC-NEG,RNAseq
110,2.0,Newcastle,,20110272,BBN_7545,,,,,"EC,MTEMP,SOM ",78.0,,,F,34,2.0,0,Control,Ndgen.BandB0,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20110272,BBN_7545,BBN_7545,IGF124041,SSC,UNS,BBN_7545,BBN-7545-SSC-UNS,RNAseq
111,2.0,Newcastle,,20110272,BBN_7545,,,,,"EC,MTEMP,SOM ",78.0,,,F,34,2.0,0,Control,Ndgen.BandB0,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20110272,BBN_7545,BBN_7545,IGF124042,SSC,GEN,BBN_7545,BBN-7545-SSC-ENR,RNAseq
112,2.0,Newcastle,,20110272,BBN_7545,,,,,"EC,MTEMP,SOM ",78.0,,,F,34,2.0,0,Control,Ndgen.BandB0,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20110272,BBN_7545,BBN_7545,IGF124057,MTG,UNS,BBN_7545,BBN-7545-MTG-UNS,RNAseq
113,2.0,Newcastle,,20110272,BBN_7545,,,,,"EC,MTEMP,SOM ",78.0,,,F,34,2.0,0,Control,Ndgen.BandB0,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20110272,BBN_7545,BBN_7545,IGF124058,MTG,GEN,BBN_7545,BBN-7545-MTG-ENR,RNAseq
114,2.0,Newcastle,,20110476,BBN_7554,,,,,"EC,MTEMP,SOM X",65.0,,,M,22,2.0,0,Control,Ndgen.BandB0,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,20110476,BBN_7554,BBN_7554,IGF128081,MTG,GEN,BBN_7554,BBN-7554-MTG-NEG,RNAseq
115,2.0,Newcastle,,20129990,BBN_7617,,,,,"EC,MTEMP,SOM ",78.0,,,F,40,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,20129990,BBN_7617,BBN_7617,IGF128419,MTG,GEN,BBN_7617,BBN-7617-MTG-ENR,RNAseq
116,2.0,Newcastle,,20129990,BBN_7617,,,,,"EC,MTEMP,SOM ",78.0,,,F,40,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,20129990,BBN_7617,BBN_7617,IGF124083,SSC,UNS,BBN_7617,BBN-7617-SSC-UNS,RNAseq
117,2.0,Newcastle,,20129990,BBN_7617,,,,,"EC,MTEMP,SOM ",78.0,,,F,40,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,20129990,BBN_7617,BBN_7617,IGF124084,SSC,GEN,BBN_7617,BBN-7617-SSC-ENR,RNAseq
118,2.0,Newcastle,,20130400,BBN_14801,,,,,"EC,MTEMP,SOM ",65.0,,,F,47,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20130400,BBN_14801,BBN_14801,IGF124063,SSC,UNS,BBN_14801,BBN-14801-SSC-UNS,RNAseq
119,2.0,Newcastle,,20130400,BBN_14801,,,,,"EC,MTEMP,SOM ",65.0,,,F,47,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20130400,BBN_14801,BBN_14801,IGF124064,SSC,GEN,BBN_14801,BBN-14801-SSC-ENR,RNAseq
120,2.0,Newcastle,,20130400,BBN_14801,,,,,"EC,MTEMP,SOM ",65.0,,,F,47,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20130400,BBN_14801,BBN_14801,IGF124069,MTG,UNS,BBN_14801,BBN-14801-MTG-UNS,RNAseq
121,2.0,Newcastle,,20130400,BBN_14801,,,,,"EC,MTEMP,SOM ",65.0,,,F,47,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20130400,BBN_14801,BBN_14801,IGF124070,MTG,GEN,BBN_14801,BBN-14801-MTG-ENR,RNAseq
122,2.0,Newcastle,,20131157,BBN_19214,,,,,"EC,MTEMP,SOM ",80.0,,,M,28,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20131157,BBN_19214,BBN_19214,IGF124071,MTG,UNS,BBN_19214,BBN-19214-MTG-UNS,RNAseq
123,2.0,Newcastle,,20131157,BBN_19214,,,,,"EC,MTEMP,SOM ",80.0,,,M,28,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20131157,BBN_19214,BBN_19214,IGF124072,MTG,GEN,BBN_19214,BBN-19214-MTG-ENR,RNAseq
124,2.0,Newcastle,,20131157,BBN_19214,,,,,"EC,MTEMP,SOM ",80.0,,,M,28,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20131157,BBN_19214,BBN_19214,IGF124079,SSC,UNS,BBN_19214,BBN-19214-SSC-UNS,RNAseq
125,2.0,Newcastle,,20131157,BBN_19214,,,,,"EC,MTEMP,SOM ",80.0,,,M,28,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20131157,BBN_19214,BBN_19214,IGF124080,SSC,GEN,BBN_19214,BBN-19214-SSC-ENR,RNAseq
126,2.0,Newcastle,,20141901,BBN_24279,,,,,"EC,MTEMP,SOM ",80.0,,,F,25,5.0,2,Control,Ndgen.BandBII,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20141901,BBN_24279,BBN_24279,IGF124039,MTG,UNS,BBN_24279,BBN-24279-MTG-UNS,RNAseq
127,2.0,Newcastle,,20141901,BBN_24279,,,,,"EC,MTEMP,SOM ",80.0,,,F,25,5.0,2,Control,Ndgen.BandBII,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20141901,BBN_24279,BBN_24279,IGF124040,MTG,GEN,BBN_24279,BBN-24279-MTG-ENR,RNAseq
128,2.0,Newcastle,,20141901,BBN_24279,,,,,"EC,MTEMP,SOM ",80.0,,,F,25,5.0,2,Control,Ndgen.BandBII,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20141901,BBN_24279,BBN_24279,IGF124059,SSC,UNS,BBN_24279,BBN-24279-SSC-UNS-,RNAseq
129,2.0,Newcastle,,20141901,BBN_24279,,,,,"EC,MTEMP,SOM ",80.0,,,F,25,5.0,2,Control,Ndgen.BandBII,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20141901,BBN_24279,BBN_24279,IGF124060,SSC,GEN,BBN_24279,BBN-24279-SSC-ENR,RNAseq
130,2.0,Newcastle,,20150712,BBN003.26941,,,,,"EC,MTEMP,SOM ",74.0,,,M,26,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E2/E3,,Y,2.0,none,,,2.0,TREM2,,,,20150712,BBN003_26941,BBN003.26941,IGF124035,SSC,GEN,BBN003_26941,BBN003-26941-SSC-ENR,RNAseq
131,2.0,Newcastle,,20150712,BBN003.26941,,,,,"EC,MTEMP,SOM ",74.0,,,M,26,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E2/E3,,Y,2.0,none,,,2.0,TREM2,,,,20150712,BBN003_26941,BBN003.26941,IGF124036,SSC,UNS,BBN003_26941,BBN003-26941-SSC-UNS,RNAseq
132,2.0,Newcastle,,20150975,BBN003.26951,,,,,"EC,MTEMP,SOM ",79.0,,,M,39,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20150975,BBN003_26951,BBN003.26951,IGF124077,SSC,UNS,BBN003_26951,BBN003-26951-SSC-UNS,RNAseq
133,2.0,Newcastle,,20150975,BBN003.26951,,,,,"EC,MTEMP,SOM ",79.0,,,M,39,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20150975,BBN003_26951,BBN003.26951,IGF124078,SSC,GEN,BBN003_26951,BBN003-26951--SSC-ENR,RNAseq
134,2.0,Newcastle,,20150975,BBN003.26951,,,,,"EC,MTEMP,SOM ",79.0,,,M,39,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20150975,BBN003_26951,BBN003.26951,IGF124087,MTG,GEN,BBN003_26951,BBN003-26951-MTG-ENR,RNAseq
135,2.0,Newcastle,,20150975,BBN003.26951,,,,,"EC,MTEMP,SOM ",79.0,,,M,39,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20150975,BBN003_26951,BBN003.26951,IGF124088,MTG,UNS,BBN003_26951,BBN003-26951-MTG-UNS,RNAseq
136,2.0,Newcastle,,20152915,BBN003.28342,,,,,"EC,MTEMP,SOM ",84.0,,,M,45,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20152915,BBN003_28342,BBN003.28342,IGF124031,MTG,UNS,BBN003_28342,BBN003-28342-MTG-UNS,RNAseq
137,2.0,Newcastle,,20152915,BBN003.28342,,,,,"EC,MTEMP,SOM ",84.0,,,M,45,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20152915,BBN003_28342,BBN003.28342,IGF124032,MTG,GEN,BBN003_28342,BBN003-28342-MTG-ENR,RNAseq
138,2.0,Newcastle,,20152915,BBN003.28342,,,,,"EC,MTEMP,SOM ",84.0,,,M,45,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20152915,BBN003_28342,BBN003.28342,IGF124055,SSC,GEN,BBN003_28342,BBN003-28342-SSC-ENR,RNAseq
139,2.0,Newcastle,,20152915,BBN003.28342,,,,,"EC,MTEMP,SOM ",84.0,,,M,45,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20152915,BBN003_28342,BBN003.28342,IGF124056,SSC,UNS,BBN003_28342,BBN003-28342-SSC-UNS,RNAseq
140,2.0,Newcastle,,20185910,BBN003.32849,,,,,"EC,MTEMP,SOM ",71.0,,,F,43,3.0,1,Control,Ndgen.BandBI,Control,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20185910,BBN003_32849,BBN003.32849,IGF124081,SSC,UNS,BBN003_32849,BBN003-32849-SSC-UNS,RNAseq
141,2.0,Newcastle,,20185910,BBN003.32849,,,,,"EC,MTEMP,SOM ",71.0,,,F,43,3.0,1,Control,Ndgen.BandBI,Control,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20185910,BBN003_32849,BBN003.32849,IGF124082,SSC,GEN,BBN003_32849,BBN003-32849-SSC-ENR,RNAseq
142,2.0,Newcastle,,20185935,BBN003.33729,,,,,"EC,MTEMP,SOM ",70.0,,,M,16,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,20185935,BBN003_33729,BBN003.33729,IGF128074,MTG,GEN,BBN003_33729,BBN003-33729-MTG-NEG,RNAseq
143,2.0,Newcastle,,20185935,BBN003.33729,,,,,"EC,MTEMP,SOM ",70.0,,,M,16,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,20185935,BBN003_33729,BBN003.33729,IGF124075,SSC,UNS,BBN003_33729,BBN003-33729-SSC-UNS,RNAseq
144,2.0,Newcastle,,20185935,BBN003.33729,,,,,"EC,MTEMP,SOM ",70.0,,,M,16,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,20185935,BBN003_33729,BBN003.33729,IGF124076,SSC,GEN,BBN003_33729,BBN003-33729-SSC-ENR,RNAseq
145,2.0,Newcastle,,20185945,BBN003.34161,,,,,"EC,MTEMP,SOM ",87.0,,,M,46,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20185945,BBN003_34161,BBN003.34161,IGF124027,MTG,UNS,BBN003_34161,BBN003-34161-MTG-UNS,RNAseq
146,2.0,Newcastle,,20185945,BBN003.34161,,,,,"EC,MTEMP,SOM ",87.0,,,M,46,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20185945,BBN003_34161,BBN003.34161,IGF124028,MTG,GEN,BBN003_34161,BBN003-34161-MTG-ENR,RNAseq
147,2.0,Newcastle,,20185945,BBN003.34161,,,,,"EC,MTEMP,SOM ",87.0,,,M,46,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20185945,BBN003_34161,BBN003.34161,IGF124085,SSC,UNS,BBN003_34161,BBN003-34161-SSC-UNS,RNAseq
148,2.0,Newcastle,,20185945,BBN003.34161,,,,,"EC,MTEMP,SOM ",87.0,,,M,46,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20185945,BBN003_34161,BBN003.34161,IGF124086,SSC,GEN,BBN003_34161,BBN003-34161-SSC-ENR,RNAseq
149,6.0,Kings,3/26/2019,A019/12,BBN_10611,,3.0,,3.0,"EC,MTEMP,SOM ",92.0,,,F,30,6.0,3,AD,Ndgen.BandBIII,Moderate,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,3/26/2019,frozen only,A019_12,BBN_10611,BBN_10611,IGF128079,SSC,GEN,BBN_10611,BBN-10611-SSC-NEG,RNAseq
150,6.0,Kings,3/26/2019,A019/12,BBN_10611,,3.0,,3.0,"EC,MTEMP,SOM ",92.0,,,F,30,6.0,3,AD,Ndgen.BandBIII,Moderate,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,3/26/2019,frozen only,A019_12,BBN_10611,BBN_10611,IGF128094,MTG,GEN,BBN_10611,BBN-10611MTG-NEG,RNAseq
151,6.0,Kings,3/26/2019,A051/14,BBN_21005,,,,,"EC,MTEMP,SOM ",76.0,,,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A051_14,BBN_21005,BBN_21005,IGF124732,MTG,,BBN_21005,BBN-21005-MTG,RNAseq
152,6.0,Kings,3/26/2019,A051/14,BBN_21005,,,,,"EC,MTEMP,SOM ",76.0,,,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A051_14,BBN_21005,BBN_21005,IGF128101,MTG,GEN,BBN_21005,BBN-21005-MTG-NEG,RNAseq
153,6.0,Kings,3/26/2019,A051/14,BBN_21005,,,,,"EC,MTEMP,SOM ",76.0,,,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A051_14,BBN_21005,BBN_21005,IGF128113,SSC,GEN,BBN_21005,BBN-21005-SSC-NEG,RNAseq
154,6.0,Kings,3/26/2019,A053/11,BBN_18399,,,,3.0,"EC,MTEMP,SOM ",77.0,,,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A053_11,BBN_18399,BBN_18399,IGF124733,MTG,,BBN_18399,BBN-18399-MTG,RNAseq
155,6.0,Kings,3/26/2019,A053/11,BBN_18399,,,,3.0,"EC,MTEMP,SOM ",77.0,,,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A053_11,BBN_18399,BBN_18399,IGF128097,MTG,GEN,BBN_18399,BBN-18399-MTG-NEG,RNAseq
156,6.0,Kings,8/25/2022,A053/11,BBN_18399,3.0,,3.0,2.0,"MTEMP, SOM",77.0,2.0,Unknown,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,metastatic prostate cancer,,,,High blood pressure,,,,,,,ABCA7/BIN1,,,,A053_11,BBN_18399,BBN_18399,IGF124733,MTG,,BBN_18399,BBN-18399-MTG,RNAseq
157,6.0,Kings,8/25/2022,A053/11,BBN_18399,3.0,,3.0,2.0,"MTEMP, SOM",77.0,2.0,Unknown,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,metastatic prostate cancer,,,,High blood pressure,,,,,,,ABCA7/BIN1,,,,A053_11,BBN_18399,BBN_18399,IGF128097,MTG,GEN,BBN_18399,BBN-18399-MTG-NEG,RNAseq
158,6.0,Kings,1/9/2020,A074/05*,BBN_9786,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",89.0,,,F,28,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A074_05,BBN_9786,BBN_9786,IGF128065,MTG,GEN,BBN_9786,BBN-9786-MTG-NEG,RNAseq
159,6.0,Kings,1/9/2020,A074/05*,BBN_9786,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",89.0,,,F,28,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A074_05,BBN_9786,BBN_9786,IGF128091,MTG,UNS,BBN_9786,BBN-9786-MTG-UNS,RNAseq
160,6.0,Kings,3/26/2019,A096/14,BBN_21792,,,,,"EC,MTEMP,SOM ",87.0,,,M,19,7.0,4,AD,Ndgen.BandBIV,Moderate,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A096_14,BBN_21792,BBN_21792,IGF128100,MTG,GEN,BBN_21792,BBN-21792-MTG-NEG,RNAseq
161,6.0,Kings,3/26/2019,A115/17,BBN002.30035,,,,3.0,"EC,MTEMP,SOM ",92.0,,,M,9,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A115_17,BBN002_30035,BBN002.30035,IGF124734,MTG,,BBN002_30035,BBN002-30035-MTG,RNAseq
162,6.0,Kings,3/26/2019,A115/17,BBN002.30035,,,,3.0,"EC,MTEMP,SOM ",92.0,,,M,9,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A115_17,BBN002_30035,BBN002.30035,IGF128104,MTG,GEN,BBN002_30035,BBN002-30035-MTG-NEG,RNAseq
163,6.0,Kings,3/26/2019,A115/17,BBN002.30035,,,,3.0,"EC,MTEMP,SOM ",92.0,,,M,9,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A115_17,BBN002_30035,BBN002.30035,IGF128109,SSC,GEN,BBN002_30035,BBN002-30035-SSC-NEG,RNAseq
164,6.0,Kings,3/26/2019,A127/11,BBN_16213,,,,3.0,"EC,MTEMP,SOM ",73.0,,,M,23,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A127_11,BBN_16213,BBN_16213,IGF124735,MTG,,BBN_16213,BBN-16213-MTG,RNAseq
165,6.0,Kings,3/26/2019,A127/11,BBN_16213,,,,3.0,"EC,MTEMP,SOM ",73.0,,,M,23,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A127_11,BBN_16213,BBN_16213,IGF128105,MTG,GEN,BBN_16213,BBN-16213-MTG-NEG,RNAseq
166,6.0,Kings,3/26/2019,A163/17,BBN002.30127,,,,,"EC,MTEMP,SOM ",83.0,,,M,19.5,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A163_17,BBN002_30127,BBN002.30127,IGF128114,MTG,GEN,BBN002_30127,BBN002-30127-MTG-NEG,RNAseq
167,6.0,Kings,3/26/2019,A169/10,BBN_9939,,,,2.0,"EC,SOM",85.0,,,F,10,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 2 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A169_10,BBN_9939,BBN_9939,IGF128088,MTG,GEN,BBN_9939,BBN-9939-MTG-NEG,RNAseq
168,6.0,Kings,3/26/2019,A169/10,BBN_9939,,,,2.0,"EC,SOM",85.0,,,F,10,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 2 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A169_10,BBN_9939,BBN_9939,IGF128089,MTG,UNS,BBN_9939,BBN-9939-MTG-UNS,RNAseq
169,6.0,Kings,3/26/2019,A170/13,BBN_18813,,,,3.0,"EC,MTEMP,SOM ",85.0,,,F,23,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A170_13,BBN_18813,BBN_18813,IGF128078,SSC,GEN,BBN_18813,BBN-18813-SSC-NEG,RNAseq
170,6.0,Kings,3/26/2019,A170/13,BBN_18813,,,,3.0,"EC,MTEMP,SOM ",85.0,,,F,23,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A170_13,BBN_18813,BBN_18813,IGF128111,MTG,GEN,BBN_18813,BBN-18813-MTG-NEG,RNAseq
171,6.0,Kings,1/9/2020,A210/05*,BBN_9796,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",84.0,,,F,24,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A210_05,BBN_9796,BBN_9796,IGF128076,MTG,GEN,BBN_9796,BBN-9796-MTG-NEG,RNAseq
172,6.0,Kings,1/9/2020,A253/12,BBN_9980,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",83.0,,,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,"MAP tissue in E166, ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22",,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A253_12,BBN_9980,BBN_9980,IGF123510,MTEMP,,BBN_9980,BBN-9980-MTEMP,
173,6.0,Kings,1/9/2020,A253/12,BBN_9980,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",83.0,,,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,"MAP tissue in E166, ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22",,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A253_12,BBN_9980,BBN_9980,IGF123516,PFC,,BBN_9980,BBN-9980-FC,
174,6.0,Kings,1/9/2020,A253/12,BBN_9980,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",83.0,,,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,"MAP tissue in E166, ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22",,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A253_12,BBN_9980,BBN_9980,IGF125056,MTG,,BBN_9980,BBN-9980-MTG_1,ATACseq
175,6.0,Kings,1/9/2020,A253/12,BBN_9980,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",83.0,,,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,"MAP tissue in E166, ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22",,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A253_12,BBN_9980,BBN_9980,IGF125062,PFC,,BBN_9980,BBN-9980-FC_1,ATACseq
176,6.0,Kings,1/9/2020,A253/12,BBN_9980,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",83.0,,,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,"MAP tissue in E166, ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22",,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A253_12,BBN_9980,BBN_9980,IGF125028,MTG,,BBN_9980,BBN-9980-MTG,RNAseq
177,6.0,Kings,1/9/2020,A253/12,BBN_9980,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",83.0,,,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,"MAP tissue in E166, ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22",,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A253_12,BBN_9980,BBN_9980,IGF125034,PFC,,BBN_9980,BBN-9980-FC,RNAseq
178,6.0,Kings,10/21/2021,A253/12,BBN_9980,2.0,2.0,10.0,8.0,"FROZEN: Frontal, Cingulate, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",83.0,2.0,Unknown,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Alzheimer's Disease,,,,TREM2 tissue in E81,,N,,,,,3.0,MAP,TREM2,,,A253_12,BBN_9980,BBN_9980,IGF123510,MTEMP,,BBN_9980,BBN-9980-MTEMP,
179,6.0,Kings,10/21/2021,A253/12,BBN_9980,2.0,2.0,10.0,8.0,"FROZEN: Frontal, Cingulate, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",83.0,2.0,Unknown,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Alzheimer's Disease,,,,TREM2 tissue in E81,,N,,,,,3.0,MAP,TREM2,,,A253_12,BBN_9980,BBN_9980,IGF123516,PFC,,BBN_9980,BBN-9980-FC,
180,6.0,Kings,10/21/2021,A253/12,BBN_9980,2.0,2.0,10.0,8.0,"FROZEN: Frontal, Cingulate, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",83.0,2.0,Unknown,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Alzheimer's Disease,,,,TREM2 tissue in E81,,N,,,,,3.0,MAP,TREM2,,,A253_12,BBN_9980,BBN_9980,IGF125056,MTG,,BBN_9980,BBN-9980-MTG_1,ATACseq
181,6.0,Kings,10/21/2021,A253/12,BBN_9980,2.0,2.0,10.0,8.0,"FROZEN: Frontal, Cingulate, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",83.0,2.0,Unknown,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Alzheimer's Disease,,,,TREM2 tissue in E81,,N,,,,,3.0,MAP,TREM2,,,A253_12,BBN_9980,BBN_9980,IGF125062,PFC,,BBN_9980,BBN-9980-FC_1,ATACseq
182,6.0,Kings,10/21/2021,A253/12,BBN_9980,2.0,2.0,10.0,8.0,"FROZEN: Frontal, Cingulate, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",83.0,2.0,Unknown,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Alzheimer's Disease,,,,TREM2 tissue in E81,,N,,,,,3.0,MAP,TREM2,,,A253_12,BBN_9980,BBN_9980,IGF125028,MTG,,BBN_9980,BBN-9980-MTG,RNAseq
183,6.0,Kings,10/21/2021,A253/12,BBN_9980,2.0,2.0,10.0,8.0,"FROZEN: Frontal, Cingulate, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",83.0,2.0,Unknown,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Alzheimer's Disease,,,,TREM2 tissue in E81,,N,,,,,3.0,MAP,TREM2,,,A253_12,BBN_9980,BBN_9980,IGF125034,PFC,,BBN_9980,BBN-9980-FC,RNAseq
184,6.0,Kings,3/26/2019,A272/15,BBN002.26094,,,,,"EC,MTEMP,SOM ",90.0,,,F,10,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A272_15,BBN002_26094,BBN002.26094,IGF128083,MTG,GEN,BBN002_26094,BBN002-26094-MTG-NEG,RNAseq
185,6.0,Kings,3/26/2019,A272/15,BBN002.26094,,,,,"EC,MTEMP,SOM ",90.0,,,F,10,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A272_15,BBN002_26094,BBN002.26094,IGF128087,SSC,GEN,BBN002_26094,BBN002-26094-SSC-NEG,RNAseq
186,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF124270,MTEMP,,BBN_9984,BBN-9984-MTEMP,
187,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF123497,PFC,,BBN_9984,BBN-9984-FC,
188,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF123505,MTEMP,,BBN_9984,BBN-9984-MTEMP,
189,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF128400,PFC,,BBN_9984,BBN-9984-FC,RNAseq
190,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF128415,EC,,BBN_9984,BBN-9984-EC,RNAseq
191,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF128429,PFC,,BBN_9984,BBN-9984-FC_1,ATACseq
192,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF128444,EC,,BBN_9984,BBN-9984-EC_1,ATACseq
193,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF125058,MTG,,BBN_9984,BBN-9984-MTG_1,ATACseq
194,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF125030,MTG,,BBN_9984,BBN-9984-MTG,RNAseq
195,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF128107,MTG,GEN,BBN_9984,BBN-9984-MTG-NEG,RNAseq
196,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF124270,MTEMP,,BBN_9984,BBN-9984-MTEMP,
197,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF123497,PFC,,BBN_9984,BBN-9984-FC,
198,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF123505,MTEMP,,BBN_9984,BBN-9984-MTEMP,
199,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF128400,PFC,,BBN_9984,BBN-9984-FC,RNAseq
200,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF128415,EC,,BBN_9984,BBN-9984-EC,RNAseq
201,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF128429,PFC,,BBN_9984,BBN-9984-FC_1,ATACseq
202,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF128444,EC,,BBN_9984,BBN-9984-EC_1,ATACseq
203,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF125058,MTG,,BBN_9984,BBN-9984-MTG_1,ATACseq
204,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF125030,MTG,,BBN_9984,BBN-9984-MTG,RNAseq
205,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF128107,MTG,GEN,BBN_9984,BBN-9984-MTG-NEG,RNAseq
206,6.0,Kings,3/26/2019,A282/14,BBN_24370,,3.0,,3.0,"EC,MTEMP,SOM ",68.0,,,F,53,6.0,3,AD,Ndgen.BandBIII,Moderate,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A282_14,BBN_24370,BBN_24370,IGF128084,MTG,GEN,BBN_24370,BBN-24370-MTG-NEG,RNAseq
207,6.0,Kings,3/26/2019,A297/16,BBN002.29089,,,,3.0,"EC,MTEMP,SOM ",81.0,,,M,10,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A297_16,BBN002_29089,BBN002.29089,IGF124736,MTG,,BBN002_29089,BBN002-29089-MTG,RNAseq
208,6.0,Kings,3/26/2019,A297/16,BBN002.29089,,,,3.0,"EC,MTEMP,SOM ",81.0,,,M,10,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A297_16,BBN002_29089,BBN002.29089,IGF128106,MTG,GEN,BBN002_29089,BBN002-29089-MTG-NEG,RNAseq
209,6.0,Kings,3/26/2019,A354/16,BBN002.29170,,,,3.0,"EC,MTEMP,SOM ",92.0,,,F,12,5.0,2,Control,Ndgen.BandBII,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A354_16,BBN002_29170,BBN002.29170,IGF124737,MTG,,BBN002_29170,BBN002-29170-MTG,RNAseq
210,6.0,Kings,3/26/2019,A354/16,BBN002.29170,,,,3.0,"EC,MTEMP,SOM ",92.0,,,F,12,5.0,2,Control,Ndgen.BandBII,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A354_16,BBN002_29170,BBN002.29170,IGF128082,SSC,GEN,BBN002_29170,BBN002-29170-SSC-NEG,RNAseq
211,6.0,Kings,3/26/2019,A354/16,BBN002.29170,,,,3.0,"EC,MTEMP,SOM ",92.0,,,F,12,5.0,2,Control,Ndgen.BandBII,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A354_16,BBN002_29170,BBN002.29170,IGF128102,MTG,GEN,BBN002_29170,BBN002-29170-MTG-NEG,RNAseq
212,6.0,Kings,3/26/2019,A402/14,BBN_24578,,3.0,,3.0,"EC,MTEMP,SOM ",83.0,,,M,10,6.0,3,AD,Ndgen.BandBIII,Moderate,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,4.0,2.0,Ndgen.CERAD2,Moderate,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A402_14,BBN_24578,BBN_24578,IGF128108,MTG,GEN,BBN_24578,BBN-24578-MTG-NEG,RNAseq
213,7.0,Bristol,,B509/962,BBN_24330,,,,,"EC,MTEMP,SOM ent, sensmot, mt",80.0,,,F,14.5,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,4.0,2.0,Ndgen.CERAD2,Moderate,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,B509_962,BBN_24330,BBN_24330,IGF128060,MTG,GEN,BBN_24330,BBN-24330-MTG-NEG,RNAseq
214,7.0,Bristol,,B509/962,BBN_24330,,,,,"EC,MTEMP,SOM ent, sensmot, mt",80.0,,,F,14.5,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,4.0,2.0,Ndgen.CERAD2,Moderate,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,B509_962,BBN_24330,BBN_24330,IGF128085,SSC,GEN,BBN_24330,BBN-24330-SSC-NEG,RNAseq
215,7.0,Bristol,,B509/962,BBN_24330,,,,,"EC,MTEMP,SOM ent, sensmot, mt",80.0,,,F,14.5,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,4.0,2.0,Ndgen.CERAD2,Moderate,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,B509_962,BBN_24330,BBN_24330,IGF128086,SSC,UNS,BBN_24330,BBN-24330-SSC-UNS,RNAseq
216,3.0,QSBB (UCL),,C19/93,BBN_11449,,,,,"MTEMP Hippo, mid temp, motor",82.0,,,M,33,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,C19_93,BBN_11449,BBN_11449,IGF128071,MTG,GEN,BBN_11449,BBN-11449-MTG-NEG,RNAseq
217,8.0,Manchester,,DPM16/44,BBN005.29520,3.0,3.0,3.0,3.0,"EC,MTEMP,SOM ent, sensmot, mt",94.0,3.0,White,M,36.5,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions and 30 FFPE slides/region arrived on 25/08/22.,,Y,8.0,R62H,rs143332484,,2.0,TREM2,ABCA7/BIN1,,,DPM16_44,BBN005_29520,BBN005.29520,IGF128093,SSC,GEN,BBN005_29520,BBN005-29520-SSC-NEG,RNAseq
218,4.0,Oxford ,,NP14/128 , BBN_24659,,,,,MTEMP 13,61.0,,,F,23,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E3/E4,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,NP14_128,BBN_24659, BBN_24659,IGF128067,MTG,GEN,BBN_24659,BBN-24659-MTG-NEG,RNAseq
219,4.0,Oxford ,,NP16/088 , BBN004.29074,,,,,MTEMP 14,75.0,,,F,46,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,NP16_088,BBN004_29074, BBN004.29074,IGF128075,MTG,GEN,BBN004_29074,BBN004-29074-MTG-NEG,RNAseq
220,4.0,Oxford ,,NP17/023 , BBN004.29828,,,,,MTEMP 14,86.0,,,M,27,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,4.0,2.0,Ndgen.CERAD2,Moderate,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,NP17_023,BBN004_29828, BBN004.29828,IGF128066,MTG,GEN,BBN004_29828,BBN004-29828-MTG-NEG,RNAseq
221,3.0,QSBB (UCL),,P3/09,BBN_8051,,,,,"MTEMP Hippo, mid temp, motor",64.0,,,M,36.15,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,P3_09,BBN_8051,BBN_8051,IGF128095,MTG,GEN,BBN_8051,BBN-8051-MTG-NEG,RNAseq
222,9.0,Imperial,,PDC016,BBN_10099,,,,,"EC,MTEMP,SOM ",93.0,2.0,Unknown,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,"Ageing related changes. This case shows substantial calcification of the pallidus, internal capsule and anterior commissure involving both the vessel wall and parenchyma",Bronchial neumonia,,,,,Y,2.0,none,,,2.0,TREM2,,,,PDC016,BBN_10099,BBN_10099,IGF128103,MTG,GEN,BBN_10099,BBN-10099-MTG-NEG,RNAseq
223,12.0,McGill,6/17/2021,RSMG1,RSMG1,,,1.0,1.0,Cortex,39.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG1,RSMG1,RSMG1,IGF119489,,,RSMG1,RSMG1-2,
224,12.0,McGill,6/17/2021,RSMG1,RSMG1,,,1.0,1.0,Cortex,39.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG1,RSMG1,RSMG1,IGF119490,,,RSMG1,RSMG1-3,
225,12.0,McGill,6/17/2021,RSMG1,RSMG1,,,1.0,1.0,Cortex,39.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG1,RSMG1,RSMG1,IGF119491,,,RSMG1,RSMG1-5,
226,12.0,McGill,6/17/2021,RSMG1,RSMG1,,,1.0,1.0,Cortex,39.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG1,RSMG1,RSMG1,IGF119494,,,RSMG1,RSMG1-6,
227,12.0,McGill,6/17/2021,RSMG1,RSMG1,,,1.0,1.0,Cortex,39.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG1,RSMG1,RSMG1,IGF119492,,,RSMG1,RSMG1-1,
228,12.0,McGill,6/17/2021,RSMG1,RSMG1,,,1.0,1.0,Cortex,39.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG1,RSMG1,RSMG1,IGF119493,,,RSMG1,RSMG1-4,
229,12.0,McGill,6/17/2021,RSMG10,RSMG10,,,1.0,1.0,Parietal-occipital cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG10,RSMG10,RSMG10,IGF119544,,,RSMG10,RSMG10-2,
230,12.0,McGill,6/17/2021,RSMG10,RSMG10,,,1.0,1.0,Parietal-occipital cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG10,RSMG10,RSMG10,IGF119545,,,RSMG10,RSMG10-5,
231,12.0,McGill,6/17/2021,RSMG10,RSMG10,,,1.0,1.0,Parietal-occipital cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG10,RSMG10,RSMG10,IGF119546,,,RSMG10,RSMG10-1,
232,12.0,McGill,6/17/2021,RSMG10,RSMG10,,,1.0,1.0,Parietal-occipital cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG10,RSMG10,RSMG10,IGF119547,,,RSMG10,RSMG10-3,
233,12.0,McGill,6/17/2021,RSMG10,RSMG10,,,1.0,1.0,Parietal-occipital cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG10,RSMG10,RSMG10,IGF119548,,,RSMG10,RSMG10-4,
234,12.0,McGill,6/17/2021,RSMG10,RSMG10,,,1.0,1.0,Parietal-occipital cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG10,RSMG10,RSMG10,IGF119549,,,RSMG10,RSMG10-6,
235,12.0,McGill,6/17/2021,RSMG11,RSMG11,,,1.0,1.0,Frontal cortex,54.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG11,RSMG11,RSMG11,IGF119550,,,RSMG11,RSMG11-2,
236,12.0,McGill,6/17/2021,RSMG11,RSMG11,,,1.0,1.0,Frontal cortex,54.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG11,RSMG11,RSMG11,IGF119551,,,RSMG11,RSMG11-5,
237,12.0,McGill,6/17/2021,RSMG11,RSMG11,,,1.0,1.0,Frontal cortex,54.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG11,RSMG11,RSMG11,IGF119552,,,RSMG11,RSMG11-1,
238,12.0,McGill,6/17/2021,RSMG11,RSMG11,,,1.0,1.0,Frontal cortex,54.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG11,RSMG11,RSMG11,IGF119553,,,RSMG11,RSMG11-3,
239,12.0,McGill,6/17/2021,RSMG11,RSMG11,,,1.0,1.0,Frontal cortex,54.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG11,RSMG11,RSMG11,IGF119554,,,RSMG11,RSMG11-4,
240,12.0,McGill,6/17/2021,RSMG11,RSMG11,,,1.0,1.0,Frontal cortex,54.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG11,RSMG11,RSMG11,IGF119555,,,RSMG11,RSMG11-6,
241,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF128418,,,RSMG12,RSMG12-4,RNAseq
242,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF119556,,,RSMG12,RSMG12-2,
243,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF119557,,,RSMG12,RSMG12-4,
244,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF119559,,,RSMG12,RSMG12-3,
245,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF119560,,,RSMG12,RSMG12-5,
246,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF119561,,,RSMG12,RSMG12-6,
247,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF119562,,,RSMG12,RSMG12-7,
248,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF119563,,,RSMG12,RSMG12-8,
249,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF119566,,,RSMG12,RSMG12-1,
250,12.0,McGill,6/17/2021,RSMG13,RSMG13,,,1.0,1.0,Frontal-temporal cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG13,RSMG13,RSMG13,IGF119558,,,RSMG13,RSMG13-5,
251,12.0,McGill,6/17/2021,RSMG13,RSMG13,,,1.0,1.0,Frontal-temporal cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG13,RSMG13,RSMG13,IGF119564,,,RSMG13,RSMG13-2,
252,12.0,McGill,6/17/2021,RSMG13,RSMG13,,,1.0,1.0,Frontal-temporal cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG13,RSMG13,RSMG13,IGF119565,,,RSMG13,RSMG13-3,
253,12.0,McGill,6/17/2021,RSMG13,RSMG13,,,1.0,1.0,Frontal-temporal cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG13,RSMG13,RSMG13,IGF119567,,,RSMG13,RSMG13-1,
254,12.0,McGill,6/17/2021,RSMG13,RSMG13,,,1.0,1.0,Frontal-temporal cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG13,RSMG13,RSMG13,IGF119568,,,RSMG13,RSMG13-4,
255,12.0,McGill,6/17/2021,RSMG13,RSMG13,,,1.0,1.0,Frontal-temporal cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG13,RSMG13,RSMG13,IGF119569,,,RSMG13,RSMG13-6,
256,12.0,McGill,6/17/2021,RSMG14,RSMG14,,,1.0,1.0,Frontal-temporal cortex,42.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG14,RSMG14,RSMG14,IGF119575,,,RSMG14,RSMG14-5,
257,12.0,McGill,6/17/2021,RSMG14,RSMG14,,,1.0,1.0,Frontal-temporal cortex,42.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG14,RSMG14,RSMG14,IGF119570,,,RSMG14,RSMG14-2,
258,12.0,McGill,6/17/2021,RSMG14,RSMG14,,,1.0,1.0,Frontal-temporal cortex,42.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG14,RSMG14,RSMG14,IGF119571,,,RSMG14,RSMG14-4,
259,12.0,McGill,6/17/2021,RSMG14,RSMG14,,,1.0,1.0,Frontal-temporal cortex,42.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG14,RSMG14,RSMG14,IGF119572,,,RSMG14,RSMG14-6,
260,12.0,McGill,6/17/2021,RSMG14,RSMG14,,,1.0,1.0,Frontal-temporal cortex,42.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG14,RSMG14,RSMG14,IGF119573,,,RSMG14,RSMG14-1,
261,12.0,McGill,6/17/2021,RSMG14,RSMG14,,,1.0,1.0,Frontal-temporal cortex,42.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG14,RSMG14,RSMG14,IGF119574,,,RSMG14,RSMG14-3,
262,12.0,McGill,6/17/2021,RSMG14,RSMG14,,,1.0,1.0,Frontal-temporal cortex,42.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG14,RSMG14,RSMG14,IGF119576,,,RSMG14,RSMG14-7,
263,12.0,McGill,6/17/2021,RSMG14,RSMG14,,,1.0,1.0,Frontal-temporal cortex,42.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG14,RSMG14,RSMG14,IGF119577,,,RSMG14,RSMG14-8,
264,12.0,McGill,6/17/2021,RSMG15,RSMG15,,,1.0,1.0,Frontal-parietal cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG15,RSMG15,RSMG15,IGF119585,,,RSMG15,RSMG15-4,
265,12.0,McGill,6/17/2021,RSMG15,RSMG15,,,1.0,1.0,Frontal-parietal cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG15,RSMG15,RSMG15,IGF119579,,,RSMG15,RSMG15-6,
266,12.0,McGill,6/17/2021,RSMG15,RSMG15,,,1.0,1.0,Frontal-parietal cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG15,RSMG15,RSMG15,IGF119578,,,RSMG15,RSMG15-2,
267,12.0,McGill,6/17/2021,RSMG15,RSMG15,,,1.0,1.0,Frontal-parietal cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG15,RSMG15,RSMG15,IGF119580,,,RSMG15,RSMG15-1,
268,12.0,McGill,6/17/2021,RSMG15,RSMG15,,,1.0,1.0,Frontal-parietal cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG15,RSMG15,RSMG15,IGF119581,,,RSMG15,RSMG15-3,
269,12.0,McGill,6/17/2021,RSMG15,RSMG15,,,1.0,1.0,Frontal-parietal cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG15,RSMG15,RSMG15,IGF119582,,,RSMG15,RSMG15-5,
270,12.0,McGill,6/17/2021,RSMG15,RSMG15,,,1.0,1.0,Frontal-parietal cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG15,RSMG15,RSMG15,IGF119583,,,RSMG15,RSMG15-7,
271,12.0,McGill,6/17/2021,RSMG16,RSMG16,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG16,RSMG16,RSMG16,IGF119586,,,RSMG16,RSMG16-4,
272,12.0,McGill,6/17/2021,RSMG16,RSMG16,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG16,RSMG16,RSMG16,IGF119587,,,RSMG16,RSMG16-6,
273,12.0,McGill,6/17/2021,RSMG16,RSMG16,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG16,RSMG16,RSMG16,IGF119588,,,RSMG16,RSMG16-1,
274,12.0,McGill,6/17/2021,RSMG16,RSMG16,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG16,RSMG16,RSMG16,IGF119589,,,RSMG16,RSMG16-3,
275,12.0,McGill,6/17/2021,RSMG16,RSMG16,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG16,RSMG16,RSMG16,IGF119590,,,RSMG16,RSMG16-5,
276,12.0,McGill,6/17/2021,RSMG16,RSMG16,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG16,RSMG16,RSMG16,IGF119591,,,RSMG16,RSMG16-7,
277,12.0,McGill,6/17/2021,RSMG16,RSMG16,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG16,RSMG16,RSMG16,IGF119584,,,RSMG16,RSMG16-2,
278,12.0,McGill,6/17/2021,RSMG17,RSMG17,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG17,RSMG17,RSMG17,IGF119592,,,RSMG17,RSMG17-2,
279,12.0,McGill,6/17/2021,RSMG17,RSMG17,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG17,RSMG17,RSMG17,IGF119593,,,RSMG17,RSMG17-4,
280,12.0,McGill,6/17/2021,RSMG17,RSMG17,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG17,RSMG17,RSMG17,IGF119594,,,RSMG17,RSMG17-6,
281,12.0,McGill,6/17/2021,RSMG17,RSMG17,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG17,RSMG17,RSMG17,IGF119595,,,RSMG17,RSMG17-1,
282,12.0,McGill,6/17/2021,RSMG17,RSMG17,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG17,RSMG17,RSMG17,IGF119596,,,RSMG17,RSMG17-3,
283,12.0,McGill,6/17/2021,RSMG17,RSMG17,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG17,RSMG17,RSMG17,IGF119597,,,RSMG17,RSMG17-5,
284,12.0,McGill,6/17/2021,RSMG17,RSMG17,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG17,RSMG17,RSMG17,IGF119598,,,RSMG17,RSMG17-7,
285,12.0,McGill,6/17/2021,RSMG2,RSMG2,,,1.0,1.0,Cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG2,RSMG2,RSMG2,IGF119496,,,RSMG2,RSMG2-3,
286,12.0,McGill,6/17/2021,RSMG2,RSMG2,,,1.0,1.0,Cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG2,RSMG2,RSMG2,IGF119495,,,RSMG2,RSMG2-2,
287,12.0,McGill,6/17/2021,RSMG2,RSMG2,,,1.0,1.0,Cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG2,RSMG2,RSMG2,IGF119497,,,RSMG2,RSMG2-5,
288,12.0,McGill,6/17/2021,RSMG2,RSMG2,,,1.0,1.0,Cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG2,RSMG2,RSMG2,IGF119498,,,RSMG2,RSMG2-1,
289,12.0,McGill,6/17/2021,RSMG2,RSMG2,,,1.0,1.0,Cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG2,RSMG2,RSMG2,IGF119499,,,RSMG2,RSMG2-4,
290,12.0,McGill,6/17/2021,RSMG2,RSMG2,,,1.0,1.0,Cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG2,RSMG2,RSMG2,IGF119500,,,RSMG2,RSMG2-6,
291,12.0,McGill,6/17/2021,RSMG3,RSMG3,,,1.0,1.0,Occipital cortex,55.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG3,RSMG3,RSMG3,IGF119504,,,RSMG3,RSMG3-1,
292,12.0,McGill,6/17/2021,RSMG3,RSMG3,,,1.0,1.0,Occipital cortex,55.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG3,RSMG3,RSMG3,IGF119501,,,RSMG3,RSMG3-2,
293,12.0,McGill,6/17/2021,RSMG3,RSMG3,,,1.0,1.0,Occipital cortex,55.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG3,RSMG3,RSMG3,IGF119502,,,RSMG3,RSMG3-3,
294,12.0,McGill,6/17/2021,RSMG3,RSMG3,,,1.0,1.0,Occipital cortex,55.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG3,RSMG3,RSMG3,IGF119503,,,RSMG3,RSMG3-5,
295,12.0,McGill,6/17/2021,RSMG3,RSMG3,,,1.0,1.0,Occipital cortex,55.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG3,RSMG3,RSMG3,IGF119505,,,RSMG3,RSMG3-4,
296,12.0,McGill,6/17/2021,RSMG3,RSMG3,,,1.0,1.0,Occipital cortex,55.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG3,RSMG3,RSMG3,IGF119506,,,RSMG3,RSMG3-6,
297,12.0,McGill,6/17/2021,RSMG4,RSMG4,,,1.0,1.0,Parietal-occipital cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG4,RSMG4,RSMG4,IGF119512,,,RSMG4,RSMG4-5,
298,12.0,McGill,6/17/2021,RSMG4,RSMG4,,,1.0,1.0,Parietal-occipital cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG4,RSMG4,RSMG4,IGF119507,,,RSMG4,RSMG4-2,
299,12.0,McGill,6/17/2021,RSMG4,RSMG4,,,1.0,1.0,Parietal-occipital cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG4,RSMG4,RSMG4,IGF119508,,,RSMG4,RSMG4-4,
300,12.0,McGill,6/17/2021,RSMG4,RSMG4,,,1.0,1.0,Parietal-occipital cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG4,RSMG4,RSMG4,IGF119509,,,RSMG4,RSMG4-6,
301,12.0,McGill,6/17/2021,RSMG4,RSMG4,,,1.0,1.0,Parietal-occipital cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG4,RSMG4,RSMG4,IGF119510,,,RSMG4,RSMG4-1,
302,12.0,McGill,6/17/2021,RSMG4,RSMG4,,,1.0,1.0,Parietal-occipital cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG4,RSMG4,RSMG4,IGF119513,,,RSMG4,RSMG4-7,
303,12.0,McGill,6/17/2021,RSMG4,RSMG4,,,1.0,1.0,Parietal-occipital cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG4,RSMG4,RSMG4,IGF119511,,,RSMG4,RSMG4-3,
304,12.0,McGill,6/17/2021,RSMG5,RSMG5,,,1.0,1.0,Occipital cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG5,RSMG5,RSMG5,IGF119514,,,RSMG5,RSMG5-2,
305,12.0,McGill,6/17/2021,RSMG5,RSMG5,,,1.0,1.0,Occipital cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG5,RSMG5,RSMG5,IGF119515,,,RSMG5,RSMG5-4,
306,12.0,McGill,6/17/2021,RSMG5,RSMG5,,,1.0,1.0,Occipital cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG5,RSMG5,RSMG5,IGF119516,,,RSMG5,RSMG5-6,
307,12.0,McGill,6/17/2021,RSMG5,RSMG5,,,1.0,1.0,Occipital cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG5,RSMG5,RSMG5,IGF119517,,,RSMG5,RSMG5-1,
308,12.0,McGill,6/17/2021,RSMG5,RSMG5,,,1.0,1.0,Occipital cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG5,RSMG5,RSMG5,IGF119518,,,RSMG5,RSMG5-3,
309,12.0,McGill,6/17/2021,RSMG5,RSMG5,,,1.0,1.0,Occipital cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG5,RSMG5,RSMG5,IGF119519,,,RSMG5,RSMG5-5,
310,12.0,McGill,6/17/2021,RSMG5,RSMG5,,,1.0,1.0,Occipital cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG5,RSMG5,RSMG5,IGF119520,,,RSMG5,RSMG5-7,
311,12.0,McGill,6/17/2021,RSMG6,RSMG6,,,1.0,1.0,Parietal-occipital cortex,64.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG6,RSMG6,RSMG6,IGF119521,,,RSMG6,RSMG6-1,
312,12.0,McGill,6/17/2021,RSMG6,RSMG6,,,1.0,1.0,Parietal-occipital cortex,64.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG6,RSMG6,RSMG6,IGF119522,,,RSMG6,RSMG6-2,
313,12.0,McGill,6/17/2021,RSMG6,RSMG6,,,1.0,1.0,Parietal-occipital cortex,64.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG6,RSMG6,RSMG6,IGF119523,,,RSMG6,RSMG6-3,
314,12.0,McGill,6/17/2021,RSMG6,RSMG6,,,1.0,1.0,Parietal-occipital cortex,64.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG6,RSMG6,RSMG6,IGF119524,,,RSMG6,RSMG6-4,
315,12.0,McGill,6/17/2021,RSMG7,RSMG7,,,1.0,1.0,Frontal-Temporal-Occipital cortex,76.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG7,RSMG7,RSMG7,IGF119525,,,RSMG7,RSMG7-1,
316,12.0,McGill,6/17/2021,RSMG7,RSMG7,,,1.0,1.0,Frontal-Temporal-Occipital cortex,76.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG7,RSMG7,RSMG7,IGF119526,,,RSMG7,RSMG7-2,
317,12.0,McGill,6/17/2021,RSMG7,RSMG7,,,1.0,1.0,Frontal-Temporal-Occipital cortex,76.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG7,RSMG7,RSMG7,IGF119527,,,RSMG7,RSMG7-3,
318,12.0,McGill,6/17/2021,RSMG7,RSMG7,,,1.0,1.0,Frontal-Temporal-Occipital cortex,76.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG7,RSMG7,RSMG7,IGF119528,,,RSMG7,RSMG7-4,
319,12.0,McGill,6/17/2021,RSMG7,RSMG7,,,1.0,1.0,Frontal-Temporal-Occipital cortex,76.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG7,RSMG7,RSMG7,IGF119529,,,RSMG7,RSMG7-5,
320,12.0,McGill,6/17/2021,RSMG7,RSMG7,,,1.0,1.0,Frontal-Temporal-Occipital cortex,76.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG7,RSMG7,RSMG7,IGF119530,,,RSMG7,RSMG7-6,
321,12.0,McGill,6/17/2021,RSMG7,RSMG7,,,1.0,1.0,Frontal-Temporal-Occipital cortex,76.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG7,RSMG7,RSMG7,IGF119531,,,RSMG7,RSMG7-7,
322,12.0,McGill,6/17/2021,RSMG8,RSMG8,,,1.0,1.0,Parietal-occipital cortex,60.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG8,RSMG8,RSMG8,IGF119532,,,RSMG8,RSMG8-2,
323,12.0,McGill,6/17/2021,RSMG8,RSMG8,,,1.0,1.0,Parietal-occipital cortex,60.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG8,RSMG8,RSMG8,IGF119533,,,RSMG8,RSMG8-4,
324,12.0,McGill,6/17/2021,RSMG8,RSMG8,,,1.0,1.0,Parietal-occipital cortex,60.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG8,RSMG8,RSMG8,IGF119534,,,RSMG8,RSMG8-1,
325,12.0,McGill,6/17/2021,RSMG8,RSMG8,,,1.0,1.0,Parietal-occipital cortex,60.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG8,RSMG8,RSMG8,IGF119535,,,RSMG8,RSMG8-3,
326,12.0,McGill,6/17/2021,RSMG8,RSMG8,,,1.0,1.0,Parietal-occipital cortex,60.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG8,RSMG8,RSMG8,IGF119536,,,RSMG8,RSMG8-5,
327,12.0,McGill,6/17/2021,RSMG9,RSMG9,,,1.0,1.0,Frontal-temporal cortex,66.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG9,RSMG9,RSMG9,IGF119537,,,RSMG9,RSMG9-2,
328,12.0,McGill,6/17/2021,RSMG9,RSMG9,,,1.0,1.0,Frontal-temporal cortex,66.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG9,RSMG9,RSMG9,IGF119541,,,RSMG9,RSMG9-3,
329,12.0,McGill,6/17/2021,RSMG9,RSMG9,,,1.0,1.0,Frontal-temporal cortex,66.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG9,RSMG9,RSMG9,IGF119538,,,RSMG9,RSMG9-4,
330,12.0,McGill,6/17/2021,RSMG9,RSMG9,,,1.0,1.0,Frontal-temporal cortex,66.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG9,RSMG9,RSMG9,IGF119539,,,RSMG9,RSMG9-6,
331,12.0,McGill,6/17/2021,RSMG9,RSMG9,,,1.0,1.0,Frontal-temporal cortex,66.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG9,RSMG9,RSMG9,IGF119540,,,RSMG9,RSMG9-1,
332,12.0,McGill,6/17/2021,RSMG9,RSMG9,,,1.0,1.0,Frontal-temporal cortex,66.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG9,RSMG9,RSMG9,IGF119542,,,RSMG9,RSMG9-5,
333,12.0,McGill,6/17/2021,RSMG9,RSMG9,,,1.0,1.0,Frontal-temporal cortex,66.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG9,RSMG9,RSMG9,IGF119543,,,RSMG9,RSMG9-7,
334,5.0,Edinburgh,20210721,SD004_19,BBN001.35182,2.0,2.0,10.0,7.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Temporal (BA21/BA22), Parietal (BA39), Calcarine, Cerebellum. FFPE: Temporal, Frontal, 30slides/region",66.0,2.0,Unknown,M,49,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,1.0,,Null,Not Assessed,1.0,,,Not assesed,2.0,Alzheimer's Disease,,,Mild non-amyloid SVD. Severe arteriolar Abeta-CAA,Alzheimer's dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,SD004_19,BBN001_35182,BBN001.35182,IGF124272,MTEMP,,BBN001_35182,BBN001-35182-MTEMP,
335,5.0,Edinburgh,20210721,SD004_19,BBN001.35182,2.0,2.0,10.0,7.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Temporal (BA21/BA22), Parietal (BA39), Calcarine, Cerebellum. FFPE: Temporal, Frontal, 30slides/region",66.0,2.0,Unknown,M,49,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,1.0,,Null,Not Assessed,1.0,,,Not assesed,2.0,Alzheimer's Disease,,,Mild non-amyloid SVD. Severe arteriolar Abeta-CAA,Alzheimer's dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,SD004_19,BBN001_35182,BBN001.35182,IGF123508,MTEMP,,BBN001_35182,BBN001-35182-MTEMP,
336,5.0,Edinburgh,20210721,SD004_19,BBN001.35182,2.0,2.0,10.0,7.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Temporal (BA21/BA22), Parietal (BA39), Calcarine, Cerebellum. FFPE: Temporal, Frontal, 30slides/region",66.0,2.0,Unknown,M,49,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,1.0,,Null,Not Assessed,1.0,,,Not assesed,2.0,Alzheimer's Disease,,,Mild non-amyloid SVD. Severe arteriolar Abeta-CAA,Alzheimer's dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,SD004_19,BBN001_35182,BBN001.35182,IGF123514,PFC,,BBN001_35182,BBN001-35182-FC,
337,5.0,Edinburgh,20210721,SD004_19,BBN001.35182,2.0,2.0,10.0,7.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Temporal (BA21/BA22), Parietal (BA39), Calcarine, Cerebellum. FFPE: Temporal, Frontal, 30slides/region",66.0,2.0,Unknown,M,49,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,1.0,,Null,Not Assessed,1.0,,,Not assesed,2.0,Alzheimer's Disease,,,Mild non-amyloid SVD. Severe arteriolar Abeta-CAA,Alzheimer's dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,SD004_19,BBN001_35182,BBN001.35182,IGF128408,PFC,,BBN001_35182,BBN001-35182-FC,RNAseq
338,5.0,Edinburgh,20210721,SD004_19,BBN001.35182,2.0,2.0,10.0,7.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Temporal (BA21/BA22), Parietal (BA39), Calcarine, Cerebellum. FFPE: Temporal, Frontal, 30slides/region",66.0,2.0,Unknown,M,49,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,1.0,,Null,Not Assessed,1.0,,,Not assesed,2.0,Alzheimer's Disease,,,Mild non-amyloid SVD. Severe arteriolar Abeta-CAA,Alzheimer's dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,SD004_19,BBN001_35182,BBN001.35182,IGF128437,PFC,,BBN001_35182,BBN001-35182-FC_1,ATACseq
339,5.0,Edinburgh,20210721,SD004_19,BBN001.35182,2.0,2.0,10.0,7.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Temporal (BA21/BA22), Parietal (BA39), Calcarine, Cerebellum. FFPE: Temporal, Frontal, 30slides/region",66.0,2.0,Unknown,M,49,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,1.0,,Null,Not Assessed,1.0,,,Not assesed,2.0,Alzheimer's Disease,,,Mild non-amyloid SVD. Severe arteriolar Abeta-CAA,Alzheimer's dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,SD004_19,BBN001_35182,BBN001.35182,IGF125072,MTG,,BBN001_35182,BBN001-35182-MTG_1,ATACseq
340,5.0,Edinburgh,20210721,SD004_19,BBN001.35182,2.0,2.0,10.0,7.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Temporal (BA21/BA22), Parietal (BA39), Calcarine, Cerebellum. FFPE: Temporal, Frontal, 30slides/region",66.0,2.0,Unknown,M,49,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,1.0,,Null,Not Assessed,1.0,,,Not assesed,2.0,Alzheimer's Disease,,,Mild non-amyloid SVD. Severe arteriolar Abeta-CAA,Alzheimer's dementia,N,N,,,N,1.0,,,,3.0,MAP,,,,SD004_19,BBN001_35182,BBN001.35182,IGF125044,MTG,,BBN001_35182,BBN001-35182-MTG,RNAseq
341,5.0,Edinburgh,20210721,SD005_14,BBN_20121,2.0,2.0,10.0,5.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Parietal (BA39), Calcarine. FFPE: Temporal, Frontal, 30slides/region.",63.0,2.0,Unknown,M,42,1.0,,Control,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,,,No significant abnormalities,Haemoptysis. Non-small cell carcinoma of the right lung. Chornic obstructive pulmonary disease.,N,N,,Sudden haemoptysis before collapse,N,1.0,,,,3.0,MAP,,,,SD005_14,BBN_20121,BBN_20121,IGF123539,PFC,,BBN_20121,BBN-20121-FC,
342,5.0,Edinburgh,20210721,SD005_14,BBN_20121,2.0,2.0,10.0,5.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Parietal (BA39), Calcarine. FFPE: Temporal, Frontal, 30slides/region.",63.0,2.0,Unknown,M,42,1.0,,Control,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,,,No significant abnormalities,Haemoptysis. Non-small cell carcinoma of the right lung. Chornic obstructive pulmonary disease.,N,N,,Sudden haemoptysis before collapse,N,1.0,,,,3.0,MAP,,,,SD005_14,BBN_20121,BBN_20121,IGF125061,PFC,,BBN_20121,BBN-20121-FC_1,ATACseq
343,5.0,Edinburgh,20210721,SD005_14,BBN_20121,2.0,2.0,10.0,5.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Parietal (BA39), Calcarine. FFPE: Temporal, Frontal, 30slides/region.",63.0,2.0,Unknown,M,42,1.0,,Control,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,,,No significant abnormalities,Haemoptysis. Non-small cell carcinoma of the right lung. Chornic obstructive pulmonary disease.,N,N,,Sudden haemoptysis before collapse,N,1.0,,,,3.0,MAP,,,,SD005_14,BBN_20121,BBN_20121,IGF125033,PFC,,BBN_20121,BBN-20121-FC,RNAseq
344,5.0,Edinburgh,20210721,SD006_14,BBN_20593,2.0,2.0,10.0,6.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Parietal (BA39), Calcarine, Cerebellum. FFPE: Temporal, Frontal, 30slides/region",60.0,2.0,Unknown,M,52,1.0,,Control,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,,,No significant abnormalities,Bronchopneumonia. Chronic lung disease. Ischaemic heart disease.,Y,N,,Sudden death after c/o chest pain,N,1.0,,,,3.0,MAP,,,,SD006_14,BBN_20593,BBN_20593,IGF123532,PFC,,BBN_20593,BBN-20593-FC,
345,5.0,Edinburgh,20210721,SD006_14,BBN_20593,2.0,2.0,10.0,6.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Parietal (BA39), Calcarine, Cerebellum. FFPE: Temporal, Frontal, 30slides/region",60.0,2.0,Unknown,M,52,1.0,,Control,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,,,No significant abnormalities,Bronchopneumonia. Chronic lung disease. Ischaemic heart disease.,Y,N,,Sudden death after c/o chest pain,N,1.0,,,,3.0,MAP,,,,SD006_14,BBN_20593,BBN_20593,IGF128411,PFC,,BBN_20593,BBN-20593-FC,RNAseq
346,5.0,Edinburgh,20210721,SD006_14,BBN_20593,2.0,2.0,10.0,6.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Parietal (BA39), Calcarine, Cerebellum. FFPE: Temporal, Frontal, 30slides/region",60.0,2.0,Unknown,M,52,1.0,,Control,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,,,No significant abnormalities,Bronchopneumonia. Chronic lung disease. Ischaemic heart disease.,Y,N,,Sudden death after c/o chest pain,N,1.0,,,,3.0,MAP,,,,SD006_14,BBN_20593,BBN_20593,IGF128440,PFC,,BBN_20593,BBN-20593-FC_1,ATACseq
347,5.0,Edinburgh,20210721,SD022_14,BBN_22612,2.0,2.0,10.0,7.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Temporal (BA21/BA22), Parietal (BA39), Calcarine, Cerebellum. FFPE: Temporal, Frontal, 30slides/region",61.0,2.0,Unknown,M,70,1.0,,Control,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,,,No significant abnormalities,"Ischaemic heart disease, coronary artery atherosclerosis",N,N,,Sudden collapse at home,N,1.0,,,,3.0,MAP,,,,SD022_14,BBN_22612,BBN_22612,IGF123502,PFC,,BBN_22612,BBN-22612-FC,
348,5.0,Edinburgh,20210721,SD022_14,BBN_22612,2.0,2.0,10.0,7.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Temporal (BA21/BA22), Parietal (BA39), Calcarine, Cerebellum. FFPE: Temporal, Frontal, 30slides/region",61.0,2.0,Unknown,M,70,1.0,,Control,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,,,No significant abnormalities,"Ischaemic heart disease, coronary artery atherosclerosis",N,N,,Sudden collapse at home,N,1.0,,,,3.0,MAP,,,,SD022_14,BBN_22612,BBN_22612,IGF123509,MTEMP,,BBN_22612,BBN-22612-MTEMP,
349,5.0,Edinburgh,20210721,SD025_11,BBN_2564,1.0,1.0,10.0,5.0,"FROZEN: Frontal (FPS), Putamen (BG), Parietal (BA39), Calcarine (Occ), Cerebellum. FFPE: Frontal Parasagital, 30slides/region",66.0,2.0,Unknown,M,69,1.0,,Control,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,,,No significant abnormalities,Cardiac tamponade. Ruptured left ventricle. Acute myocardial infarct. Coronary artery atherosclerosis,N,N,,Found dead in the garden,N,1.0,,,,3.0,MAP,,,,SD025_11,BBN_2564,BBN_2564,IGF123540,PFC,,BBN_2564,BBN-2564-FC,
350,5.0,Edinburgh,20210721,SD025_11,BBN_2564,1.0,1.0,10.0,5.0,"FROZEN: Frontal (FPS), Putamen (BG), Parietal (BA39), Calcarine (Occ), Cerebellum. FFPE: Frontal Parasagital, 30slides/region",66.0,2.0,Unknown,M,69,1.0,,Control,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,,,No significant abnormalities,Cardiac tamponade. Ruptured left ventricle. Acute myocardial infarct. Coronary artery atherosclerosis,N,N,,Found dead in the garden,N,1.0,,,,3.0,MAP,,,,SD025_11,BBN_2564,BBN_2564,IGF125060,PFC,,BBN_2564,BBN-2564-FC_1,ATACseq
351,5.0,Edinburgh,20210721,SD025_11,BBN_2564,1.0,1.0,10.0,5.0,"FROZEN: Frontal (FPS), Putamen (BG), Parietal (BA39), Calcarine (Occ), Cerebellum. FFPE: Frontal Parasagital, 30slides/region",66.0,2.0,Unknown,M,69,1.0,,Control,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,,,No significant abnormalities,Cardiac tamponade. Ruptured left ventricle. Acute myocardial infarct. Coronary artery atherosclerosis,N,N,,Found dead in the garden,N,1.0,,,,3.0,MAP,,,,SD025_11,BBN_2564,BBN_2564,IGF125032,PFC,,BBN_2564,BBN-2564-FC,RNAseq
352,5.0,Edinburgh,20210721,SD034_17,BBN001.30883,1.0,1.0,10.0,6.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Parietal (BA39), Calcarine, Cerebellum. FFPE: Frontal, 30slides/region",61.0,2.0,Unknown,M,69,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,1.0,,Null,Not Assessed,1.0,,,Not assesed,2.0,Alzheimer's Disease,,,Moderate non-amyloid SVD. Moderate arteriolar Abeta-CAA,Sepsis. Advanced dementia,N,N,,Intracranial haemorrhage (nontraumatic),N,1.0,,,,3.0,MAP,,,,SD034_17,BBN001_30883,BBN001.30883,IGF123528,PFC,,BBN001_30883,BBN001-30883-FC,
353,5.0,Edinburgh,20210721,SD034_17,BBN001.30883,1.0,1.0,10.0,6.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Parietal (BA39), Calcarine, Cerebellum. FFPE: Frontal, 30slides/region",61.0,2.0,Unknown,M,69,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,1.0,,Null,Not Assessed,1.0,,,Not assesed,2.0,Alzheimer's Disease,,,Moderate non-amyloid SVD. Moderate arteriolar Abeta-CAA,Sepsis. Advanced dementia,N,N,,Intracranial haemorrhage (nontraumatic),N,1.0,,,,3.0,MAP,,,,SD034_17,BBN001_30883,BBN001.30883,IGF128402,PFC,,BBN001_30883,BBN001-30883-FC,RNAseq
354,5.0,Edinburgh,20210721,SD034_17,BBN001.30883,1.0,1.0,10.0,6.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Parietal (BA39), Calcarine, Cerebellum. FFPE: Frontal, 30slides/region",61.0,2.0,Unknown,M,69,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,1.0,,Null,Not Assessed,1.0,,,Not assesed,2.0,Alzheimer's Disease,,,Moderate non-amyloid SVD. Moderate arteriolar Abeta-CAA,Sepsis. Advanced dementia,N,N,,Intracranial haemorrhage (nontraumatic),N,1.0,,,,3.0,MAP,,,,SD034_17,BBN001_30883,BBN001.30883,IGF128431,PFC,,BBN001_30883,BBN001-30883-FC_1,ATACseq
355,5.0,Edinburgh,20210721,SD046_13,BBN_18407,1.0,1.0,10.0,7.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Temporal (BA21/BA22), Parietal (BA39), Calcarine, Cerebellum. FFPE: Frontal, 30slides/region",62.0,2.0,Unknown,M,41,1.0,,Control,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,,,No significant abnormalities,Ischaemic heart disease. Coronary artery atheroma,N,N,,Sudden collapse while out cycling,N,1.0,,,,3.0,MAP,,,,SD046_13,BBN_18407,BBN_18407,IGF123498,MTEMP,,BBN_18407,BBN-18407-MTEMP,
356,5.0,Edinburgh,20210721,SD046_13,BBN_18407,1.0,1.0,10.0,7.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Temporal (BA21/BA22), Parietal (BA39), Calcarine, Cerebellum. FFPE: Frontal, 30slides/region",62.0,2.0,Unknown,M,41,1.0,,Control,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,,,No significant abnormalities,Ischaemic heart disease. Coronary artery atheroma,N,N,,Sudden collapse while out cycling,N,1.0,,,,3.0,MAP,,,,SD046_13,BBN_18407,BBN_18407,IGF123518,PFC,,BBN_18407,BBN-18407-FC,
357,5.0,Edinburgh,20210721,SD046_13,BBN_18407,1.0,1.0,10.0,7.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Temporal (BA21/BA22), Parietal (BA39), Calcarine, Cerebellum. FFPE: Frontal, 30slides/region",62.0,2.0,Unknown,M,41,1.0,,Control,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,,,No significant abnormalities,Ischaemic heart disease. Coronary artery atheroma,N,N,,Sudden collapse while out cycling,N,1.0,,,,3.0,MAP,,,,SD046_13,BBN_18407,BBN_18407,IGF125064,PFC,,BBN_18407,BBN-18407-FC_1,ATACseq
358,5.0,Edinburgh,20210721,SD046_13,BBN_18407,1.0,1.0,10.0,7.0,"FROZEN: Frontal (BA9), Cingulate (BA23/BA24), Putamen, Temporal (BA21/BA22), Parietal (BA39), Calcarine, Cerebellum. FFPE: Frontal, 30slides/region",62.0,2.0,Unknown,M,41,1.0,,Control,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,,,No significant abnormalities,Ischaemic heart disease. Coronary artery atheroma,N,N,,Sudden collapse while out cycling,N,1.0,,,,3.0,MAP,,,,SD046_13,BBN_18407,BBN_18407,IGF125036,PFC,,BBN_18407,BBN-18407-FC,RNAseq
359,11.0,Netherlands,10/26/2021,2015-027,S15/027,1.0,1.0,1.0,1.0,"Inferior temporal gyrus (FF, FFPE)",76.0,2.0,Unknown,F,4:45,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,No significant abnormalities. Slight atherosclerosis.,Adenocarcinoma,N,,,Some signs of hypertension. Signs of high blood pressure.,N,,,,,4.0,Tissue Quality Control,,,,2015_027,S15_027,S15/027,IGF123550,ITG,,S15_027,S15-027-ITG,
360,11.0,Netherlands,10/26/2021,2017-109,S17/109,1.0,1.0,1.0,1.0,"Inferior temporal gyrus (FF, FFPE)",91.0,,Unknown,M,5:05,,3,Control,Ndgen.BandBIII,Moderate,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,Diffuse atherosclerosis. Few amyloid plaques. Moderate glial tauopathy. No significant abnormalities detected.,Euthanasia,Y,,FFPE regions arrived on 03-09-2021,Mild cognitive abnormalities,N,,,,,4.0,Tissue Quality Control,,,,2017_109,S17_109,S17/109,IGF123494,ITG,,S17_109,S17-109-ITG,
361,11.0,Netherlands,10/26/2021,2017-016,S17/016,1.0,1.0,1.0,1.0,"Inferior temporal gyrus (FF, FFPE)",72.0,2.0,Unknown,M,4:20,5.0,2,Control,Ndgen.BandBII,Control,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,1.0,,1.0,,Signs of terminal hypoxia.,Combined cardiogenic and distributive shock after cardial mitral valve surgery due to endocardities.,N,,FFPE regions arrived on 03-09-2021,Diagnosed Bipolar disorder ,N,,,,,4.0,Tissue Quality Control,,,,2017_016,S17_016,S17/016,IGF123499,ITG,,S17_016,S17-016-ITG,
362,11.0,Netherlands,10/26/2021,2018-123,S18/123,1.0,1.0,1.0,1.0,Inferior temporal gyrus (FF) Middle temporal gyrus (FFPE),82.0,2.0,Unknown,F,6:20,6.0,3,Control,Ndgen.BandBIII,Moderate,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,1.0,,1.0,,Slight diffuse atherosclerosis. Signs of terminal hypoxia and slight angiopathy of small vessels.,"Physical deterioration, cachexia, dehydratation, in patient with COPD and pulmonary hypertension",Y,,FFPE regions arrived on 03-09-2021,Squamous cell carcinoma. Pulmonary hypertension and heart failure.,N,,,,,4.0,Tissue Quality Control,,,,2018_123,S18_123,S18/123,IGF123512,ITG,,S18_123,S18-123-ITG,
363,11.0,Netherlands,10/26/2021,2018-105,S18/105,1.0,1.0,1.0,1.0,Inferior temporal gyrus (FF) Middle temporal gyrus (FFPE),86.0,2.0,Unknown,M,6:45,6.0,3,Control,Ndgen.BandBIII,Moderate,2.0,0.0,Ndgen.Thal0,No amyloid deposition,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,No  significant abnormalities.,"Intra-abdominal leakage of fluid causing abdominal infection, after endovascular aneurysm repair.",N,,FFPE regions arrived on 03-09-2021,"History with vascular problems, with an abdominal aortic aneurysm.",N,,,,,4.0,Tissue Quality Control,,,,2018_105,S18_105,S18/105,IGF123555,ITG,,S18_105,S18-105-ITG,
364,11.0,Netherlands,10/26/2021,2015-033,S15/033,1.0,1.0,1.0,1.0,"Inferior temporal gyrus (FF, FFPE)",93.0,2.0,Unknown,M,7:40,2.0,0,Control,Ndgen.BandB0,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,Moderate atherosclerosis. Very few amyloid beta plaques/diffuse depositions. Small infarction.,Heart failure,N,,FFPE regions arrived on 03-09-2021,Effort-related dyspnea ,N,,,,,4.0,Tissue Quality Control,,,,2015_033,S15_033,S15/033,IGF123513,ITG,,S15_033,S15-033-ITG,
365,11.0,Netherlands,10/26/2021,2018-112,S18/112,1.0,1.0,1.0,1.0,Inferior temporal gyrus (FF) Middle temporal gyrus (FFPE),95.0,2.0,Unknown,F,4:20,6.0,3,Control,Ndgen.BandBIII,Moderate,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,No  significant abnormalities.,Ileus caused by tumor,Y,,FFPE regions arrived on 03-09-2021,Intestinal tumor. Atrial fibrillation,N,,,,,4.0,Tissue Quality Control,,,,2018_112,S18_112,S18/112,IGF123531,ITG,,S18_112,S18-112-ITG,
366,11.0,Netherlands,10/26/2021,2015-074,S15/074,1.0,1.0,1.0,1.0,Inferior temporal gyrus (FF) Middle temporal gyrus (FFPE),89.0,2.0,Unknown,F,13:00,3.0,1,Control,Ndgen.BandBI,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,No  significant abnormalities.,Suicide by medication,N,,FFPE regions arrived on 03-09-2021,Slight hypoxia and very slight age-related symotoms,N,,,,,4.0,Tissue Quality Control,,,,2015_074,S15_074,S15/074,IGF123556,ITG,,S15_074,S15-074-ITG,
367,11.0,Netherlands,10/26/2021,2017-005,S17/005,,,1.0,1.0,Inferior temporal gyrus (FF),60.0,2.0,Unknown,F,5:30,2.0,0,Control,Ndgen.BandB0,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,"No significant abnormalities. Early CAA type 2, stage 1.",Euthanasia,N,,,Metastatic breast cancer. She wished euthanasia,N,,,,,4.0,Tissue Quality Control,,,,2017_005,S17_005,S17/005,IGF123523,ITG,,S17_005,S17-005-ITG,
368,11.0,Netherlands,10/26/2021,2018-030,S18/030,1.0,1.0,1.0,1.0,Inferior temporal gyrus (FF) Middle temporal gyrus (FFPE),102.0,2.0,Unknown,F,5:10,7.0,4,Control,Ndgen.BandBIV,Moderate,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,Extensive primary age-related tauopathy. Three old infarctions. Few diffuse amyloid beta plaques.,"Physical deterioration, heart failure",Y,,FFPE regions arrived on 03-09-2021,Heart problems. Macular degeneration in eyes. ,N,,,,,4.0,Tissue Quality Control,,,,2018_030,S18_030,S18/030,IGF123537,ITG,,S18_030,S18-030-ITG,
369,11.0,Netherlands,10/26/2021,2015-016,S15/016,1.0,1.0,1.0,1.0,Inferior temporal gyrus (FF) Middle temporal gyrus (FFPE),95.0,2.0,Unknown,F,7:05,6.0,3,Control,Ndgen.BandBIII,Moderate,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,1.0,,1.0,,Strong atherosclerosis. Moderate number of amyloid beta depositions. AT8 few dystrophic neurites.,Liver abscess with sepsis,N,,FFPE regions arrived on 03-09-2021,Severe impaired vision with macular degeneration. Diabetes mellitus type 2.,N,,,,,4.0,Tissue Quality Control,,,,2015_016,S15_016,S15/016,IGF124275,ITG,,S15_016,S15-016-ITG,
370,11.0,Netherlands,10/26/2021,2015-016,S15/016,1.0,1.0,1.0,1.0,Inferior temporal gyrus (FF) Middle temporal gyrus (FFPE),95.0,2.0,Unknown,F,7:05,6.0,3,Control,Ndgen.BandBIII,Moderate,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,1.0,,1.0,,Strong atherosclerosis. Moderate number of amyloid beta depositions. AT8 few dystrophic neurites.,Liver abscess with sepsis,N,,FFPE regions arrived on 03-09-2021,Severe impaired vision with macular degeneration. Diabetes mellitus type 2.,N,,,,,4.0,Tissue Quality Control,,,,2015_016,S15_016,S15/016,IGF123495,ITG,,S15_016,S15-016-ITG,
371,11.0,Netherlands,10/26/2021,2017-093,S17/093,1.0,1.0,1.0,1.0,Inferior temporal gyrus (FF) Superior temporal gyrus (FFPE),82.0,2.0,Unknown,M,5:45,2.0,0,Control,Ndgen.BandB0,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,No significant abnormalities,Euthanasia,N,,,Lyme arthritis,N,,,,,4.0,Tissue Quality Control,,,,2017_093,S17_093,S17/093,IGF123506,ITG,,S17_093,S17-093-ITG,
372,6.0,Kings,10/21/2021,A237/16,BBN002.28858,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",80.0,3.0,White,M,58,3.0,1,Control,Ndgen.BandBI,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,1.0,,1.0,,No significant abnormalities,Cancer,,,,Some memory problems due to ageing,N,,,,,3.0,MAP,,,,A237_16,BBN002_28858,BBN002.28858,IGF123507,PFC,,BBN002_28858,BBN002-28858-FC,
373,6.0,Kings,10/21/2021,A237/16,BBN002.28858,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",80.0,3.0,White,M,58,3.0,1,Control,Ndgen.BandBI,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,1.0,,1.0,,No significant abnormalities,Cancer,,,,Some memory problems due to ageing,N,,,,,3.0,MAP,,,,A237_16,BBN002_28858,BBN002.28858,IGF123549,MTEMP,,BBN002_28858,BBN002-28858-MTEMP,
374,6.0,Kings,10/21/2021,A237/16,BBN002.28858,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",80.0,3.0,White,M,58,3.0,1,Control,Ndgen.BandBI,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,1.0,,1.0,,No significant abnormalities,Cancer,,,,Some memory problems due to ageing,N,,,,,3.0,MAP,,,,A237_16,BBN002_28858,BBN002.28858,IGF128399,PFC,,BBN002_28858,BBN002-28858-FC,RNAseq
375,6.0,Kings,10/21/2021,A237/16,BBN002.28858,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",80.0,3.0,White,M,58,3.0,1,Control,Ndgen.BandBI,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,1.0,,1.0,,No significant abnormalities,Cancer,,,,Some memory problems due to ageing,N,,,,,3.0,MAP,,,,A237_16,BBN002_28858,BBN002.28858,IGF128428,PFC,,BBN002_28858,BBN002-28858-FC_1,ATACseq
376,6.0,Kings,10/21/2021,A237/16,BBN002.28858,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",80.0,3.0,White,M,58,3.0,1,Control,Ndgen.BandBI,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,1.0,,1.0,,No significant abnormalities,Cancer,,,,Some memory problems due to ageing,N,,,,,3.0,MAP,,,,A237_16,BBN002_28858,BBN002.28858,IGF125076,MTG,,BBN002_28858,BBN002-28858-MTG_1,ATACseq
377,6.0,Kings,10/21/2021,A237/16,BBN002.28858,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",80.0,3.0,White,M,58,3.0,1,Control,Ndgen.BandBI,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,1.0,,1.0,,No significant abnormalities,Cancer,,,,Some memory problems due to ageing,N,,,,,3.0,MAP,,,,A237_16,BBN002_28858,BBN002.28858,IGF125048,MTG,,BBN002_28858,BBN002-28858-MTG,RNAseq
378,6.0,Kings,10/21/2021,A311/17,BBN002.30840,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",72.0,2.0,Unknown,M,61,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate/severe occipital leptomeningeal CAA,,,,,Alzheimer's disease with early onset,N,,,,,3.0,MAP,,,,A311_17,BBN002_30840,BBN002.30840,IGF123548,PFC,,BBN002_30840,BBN002-30840-FC,
379,6.0,Kings,10/21/2021,A311/17,BBN002.30840,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",72.0,2.0,Unknown,M,61,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate/severe occipital leptomeningeal CAA,,,,,Alzheimer's disease with early onset,N,,,,,3.0,MAP,,,,A311_17,BBN002_30840,BBN002.30840,IGF123553,MTEMP,,BBN002_30840,BBN002-30840-MTEMP,
380,6.0,Kings,10/21/2021,A311/17,BBN002.30840,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",72.0,2.0,Unknown,M,61,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate/severe occipital leptomeningeal CAA,,,,,Alzheimer's disease with early onset,N,,,,,3.0,MAP,,,,A311_17,BBN002_30840,BBN002.30840,IGF125063,MTG,,BBN002_30840,BBN002-30840-MTG_1,ATACseq
381,6.0,Kings,10/21/2021,A311/17,BBN002.30840,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",72.0,2.0,Unknown,M,61,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate/severe occipital leptomeningeal CAA,,,,,Alzheimer's disease with early onset,N,,,,,3.0,MAP,,,,A311_17,BBN002_30840,BBN002.30840,IGF125035,MTG,,BBN002_30840,BBN002-30840-MTG,RNAseq
382,6.0,Kings,10/21/2021,A080/18,BBN002.32628,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",93.0,2.0,Unknown,M,26,9.0,5,Control,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,4.0,2.0,Ndgen.CERAD2,Moderate,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,1.0,,1.0,,No significant abnormalities,Discitis,,,,Intermediate probability od dementia due to Alzheimer's disease,N,,,,,3.0,MAP,,,,A080_18,BBN002_32628,BBN002.32628,IGF123500,MTEMP,,BBN002_32628,BBN002-32628-MTEMP,
383,6.0,Kings,10/21/2021,A080/18,BBN002.32628,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",93.0,2.0,Unknown,M,26,9.0,5,Control,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,4.0,2.0,Ndgen.CERAD2,Moderate,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,1.0,,1.0,,No significant abnormalities,Discitis,,,,Intermediate probability od dementia due to Alzheimer's disease,N,,,,,3.0,MAP,,,,A080_18,BBN002_32628,BBN002.32628,IGF123534,PFC,,BBN002_32628,BBN002-32628-FC,
384,6.0,Kings,10/21/2021,A080/18,BBN002.32628,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",93.0,2.0,Unknown,M,26,9.0,5,Control,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,4.0,2.0,Ndgen.CERAD2,Moderate,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,1.0,,1.0,,No significant abnormalities,Discitis,,,,Intermediate probability od dementia due to Alzheimer's disease,N,,,,,3.0,MAP,,,,A080_18,BBN002_32628,BBN002.32628,IGF128414,PFC,,BBN002_32628,BBN002-32628-FC,RNAseq
385,6.0,Kings,10/21/2021,A080/18,BBN002.32628,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",93.0,2.0,Unknown,M,26,9.0,5,Control,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,4.0,2.0,Ndgen.CERAD2,Moderate,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,1.0,,1.0,,No significant abnormalities,Discitis,,,,Intermediate probability od dementia due to Alzheimer's disease,N,,,,,3.0,MAP,,,,A080_18,BBN002_32628,BBN002.32628,IGF128443,PFC,,BBN002_32628,BBN002-32628-FC_1,ATACseq
386,6.0,Kings,10/21/2021,A080/18,BBN002.32628,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",93.0,2.0,Unknown,M,26,9.0,5,Control,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,4.0,2.0,Ndgen.CERAD2,Moderate,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,1.0,,1.0,,No significant abnormalities,Discitis,,,,Intermediate probability od dementia due to Alzheimer's disease,N,,,,,3.0,MAP,,,,A080_18,BBN002_32628,BBN002.32628,IGF125081,MTG,,BBN002_32628,BBN002-32628-MTG_1,ATACseq
387,6.0,Kings,10/21/2021,A080/18,BBN002.32628,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",93.0,2.0,Unknown,M,26,9.0,5,Control,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,4.0,2.0,Ndgen.CERAD2,Moderate,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,1.0,,1.0,,No significant abnormalities,Discitis,,,,Intermediate probability od dementia due to Alzheimer's disease,N,,,,,3.0,MAP,,,,A080_18,BBN002_32628,BBN002.32628,IGF125053,MTG,,BBN002_32628,BBN002-32628-MTG,RNAseq
388,6.0,Kings,10/21/2021,A041/20,BBN002.35951,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",75.0,3.0,White,M,36,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,1.0,,,Not assesed,1.0,,1.0,,Severe amyloid angiopathy and Lewy bodies confined to the amygdala,,,,,,N,,,,,3.0,MAP,,,,A041_20,BBN002_35951,BBN002.35951,IGF124268,PFC,,BBN002_35951,BBN002-35951-FC,
389,6.0,Kings,10/21/2021,A041/20,BBN002.35951,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",75.0,3.0,White,M,36,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,1.0,,,Not assesed,1.0,,1.0,,Severe amyloid angiopathy and Lewy bodies confined to the amygdala,,,,,,N,,,,,3.0,MAP,,,,A041_20,BBN002_35951,BBN002.35951,IGF124278,MTEMP,,BBN002_35951,BBN002-35951-MTEMP,
390,6.0,Kings,10/21/2021,A041/20,BBN002.35951,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",75.0,3.0,White,M,36,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,1.0,,,Not assesed,1.0,,1.0,,Severe amyloid angiopathy and Lewy bodies confined to the amygdala,,,,,,N,,,,,3.0,MAP,,,,A041_20,BBN002_35951,BBN002.35951,IGF123501,PFC,,BBN002_35951,BBN002-35951-FC,
391,6.0,Kings,10/21/2021,A041/20,BBN002.35951,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",75.0,3.0,White,M,36,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,1.0,,,Not assesed,1.0,,1.0,,Severe amyloid angiopathy and Lewy bodies confined to the amygdala,,,,,,N,,,,,3.0,MAP,,,,A041_20,BBN002_35951,BBN002.35951,IGF123536,MTEMP,,BBN002_35951,BBN002-35951-MTEMP,
392,6.0,Kings,10/21/2021,A041/20,BBN002.35951,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",75.0,3.0,White,M,36,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,1.0,,,Not assesed,1.0,,1.0,,Severe amyloid angiopathy and Lewy bodies confined to the amygdala,,,,,,N,,,,,3.0,MAP,,,,A041_20,BBN002_35951,BBN002.35951,IGF128397,PFC,,BBN002_35951,BBN002-35951-FC,RNAseq
393,6.0,Kings,10/21/2021,A041/20,BBN002.35951,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",75.0,3.0,White,M,36,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,1.0,,,Not assesed,1.0,,1.0,,Severe amyloid angiopathy and Lewy bodies confined to the amygdala,,,,,,N,,,,,3.0,MAP,,,,A041_20,BBN002_35951,BBN002.35951,IGF128426,PFC,,BBN002_35951,BBN002-35951-FC_1,ATACseq
394,6.0,Kings,10/21/2021,A041/20,BBN002.35951,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",75.0,3.0,White,M,36,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,1.0,,,Not assesed,1.0,,1.0,,Severe amyloid angiopathy and Lewy bodies confined to the amygdala,,,,,,N,,,,,3.0,MAP,,,,A041_20,BBN002_35951,BBN002.35951,IGF125065,PFC,,BBN002_35951,BBN002-35951-FC_1,ATACseq
395,6.0,Kings,10/21/2021,A041/20,BBN002.35951,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",75.0,3.0,White,M,36,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,1.0,,,Not assesed,1.0,,1.0,,Severe amyloid angiopathy and Lewy bodies confined to the amygdala,,,,,,N,,,,,3.0,MAP,,,,A041_20,BBN002_35951,BBN002.35951,IGF125037,PFC,,BBN002_35951,BBN002-35951-FC,RNAseq
396,6.0,Kings,10/21/2021,A119/20,BBN002.36130,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",95.0,2.0,Unknown,M,19,5.0,2,Control,Ndgen.BandBII,Control,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,1.0,,1.0,,"No abnormalities detected, marked CAA",Senile corporeal degeneration. Heart failure. Chronic kidney disease,,,,,N,,,,,3.0,MAP,,,,A119_20,BBN002_36130,BBN002.36130,IGF124279,MTEMP,,BBN002_36130,BBN002-36130-MTEMP,
397,6.0,Kings,10/21/2021,A119/20,BBN002.36130,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",95.0,2.0,Unknown,M,19,5.0,2,Control,Ndgen.BandBII,Control,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,1.0,,1.0,,"No abnormalities detected, marked CAA",Senile corporeal degeneration. Heart failure. Chronic kidney disease,,,,,N,,,,,3.0,MAP,,,,A119_20,BBN002_36130,BBN002.36130,IGF124269,PFC,,BBN002_36130,BBN002-36130-FC,
398,6.0,Kings,10/21/2021,A119/20,BBN002.36130,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",95.0,2.0,Unknown,M,19,5.0,2,Control,Ndgen.BandBII,Control,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,1.0,,1.0,,"No abnormalities detected, marked CAA",Senile corporeal degeneration. Heart failure. Chronic kidney disease,,,,,N,,,,,3.0,MAP,,,,A119_20,BBN002_36130,BBN002.36130,IGF123496,PFC,,BBN002_36130,BBN002-36130-FC,
399,6.0,Kings,10/21/2021,A119/20,BBN002.36130,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",95.0,2.0,Unknown,M,19,5.0,2,Control,Ndgen.BandBII,Control,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,1.0,,1.0,,"No abnormalities detected, marked CAA",Senile corporeal degeneration. Heart failure. Chronic kidney disease,,,,,N,,,,,3.0,MAP,,,,A119_20,BBN002_36130,BBN002.36130,IGF123541,MTEMP,,BBN002_36130,BBN002-36130-MTEMP,
400,6.0,Kings,10/21/2021,A119/20,BBN002.36130,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",95.0,2.0,Unknown,M,19,5.0,2,Control,Ndgen.BandBII,Control,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,1.0,,1.0,,"No abnormalities detected, marked CAA",Senile corporeal degeneration. Heart failure. Chronic kidney disease,,,,,N,,,,,3.0,MAP,,,,A119_20,BBN002_36130,BBN002.36130,IGF128401,PFC,,BBN002_36130,BBN002-36130-FC,RNAseq
401,6.0,Kings,10/21/2021,A119/20,BBN002.36130,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",95.0,2.0,Unknown,M,19,5.0,2,Control,Ndgen.BandBII,Control,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,1.0,,1.0,,"No abnormalities detected, marked CAA",Senile corporeal degeneration. Heart failure. Chronic kidney disease,,,,,N,,,,,3.0,MAP,,,,A119_20,BBN002_36130,BBN002.36130,IGF128412,EC,,BBN002_36130,BBN002-36130-EC,RNAseq
402,6.0,Kings,10/21/2021,A119/20,BBN002.36130,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",95.0,2.0,Unknown,M,19,5.0,2,Control,Ndgen.BandBII,Control,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,1.0,,1.0,,"No abnormalities detected, marked CAA",Senile corporeal degeneration. Heart failure. Chronic kidney disease,,,,,N,,,,,3.0,MAP,,,,A119_20,BBN002_36130,BBN002.36130,IGF128430,PFC,,BBN002_36130,BBN002-36130-FC_1,ATACseq
403,6.0,Kings,10/21/2021,A119/20,BBN002.36130,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",95.0,2.0,Unknown,M,19,5.0,2,Control,Ndgen.BandBII,Control,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,1.0,,1.0,,"No abnormalities detected, marked CAA",Senile corporeal degeneration. Heart failure. Chronic kidney disease,,,,,N,,,,,3.0,MAP,,,,A119_20,BBN002_36130,BBN002.36130,IGF128441,EC,,BBN002_36130,BBN002-36130-EC_1,ATACseq
404,6.0,Kings,10/21/2021,A119/20,BBN002.36130,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",95.0,2.0,Unknown,M,19,5.0,2,Control,Ndgen.BandBII,Control,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,1.0,,1.0,,"No abnormalities detected, marked CAA",Senile corporeal degeneration. Heart failure. Chronic kidney disease,,,,,N,,,,,3.0,MAP,,,,A119_20,BBN002_36130,BBN002.36130,IGF125075,MTG,,BBN002_36130,BBN002-36130-MTG_1,ATACseq
405,6.0,Kings,10/21/2021,A119/20,BBN002.36130,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",95.0,2.0,Unknown,M,19,5.0,2,Control,Ndgen.BandBII,Control,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,1.0,,1.0,,"No abnormalities detected, marked CAA",Senile corporeal degeneration. Heart failure. Chronic kidney disease,,,,,N,,,,,3.0,MAP,,,,A119_20,BBN002_36130,BBN002.36130,IGF125047,MTG,,BBN002_36130,BBN002-36130-MTG,RNAseq
406,6.0,Kings,10/21/2021,A026/14,BBN_20618,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",85.0,3.0,White,F,35,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,1.0,,1.0,,Vascular dementia present. Moderate amyloid angiopathy and moderate to severe white matter cerebrovascular disease,,,,,,N,,,,,3.0,MAP,,,,A026_14,BBN_20618,BBN_20618,IGF124276,PFC,,BBN_20618,BBN-20618-FC,
407,6.0,Kings,10/21/2021,A026/14,BBN_20618,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",85.0,3.0,White,F,35,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,1.0,,1.0,,Vascular dementia present. Moderate amyloid angiopathy and moderate to severe white matter cerebrovascular disease,,,,,,N,,,,,3.0,MAP,,,,A026_14,BBN_20618,BBN_20618,IGF124264,MTEMP,,BBN_20618,BBN-20618-MTEMP,
408,6.0,Kings,10/21/2021,A026/14,BBN_20618,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",85.0,3.0,White,F,35,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,1.0,,1.0,,Vascular dementia present. Moderate amyloid angiopathy and moderate to severe white matter cerebrovascular disease,,,,,,N,,,,,3.0,MAP,,,,A026_14,BBN_20618,BBN_20618,IGF123493,MTEMP,,BBN_20618,BBN-20618-MTEMP,
409,6.0,Kings,10/21/2021,A026/14,BBN_20618,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",85.0,3.0,White,F,35,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,1.0,,1.0,,Vascular dementia present. Moderate amyloid angiopathy and moderate to severe white matter cerebrovascular disease,,,,,,N,,,,,3.0,MAP,,,,A026_14,BBN_20618,BBN_20618,IGF123545,PFC,,BBN_20618,BBN-20618-FC,
410,6.0,Kings,10/21/2021,A026/14,BBN_20618,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",85.0,3.0,White,F,35,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,1.0,,1.0,,Vascular dementia present. Moderate amyloid angiopathy and moderate to severe white matter cerebrovascular disease,,,,,,N,,,,,3.0,MAP,,,,A026_14,BBN_20618,BBN_20618,IGF128394,PFC,,BBN_20618,BBN-20618-FC,RNAseq
411,6.0,Kings,10/21/2021,A026/14,BBN_20618,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",85.0,3.0,White,F,35,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,1.0,,1.0,,Vascular dementia present. Moderate amyloid angiopathy and moderate to severe white matter cerebrovascular disease,,,,,,N,,,,,3.0,MAP,,,,A026_14,BBN_20618,BBN_20618,IGF128416,EC,,BBN_20618,BBN-20618-EC,RNAseq
412,6.0,Kings,10/21/2021,A026/14,BBN_20618,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",85.0,3.0,White,F,35,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,1.0,,1.0,,Vascular dementia present. Moderate amyloid angiopathy and moderate to severe white matter cerebrovascular disease,,,,,,N,,,,,3.0,MAP,,,,A026_14,BBN_20618,BBN_20618,IGF128423,PFC,,BBN_20618,BBN-20618-FC_1,ATACseq
413,6.0,Kings,10/21/2021,A026/14,BBN_20618,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",85.0,3.0,White,F,35,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,1.0,,1.0,,Vascular dementia present. Moderate amyloid angiopathy and moderate to severe white matter cerebrovascular disease,,,,,,N,,,,,3.0,MAP,,,,A026_14,BBN_20618,BBN_20618,IGF128445,EC,,BBN_20618,BBN-20618-EC_1,ATACseq
414,6.0,Kings,10/21/2021,A026/14,BBN_20618,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",85.0,3.0,White,F,35,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,1.0,,1.0,,Vascular dementia present. Moderate amyloid angiopathy and moderate to severe white matter cerebrovascular disease,,,,,,N,,,,,3.0,MAP,,,,A026_14,BBN_20618,BBN_20618,IGF125080,MTG,,BBN_20618,BBN-20618-MTG_1,ATACseq
415,6.0,Kings,10/21/2021,A026/14,BBN_20618,2.0,2.0,10.0,10.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum, ChorPlex. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22).",85.0,3.0,White,F,35,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,1.0,,1.0,,Vascular dementia present. Moderate amyloid angiopathy and moderate to severe white matter cerebrovascular disease,,,,,,N,,,,,3.0,MAP,,,,A026_14,BBN_20618,BBN_20618,IGF125052,MTG,,BBN_20618,BBN-20618-MTG,RNAseq
416,6.0,Kings,10/21/2021,A250/14,BBN_24243,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",69.0,3.0,White,F,48,2.0,0,Control,Ndgen.BandB0,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,No abnormally detected,Advanced pancreatic cancer,,,,,N,,,,,3.0,MAP,,,,A250_14,BBN_24243,BBN_24243,IGF123525,MTEMP,,BBN_24243,BBN-24243-MTEMP,
417,6.0,Kings,10/21/2021,A250/14,BBN_24243,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",69.0,3.0,White,F,48,2.0,0,Control,Ndgen.BandB0,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,No abnormally detected,Advanced pancreatic cancer,,,,,N,,,,,3.0,MAP,,,,A250_14,BBN_24243,BBN_24243,IGF123542,PFC,,BBN_24243,BBN-24243-FC,
418,6.0,Kings,10/21/2021,A250/14,BBN_24243,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",69.0,3.0,White,F,48,2.0,0,Control,Ndgen.BandB0,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,No abnormally detected,Advanced pancreatic cancer,,,,,N,,,,,3.0,MAP,,,,A250_14,BBN_24243,BBN_24243,IGF125077,MTG,,BBN_24243,BBN-24243-MTG_1,ATACseq
419,6.0,Kings,10/21/2021,A250/14,BBN_24243,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",69.0,3.0,White,F,48,2.0,0,Control,Ndgen.BandB0,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,No abnormally detected,Advanced pancreatic cancer,,,,,N,,,,,3.0,MAP,,,,A250_14,BBN_24243,BBN_24243,IGF125049,MTG,,BBN_24243,BBN-24243-MTG,RNAseq
420,6.0,Kings,10/21/2021,A282/15,BBN002.26278,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",75.0,2.0,Unknown,M,59,9.0,5,AD,Ndgen.BandBV,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Severe arteriolar amyloid-beta CAA,"Community acquired Pneumonia. Prostate cancer, heart disease, deep vein thrombosis",,,,,N,,,,,3.0,MAP,,,,A282_15,BBN002_26278,BBN002.26278,IGF124271,MTEMP,,BBN002_26278,BBN002-26278-MTEMP,
421,6.0,Kings,10/21/2021,A282/15,BBN002.26278,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",75.0,2.0,Unknown,M,59,9.0,5,AD,Ndgen.BandBV,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Severe arteriolar amyloid-beta CAA,"Community acquired Pneumonia. Prostate cancer, heart disease, deep vein thrombosis",,,,,N,,,,,3.0,MAP,,,,A282_15,BBN002_26278,BBN002.26278,IGF123517,PFC,,BBN002_26278,BBN002-26278-FC,
422,6.0,Kings,10/21/2021,A282/15,BBN002.26278,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",75.0,2.0,Unknown,M,59,9.0,5,AD,Ndgen.BandBV,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Severe arteriolar amyloid-beta CAA,"Community acquired Pneumonia. Prostate cancer, heart disease, deep vein thrombosis",,,,,N,,,,,3.0,MAP,,,,A282_15,BBN002_26278,BBN002.26278,IGF123529,MTEMP,,BBN002_26278,BBN002-26278-MTEMP,
423,6.0,Kings,10/21/2021,A282/15,BBN002.26278,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",75.0,2.0,Unknown,M,59,9.0,5,AD,Ndgen.BandBV,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Severe arteriolar amyloid-beta CAA,"Community acquired Pneumonia. Prostate cancer, heart disease, deep vein thrombosis",,,,,N,,,,,3.0,MAP,,,,A282_15,BBN002_26278,BBN002.26278,IGF128405,PFC,,BBN002_26278,BBN002-26278-FC,RNAseq
424,6.0,Kings,10/21/2021,A282/15,BBN002.26278,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",75.0,2.0,Unknown,M,59,9.0,5,AD,Ndgen.BandBV,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Severe arteriolar amyloid-beta CAA,"Community acquired Pneumonia. Prostate cancer, heart disease, deep vein thrombosis",,,,,N,,,,,3.0,MAP,,,,A282_15,BBN002_26278,BBN002.26278,IGF128434,PFC,,BBN002_26278,BBN002-26278-FC_1,ATACseq
425,6.0,Kings,10/21/2021,A282/15,BBN002.26278,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",75.0,2.0,Unknown,M,59,9.0,5,AD,Ndgen.BandBV,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Severe arteriolar amyloid-beta CAA,"Community acquired Pneumonia. Prostate cancer, heart disease, deep vein thrombosis",,,,,N,,,,,3.0,MAP,,,,A282_15,BBN002_26278,BBN002.26278,IGF125074,MTG,,BBN002_26278,BBN002-26278-MTG_1,ATACseq
426,6.0,Kings,10/21/2021,A282/15,BBN002.26278,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",75.0,2.0,Unknown,M,59,9.0,5,AD,Ndgen.BandBV,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Severe arteriolar amyloid-beta CAA,"Community acquired Pneumonia. Prostate cancer, heart disease, deep vein thrombosis",,,,,N,,,,,3.0,MAP,,,,A282_15,BBN002_26278,BBN002.26278,IGF125046,MTG,,BBN002_26278,BBN002-26278-MTG,RNAseq
427,6.0,Kings,10/21/2021,A141/18,BBN002.32844,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",81.0,3.0,White,F,42,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,1.0,,1.0,,No abnormally detected,,,,,,N,,,,,3.0,MAP,,,,A141_18,BBN002_32844,BBN002.32844,IGF123503,PFC,,BBN002_32844,BBN002-32844-FC,
428,6.0,Kings,10/21/2021,A141/18,BBN002.32844,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",81.0,3.0,White,F,42,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,1.0,,1.0,,No abnormally detected,,,,,,N,,,,,3.0,MAP,,,,A141_18,BBN002_32844,BBN002.32844,IGF123547,MTEMP,,BBN002_32844,BBN002-32844-MTEMP,
429,6.0,Kings,10/21/2021,A141/18,BBN002.32844,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",81.0,3.0,White,F,42,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,1.0,,1.0,,No abnormally detected,,,,,,N,,,,,3.0,MAP,,,,A141_18,BBN002_32844,BBN002.32844,IGF128395,PFC,,BBN002_32844,BBN002-32844-FC,RNAseq
430,6.0,Kings,10/21/2021,A141/18,BBN002.32844,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",81.0,3.0,White,F,42,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,1.0,,1.0,,No abnormally detected,,,,,,N,,,,,3.0,MAP,,,,A141_18,BBN002_32844,BBN002.32844,IGF128424,PFC,,BBN002_32844,BBN002-32844-FC_1,ATACseq
431,6.0,Kings,10/21/2021,A141/18,BBN002.32844,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",81.0,3.0,White,F,42,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,1.0,,1.0,,No abnormally detected,,,,,,N,,,,,3.0,MAP,,,,A141_18,BBN002_32844,BBN002.32844,IGF125071,MTG,,BBN002_32844,BBN002-32844-MTG_1,ATACseq
432,6.0,Kings,10/21/2021,A141/18,BBN002.32844,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",81.0,3.0,White,F,42,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,1.0,,1.0,,No abnormally detected,,,,,,N,,,,,3.0,MAP,,,,A141_18,BBN002_32844,BBN002.32844,IGF125043,MTG,,BBN002_32844,BBN002-32844-MTG,RNAseq
0,2.0,Newcastle,,19891015,BBN003.32181,,,,,SOM X,77.0,,,F,36,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19891015,BBN003_32181,BBN003.32181,IGF122205,EC,,19891015,19891015-EC,
1,2.0,Newcastle,,19891015,BBN003.32181,,,,,SOM X,77.0,,,F,36,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19891015,BBN003_32181,BBN003.32181,IGF120775,MTG,,19891015,19891015-MTG_1,
2,2.0,Newcastle,,19891015,BBN003.32181,,,,,SOM X,77.0,,,F,36,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19891015,BBN003_32181,BBN003.32181,IGF120795,SSC,,19891015,19891015-SSC_1,
3,2.0,Newcastle,,19891015,BBN003.32181,,,,,SOM X,77.0,,,F,36,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19891015,BBN003_32181,BBN003.32181,IGF117797,SOM,,19891015,19891015-SOM,
4,2.0,Newcastle,,19891015,BBN003.32181,,,,,SOM X,77.0,,,F,36,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19891015,BBN003_32181,BBN003.32181,IGF117774,MTEMP,,19891015,19891015-MTEMP,
5,2.0,Newcastle,,19891053,BBN003.32184,,,,,"EC,MTEMP,SOM X",77.0,,,M,43,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19891053,BBN003_32184,BBN003.32184,IGF122181,EC,,19891053,19891053-EC,
6,2.0,Newcastle,,19891053,BBN003.32184,,,,,"EC,MTEMP,SOM X",77.0,,,M,43,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19891053,BBN003_32184,BBN003.32184,IGF120772,EC,,19891053,19891053-EC_1,
7,2.0,Newcastle,,19891053,BBN003.32184,,,,,"EC,MTEMP,SOM X",77.0,,,M,43,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19891053,BBN003_32184,BBN003.32184,IGF120791,SSC,,19891053,19891053-SSC_1,
8,2.0,Newcastle,,19891053,BBN003.32184,,,,,"EC,MTEMP,SOM X",77.0,,,M,43,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19891053,BBN003_32184,BBN003.32184,IGF117752,SOM,,19891053,19891053-SOM,
9,2.0,Newcastle,,19891053,BBN003.32184,,,,,"EC,MTEMP,SOM X",77.0,,,M,43,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19891053,BBN003_32184,BBN003.32184,IGF117819,MTEMP,,19891053,19891053-MTEMP,
10,2.0,Newcastle,,19910006,BBN003.32185,,,,,"EC,MTEMP,SOM ",67.0,,,F,8,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E4/E4,,Y,2.0,none,,,2.0,TREM2,,,,19910006,BBN003_32185,BBN003.32185,IGF122112,SSC,,19910006,19910006-SSC,
11,2.0,Newcastle,,19910006,BBN003.32185,,,,,"EC,MTEMP,SOM ",67.0,,,F,8,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E4/E4,,Y,2.0,none,,,2.0,TREM2,,,,19910006,BBN003_32185,BBN003.32185,IGF122136,EC,,19910006,19910006-EC,
12,2.0,Newcastle,,19910006,BBN003.32185,,,,,"EC,MTEMP,SOM ",67.0,,,F,8,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E4/E4,,Y,2.0,none,,,2.0,TREM2,,,,19910006,BBN003_32185,BBN003.32185,IGF117807,MTEMP,,19910006,19910006-MTEMP,
13,2.0,Newcastle,,19910318,BBN003.32194,,,,,"EC,MTEMP,SOM X",75.0,,,F,27,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,19910318,BBN003_32194,BBN003.32194,IGF122218,EC,,19910318,19910318-EC,
14,2.0,Newcastle,,19910318,BBN003.32194,,,,,"EC,MTEMP,SOM X",75.0,,,F,27,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,19910318,BBN003_32194,BBN003.32194,IGF120788,SSC,,19910318,19910318-SSC_1,
15,2.0,Newcastle,,19910318,BBN003.32194,,,,,"EC,MTEMP,SOM X",75.0,,,F,27,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,19910318,BBN003_32194,BBN003.32194,IGF117777,SOM,,19910318,19910318-SOM,
16,2.0,Newcastle,,19910318,BBN003.32194,,,,,"EC,MTEMP,SOM X",75.0,,,F,27,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,19910318,BBN003_32194,BBN003.32194,IGF117781,MTEMP,,19910318,19910318-MTEMP,
17,2.0,Newcastle,,19910334,BBN003.32196,,,,,"EC,MTEMP,SOM ",77.0,,,F,48,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3,,Y,2.0,none,,,2.0,TREM2,,,,19910334,BBN003_32196,BBN003.32196,IGF122098,EC,,19910334,19910334-EC,
18,2.0,Newcastle,,19910334,BBN003.32196,,,,,"EC,MTEMP,SOM ",77.0,,,F,48,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3,,Y,2.0,none,,,2.0,TREM2,,,,19910334,BBN003_32196,BBN003.32196,IGF122244,SSC,,19910334,19910334-SSC,
19,2.0,Newcastle,,19910334,BBN003.32196,,,,,"EC,MTEMP,SOM ",77.0,,,F,48,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3,,Y,2.0,none,,,2.0,TREM2,,,,19910334,BBN003_32196,BBN003.32196,IGF117810,MTEMP,,19910334,19910334-MTEMP,
20,2.0,Newcastle,,19920001,BBN_24610,,,,,"EC,MTEMP,SOM X",68.0,,,M,48,11.0,6,AD,Ndgen.BandBVI,Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19920001,BBN_24610,BBN_24610,IGF122171,EC,,19920001,19920001-EC,
21,2.0,Newcastle,,19920001,BBN_24610,,,,,"EC,MTEMP,SOM X",68.0,,,M,48,11.0,6,AD,Ndgen.BandBVI,Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19920001,BBN_24610,BBN_24610,IGF120782,SSC,,19920001,19920001-SSC_1,
22,2.0,Newcastle,,19920001,BBN_24610,,,,,"EC,MTEMP,SOM X",68.0,,,M,48,11.0,6,AD,Ndgen.BandBVI,Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19920001,BBN_24610,BBN_24610,IGF117820,MTEMP,,19920001,19920001-MTEMP,
23,2.0,Newcastle,,19920001,BBN_24610,,,,,"EC,MTEMP,SOM X",68.0,,,M,48,11.0,6,AD,Ndgen.BandBVI,Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19920001,BBN_24610,BBN_24610,IGF117749,SOM,,19920001,19920001-SOM,
24,2.0,Newcastle,,19920035,BBN003.32201,,,,,"EC,MTEMP,SOM ",79.0,,,F,24,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19920035,BBN003_32201,BBN003.32201,IGF122140,EC,,19920035,19920035-EC,
25,2.0,Newcastle,,19920035,BBN003.32201,,,,,"EC,MTEMP,SOM ",79.0,,,F,24,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19920035,BBN003_32201,BBN003.32201,IGF122152,SSC,,19920035,19920035-SSC,
26,2.0,Newcastle,,19920035,BBN003.32201,,,,,"EC,MTEMP,SOM ",79.0,,,F,24,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19920035,BBN003_32201,BBN003.32201,IGF117815,MTEMP,,19920035,19920035-MTEMP,
27,2.0,Newcastle,,19920077,BBN003.32205,,,,,"EC,MTEMP,SOM ",76.0,,,M,30,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19920077,BBN003_32205,BBN003.32205,IGF122134,SSC,,19920077,19920077-SSC,
28,2.0,Newcastle,,19920077,BBN003.32205,,,,,"EC,MTEMP,SOM ",76.0,,,M,30,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19920077,BBN003_32205,BBN003.32205,IGF122229,EC,,19920077,19920077-EC,
29,2.0,Newcastle,,19920077,BBN003.32205,,,,,"EC,MTEMP,SOM ",76.0,,,M,30,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19920077,BBN003_32205,BBN003.32205,IGF117800,MTEMP,,19920077,19920077-MTEMP,
30,2.0,Newcastle,,19920179,BBN003.32209,,,,,"EC,MTEMP,SOM X",58.0,,,M,28,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,19920179,BBN003_32209,BBN003.32209,IGF122142,EC,,19920179,19920179-EC,
31,2.0,Newcastle,,19920179,BBN003.32209,,,,,"EC,MTEMP,SOM X",58.0,,,M,28,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,19920179,BBN003_32209,BBN003.32209,IGF120771,EC,,19920179,19920179-EC_1,
32,2.0,Newcastle,,19920179,BBN003.32209,,,,,"EC,MTEMP,SOM X",58.0,,,M,28,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,19920179,BBN003_32209,BBN003.32209,IGF120776,MTG,,19920179,19920179-MTG_1,
33,2.0,Newcastle,,19920179,BBN003.32209,,,,,"EC,MTEMP,SOM X",58.0,,,M,28,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,19920179,BBN003_32209,BBN003.32209,IGF117755,SOM,,19920179,19920179-SOM,
34,2.0,Newcastle,,19920179,BBN003.32209,,,,,"EC,MTEMP,SOM X",58.0,,,M,28,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,19920179,BBN003_32209,BBN003.32209,IGF117805,MTEMP,,19920179,19920179-MTEMP,
35,2.0,Newcastle,,19920194,BBN003.32211,,,,,"EC,MTEMP,SOM X",72.0,,,M,15,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E4/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,19920194,BBN003_32211,BBN003.32211,IGF122195,EC,,19920194,19920194-EC,
36,2.0,Newcastle,,19920194,BBN003.32211,,,,,"EC,MTEMP,SOM X",72.0,,,M,15,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E4/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,19920194,BBN003_32211,BBN003.32211,IGF120777,MTG,,19920194,19920194-MTG_1,
37,2.0,Newcastle,,19920194,BBN003.32211,,,,,"EC,MTEMP,SOM X",72.0,,,M,15,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E4/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,19920194,BBN003_32211,BBN003.32211,IGF120786,SSC,,19920194,19920194-SSC_1,
38,2.0,Newcastle,,19920194,BBN003.32211,,,,,"EC,MTEMP,SOM X",72.0,,,M,15,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E4/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,19920194,BBN003_32211,BBN003.32211,IGF117762,SOM,,19920194,19920194-SOM,
39,2.0,Newcastle,,19920194,BBN003.32211,,,,,"EC,MTEMP,SOM X",72.0,,,M,15,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E4/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,19920194,BBN003_32211,BBN003.32211,IGF117785,MTEMP,,19920194,19920194-MTEMP,
40,2.0,Newcastle,,19920200,BBN003.32212,,,,,"EC,MTEMP,SOM ",64.0,,,M,10,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,prevously E3/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19920200,BBN003_32212,BBN003.32212,IGF122135,EC,,19920200,19920200-EC,
41,2.0,Newcastle,,19920200,BBN003.32212,,,,,"EC,MTEMP,SOM ",64.0,,,M,10,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,prevously E3/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19920200,BBN003_32212,BBN003.32212,IGF117769,SOM,,19920200,19920200-SOM,
42,2.0,Newcastle,,19920200,BBN003.32212,,,,,"EC,MTEMP,SOM ",64.0,,,M,10,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,prevously E3/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19920200,BBN003_32212,BBN003.32212,IGF117803,MTEMP,,19920200,19920200-MTEMP,
43,2.0,Newcastle,,19930148,BBN003.32227,,,,,"EC,MTEMP,SOM ",66.0,,,M,41,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19930148,BBN003_32227,BBN003.32227,IGF122096,EC,,19930148,19930148-EC,
44,2.0,Newcastle,,19930148,BBN003.32227,,,,,"EC,MTEMP,SOM ",66.0,,,M,41,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19930148,BBN003_32227,BBN003.32227,IGF117784,MTEMP,,19930148,19930148-MTEMP,
45,2.0,Newcastle,,19930154,BBN003.32228,,,,,"EC,MTEMP,SOM ",69.0,,,M,8,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19930154,BBN003_32228,BBN003.32228,IGF122233,SSC,,19930154,19930154-SSC,
46,2.0,Newcastle,,19930154,BBN003.32228,,,,,"EC,MTEMP,SOM ",69.0,,,M,8,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19930154,BBN003_32228,BBN003.32228,IGF122238,EC,,19930154,19930154-EC,
47,2.0,Newcastle,,19930154,BBN003.32228,,,,,"EC,MTEMP,SOM ",69.0,,,M,8,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19930154,BBN003_32228,BBN003.32228,IGF117789,MTEMP,,19930154,19930154-MTEMP,
48,2.0,Newcastle,,19930222,BBN003.32235,,,,,"EC,MTEMP,SOM ",67.0,,,M,48,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,previously E2/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19930222,BBN003_32235,BBN003.32235,IGF122146,EC,,19930222,19930222-EC,
49,2.0,Newcastle,,19930222,BBN003.32235,,,,,"EC,MTEMP,SOM ",67.0,,,M,48,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,previously E2/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19930222,BBN003_32235,BBN003.32235,IGF122161,SSC,,19930222,19930222-SSC,
50,2.0,Newcastle,,19930222,BBN003.32235,,,,,"EC,MTEMP,SOM ",67.0,,,M,48,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,previously E2/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,19930222,BBN003_32235,BBN003.32235,IGF117756,MTEMP,,19930222,19930222-MTEMP,
51,2.0,Newcastle,,19950030,BBN003.32247,,,,,"EC,MTEMP,SOM X",62.0,,,M,48,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19950030,BBN003_32247,BBN003.32247,IGF122185,EC,,19950030,19950030-EC,
52,2.0,Newcastle,,19950030,BBN003.32247,,,,,"EC,MTEMP,SOM X",62.0,,,M,48,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19950030,BBN003_32247,BBN003.32247,IGF120787,MTG,,19950030,19950030-MTG_1,
53,2.0,Newcastle,,19950030,BBN003.32247,,,,,"EC,MTEMP,SOM X",62.0,,,M,48,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19950030,BBN003_32247,BBN003.32247,IGF120792,SSC,,19950030,19950030-SSC_1,
54,2.0,Newcastle,,19950030,BBN003.32247,,,,,"EC,MTEMP,SOM X",62.0,,,M,48,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19950030,BBN003_32247,BBN003.32247,IGF117746,SOM,,19950030,19950030-SOM,
55,2.0,Newcastle,,19950030,BBN003.32247,,,,,"EC,MTEMP,SOM X",62.0,,,M,48,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19950030,BBN003_32247,BBN003.32247,IGF117801,MTEMP,,19950030,19950030-MTEMP,
56,2.0,Newcastle,,19950136,BBN003.26332,,,,,"EC,MTEMP,SOM ",87.0,,,F,10,9.0,5,AD,Ndgen.BandBV,Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,2.0,none,,,2.0,TREM2,,,,19950136,BBN003_26332,BBN003.26332,IGF122085,EC,,19950136,19950136-EC,
57,2.0,Newcastle,,19950136,BBN003.26332,,,,,"EC,MTEMP,SOM ",87.0,,,F,10,9.0,5,AD,Ndgen.BandBV,Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,2.0,none,,,2.0,TREM2,,,,19950136,BBN003_26332,BBN003.26332,IGF122124,SSC,,19950136,19950136-SSC,
58,2.0,Newcastle,,19950136,BBN003.26332,,,,,"EC,MTEMP,SOM ",87.0,,,F,10,9.0,5,AD,Ndgen.BandBV,Severe,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,2.0,none,,,2.0,TREM2,,,,19950136,BBN003_26332,BBN003.26332,IGF122225,MTG,,19950136,19950136-MTG,
59,2.0,Newcastle,,19960052,BBN003.26333,,,,,"EC,MTEMP,SOM ",88.0,,,F,9,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,19960052,BBN003_26333,BBN003.26333,IGF122083,SSC,,19960052,19960052-SSC,
60,2.0,Newcastle,,19960052,BBN003.26333,,,,,"EC,MTEMP,SOM ",88.0,,,F,9,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,19960052,BBN003_26333,BBN003.26333,IGF122141,MTG,,19960052,19960052-MTG,
61,2.0,Newcastle,,19960052,BBN003.26333,,,,,"EC,MTEMP,SOM ",88.0,,,F,9,1.0,,AD,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,19960052,BBN003_26333,BBN003.26333,IGF122151,EC,,19960052,19960052-EC,
62,2.0,Newcastle,,19960064,BBN003.32261,,,,,MTEMP X,72.0,,,F,28,3.0,1,Control,Ndgen.BandBI,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19960064,BBN003_32261,BBN003.32261,IGF122114,EC,,19960064,19960064-EC,
63,2.0,Newcastle,,19960064,BBN003.32261,,,,,MTEMP X,72.0,,,F,28,3.0,1,Control,Ndgen.BandBI,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19960064,BBN003_32261,BBN003.32261,IGF122188,MTG,,19960064,19960064-MTG,
64,2.0,Newcastle,,19960064,BBN003.32261,,,,,MTEMP X,72.0,,,F,28,3.0,1,Control,Ndgen.BandBI,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19960064,BBN003_32261,BBN003.32261,IGF122208,MTG,,19960064,19960064-MTG-2,
65,2.0,Newcastle,,19960064,BBN003.32261,,,,,MTEMP X,72.0,,,F,28,3.0,1,Control,Ndgen.BandBI,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19960064,BBN003_32261,BBN003.32261,IGF120767,SSC,,19960064,19960064-SSC_1,
66,2.0,Newcastle,,19960064,BBN003.32261,,,,,MTEMP X,72.0,,,F,28,3.0,1,Control,Ndgen.BandBI,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19960064,BBN003_32261,BBN003.32261,IGF120769,MTG,,19960064,19960064-MTG_1,
67,2.0,Newcastle,,19960064,BBN003.32261,,,,,MTEMP X,72.0,,,F,28,3.0,1,Control,Ndgen.BandBI,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E3/E4; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,19960064,BBN003_32261,BBN003.32261,IGF117818,MTEMP,,19960064,19960064-MTEMP,
68,2.0,Newcastle,,19980098,BBN003.32295,,,,,"EC,MTEMP,SOM ",75.0,,,F,27,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,19980098,BBN003_32295,BBN003.32295,IGF122094,EC,,19980098,19980098-EC,
69,2.0,Newcastle,,19980098,BBN003.32295,,,,,"EC,MTEMP,SOM ",75.0,,,F,27,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,19980098,BBN003_32295,BBN003.32295,IGF122110,MTG,,19980098,19980098-MTG,
70,2.0,Newcastle,,19980098,BBN003.32295,,,,,"EC,MTEMP,SOM ",75.0,,,F,27,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,19980098,BBN003_32295,BBN003.32295,IGF122226,SSC,,19980098,19980098-SSC,
71,2.0,Newcastle,,20000034,BBN_6122,,,,,"EC,SOM X",70.0,,,M,119,2.0,0,Control,Ndgen.BandB0,Control,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,20000034,BBN_6122,BBN_6122,IGF122148,EC,,20000034,20000034-EC,
72,2.0,Newcastle,,20000034,BBN_6122,,,,,"EC,SOM X",70.0,,,M,119,2.0,0,Control,Ndgen.BandB0,Control,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,20000034,BBN_6122,BBN_6122,IGF122211,MTG,,20000034,20000034-MTG,
73,2.0,Newcastle,,20030099,BBN_7333,,,,,"EC,MTEMP,SOM X",89.0,,,F,49,7.0,4,AD,Ndgen.BandBIV,Moderate,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,20030099,BBN_7333,BBN_7333,IGF122089,EC,,20030099,20030099-EC,
74,2.0,Newcastle,,20030099,BBN_7333,,,,,"EC,MTEMP,SOM X",89.0,,,F,49,7.0,4,AD,Ndgen.BandBIV,Moderate,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,20030099,BBN_7333,BBN_7333,IGF122107,MTG,,20030099,20030099-MTG,
75,2.0,Newcastle,,20030099,BBN_7333,,,,,"EC,MTEMP,SOM X",89.0,,,F,49,7.0,4,AD,Ndgen.BandBIV,Moderate,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,20030099,BBN_7333,BBN_7333,IGF122133,SSC,,20030099,20030099-SSC,
76,2.0,Newcastle,,20050033,BBN_2625,,,,,"EC,MTEMP,SOM X",75.0,,,M,28,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,20050033,BBN_2625,BBN_2625,IGF122105,SSC,,20050033,20050033-SSC,
77,2.0,Newcastle,,20050033,BBN_2625,,,,,"EC,MTEMP,SOM X",75.0,,,M,28,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,20050033,BBN_2625,BBN_2625,IGF122204,EC,,20050033,20050033-EC,
78,2.0,Newcastle,,20050033,BBN_2625,,,,,"EC,MTEMP,SOM X",75.0,,,M,28,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,20050033,BBN_2625,BBN_2625,IGF122223,MTG,,20050033,20050033-MTG-,
79,2.0,Newcastle,,20050102,BBN_7115,,,,,"EC,MTEMP,SOM ",72.0,,,M,17,3.0,1,Control,Ndgen.BandBI,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20050102,BBN_7115,BBN_7115,IGF122128,SSC,,20050102,20050102-SSC,
80,2.0,Newcastle,,20050102,BBN_7115,,,,,"EC,MTEMP,SOM ",72.0,,,M,17,3.0,1,Control,Ndgen.BandBI,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20050102,BBN_7115,BBN_7115,IGF122144,MTG,,20050102,20050102-MTG,
81,2.0,Newcastle,,20050102,BBN_7115,,,,,"EC,MTEMP,SOM ",72.0,,,M,17,3.0,1,Control,Ndgen.BandBI,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20050102,BBN_7115,BBN_7115,IGF122200,EC,,20050102,20050102-EC,
82,2.0,Newcastle,,20060093,BBN_7403,,,,,"EC,MTEMP,SOM ",78.0,,,F,23,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20060093,BBN_7403,BBN_7403,IGF122090,EC,,20060093,20060093-EC,
83,2.0,Newcastle,,20060093,BBN_7403,,,,,"EC,MTEMP,SOM ",78.0,,,F,23,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20060093,BBN_7403,BBN_7403,IGF122100,MTG,,20060093,20060093-MTG,
84,2.0,Newcastle,,20060093,BBN_7403,,,,,"EC,MTEMP,SOM ",78.0,,,F,23,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20060093,BBN_7403,BBN_7403,IGF122154,SSC,,20060093,20060093-SSC,
85,2.0,Newcastle,,20060099,BBN_7404,,,,,"EC,MTEMP,SOM ",89.0,,,F,24,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20060099,BBN_7404,BBN_7404,IGF122092,SSC,,20060099,20060099-SSC,
86,2.0,Newcastle,,20060099,BBN_7404,,,,,"EC,MTEMP,SOM ",89.0,,,F,24,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20060099,BBN_7404,BBN_7404,IGF122137,MTG,,20060099,20060099-MTG,
87,2.0,Newcastle,,20060099,BBN_7404,,,,,"EC,MTEMP,SOM ",89.0,,,F,24,5.0,2,Control,Ndgen.BandBII,Control,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20060099,BBN_7404,BBN_7404,IGF122237,EC,,20060099,20060099-EC,
88,2.0,Newcastle,,20100742,BBN_7519,,,,,"EC,MTEMP,SOM ",67.0,,,M,22,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,,,,20100742,BBN_7519,BBN_7519,IGF122104,EC,,20100742,20100742-EC,
89,2.0,Newcastle,,20100742,BBN_7519,,,,,"EC,MTEMP,SOM ",67.0,,,M,22,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,,,,20100742,BBN_7519,BBN_7519,IGF117748,SOM,,20100742,20100742-SOM,
90,2.0,Newcastle,,20100742,BBN_7519,,,,,"EC,MTEMP,SOM ",67.0,,,M,22,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,,,,20100742,BBN_7519,BBN_7519,IGF117772,MTEMP,,20100742,20100742-MTEMP,
91,2.0,Newcastle,,20110137,BBN_7540,,,,,"EC,MTEMP,SOM ",75.0,,,F,33,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,20110137,BBN_7540,BBN_7540,IGF122242,SSC,,20110137,20110137-SSC,
92,2.0,Newcastle,,20110137,BBN_7540,,,,,"EC,MTEMP,SOM ",75.0,,,F,33,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,20110137,BBN_7540,BBN_7540,IGF120773,MTG,,20110137,20110137-MTG_1,
93,2.0,Newcastle,,20110137,BBN_7540,,,,,"EC,MTEMP,SOM ",75.0,,,F,33,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,20110137,BBN_7540,BBN_7540,IGF117778,MTEMP,,20110137,20110137-MTEMP,
94,2.0,Newcastle,,20110272,BBN_7545,,,,,"EC,MTEMP,SOM ",78.0,,,F,34,2.0,0,Control,Ndgen.BandB0,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20110272,BBN_7545,BBN_7545,IGF122099,MTG,,20110272,20110272-MTG,
95,2.0,Newcastle,,20110272,BBN_7545,,,,,"EC,MTEMP,SOM ",78.0,,,F,34,2.0,0,Control,Ndgen.BandB0,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20110272,BBN_7545,BBN_7545,IGF122125,EC,,20110272,20110272-EC,
96,2.0,Newcastle,,20110272,BBN_7545,,,,,"EC,MTEMP,SOM ",78.0,,,F,34,2.0,0,Control,Ndgen.BandB0,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20110272,BBN_7545,BBN_7545,IGF122127,SSC,,20110272,20110272-SSC,
97,2.0,Newcastle,,20110476,BBN_7554,,,,,"EC,MTEMP,SOM X",65.0,,,M,22,2.0,0,Control,Ndgen.BandB0,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,20110476,BBN_7554,BBN_7554,IGF122177,EC,,20110476,20110476-EC,
98,2.0,Newcastle,,20110476,BBN_7554,,,,,"EC,MTEMP,SOM X",65.0,,,M,22,2.0,0,Control,Ndgen.BandB0,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,20110476,BBN_7554,BBN_7554,IGF122203,SSC,,20110476,20110476-SSC,
99,2.0,Newcastle,,20110476,BBN_7554,,,,,"EC,MTEMP,SOM X",65.0,,,M,22,2.0,0,Control,Ndgen.BandB0,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,20110476,BBN_7554,BBN_7554,IGF122241,MTG,,20110476,20110476-MTG,
100,2.0,Newcastle,,20110477,BBN_7555,,,,,MTEMP/SOM X,95.0,,,F,66,6.0,3,AD,Ndgen.BandBIII,Moderate,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,20110477,BBN_7555,BBN_7555,IGF122216,SSC,,20110477,20110477-SSC-2,
101,2.0,Newcastle,,20110477,BBN_7555,,,,,MTEMP/SOM X,95.0,,,F,66,6.0,3,AD,Ndgen.BandBIII,Moderate,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,20110477,BBN_7555,BBN_7555,IGF122230,SSC,,20110477,20110477-SSC,
102,2.0,Newcastle,,20129990,BBN_7617,,,,,"EC,MTEMP,SOM ",78.0,,,F,40,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,20129990,BBN_7617,BBN_7617,IGF122129,EC,,20129990,20129990-EC,
103,2.0,Newcastle,,20129990,BBN_7617,,,,,"EC,MTEMP,SOM ",78.0,,,F,40,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,20129990,BBN_7617,BBN_7617,IGF122143,SSC,,20129990,20129990-SSC,
104,2.0,Newcastle,,20129990,BBN_7617,,,,,"EC,MTEMP,SOM ",78.0,,,F,40,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E3/E3; Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,20129990,BBN_7617,BBN_7617,IGF117759,MTEMP,,20129990,20129990-MTEMP,
105,2.0,Newcastle,,20130325,BBN_14795,,,,,"EC,MTEMP,SOM X",76.0,,,M,23,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,previously E3/E3,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,20130325,BBN_14795,BBN_14795,IGF122158,EC,,20130325,20130325-EC,
106,2.0,Newcastle,,20130325,BBN_14795,,,,,"EC,MTEMP,SOM X",76.0,,,M,23,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,previously E3/E3,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,20130325,BBN_14795,BBN_14795,IGF120790,SSC,,20130325,20130325-SSC_1,
107,2.0,Newcastle,,20130325,BBN_14795,,,,,"EC,MTEMP,SOM X",76.0,,,M,23,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,previously E3/E3,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,20130325,BBN_14795,BBN_14795,IGF117821,MTEMP,,20130325,20130325-MTEMP,
108,2.0,Newcastle,,20130325,BBN_14795,,,,,"EC,MTEMP,SOM X",76.0,,,M,23,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,previously E3/E3,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,20130325,BBN_14795,BBN_14795,IGF117768,SOM,,20130325,20130325-SOM,
109,2.0,Newcastle,,20130400,BBN_14801,,,,,"EC,MTEMP,SOM ",65.0,,,F,47,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20130400,BBN_14801,BBN_14801,IGF122101,SSC,,20130400,20130400-SSC,
110,2.0,Newcastle,,20130400,BBN_14801,,,,,"EC,MTEMP,SOM ",65.0,,,F,47,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20130400,BBN_14801,BBN_14801,IGF122106,EC,,20130400,20130400-EC,
111,2.0,Newcastle,,20130400,BBN_14801,,,,,"EC,MTEMP,SOM ",65.0,,,F,47,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20130400,BBN_14801,BBN_14801,IGF122119,MTG,,20130400,20130400-MTG,
112,2.0,Newcastle,,20130871,BBN_19191,,,,,MTEMP X,76.0,,,M,53,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,7.0,R47H,rs75932628,,2.0,TREM2,,,,20130871,BBN_19191,BBN_19191,IGF122088,SSC,,20130871,20130871-SSC,
113,2.0,Newcastle,,20131157,BBN_19214,,,,,"EC,MTEMP,SOM ",80.0,,,M,28,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20131157,BBN_19214,BBN_19214,IGF122087,SSC,,20131157,20131157-SSC,
114,2.0,Newcastle,,20131157,BBN_19214,,,,,"EC,MTEMP,SOM ",80.0,,,M,28,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20131157,BBN_19214,BBN_19214,IGF122108,EC,,20131157,20131157-EC,
115,2.0,Newcastle,,20131157,BBN_19214,,,,,"EC,MTEMP,SOM ",80.0,,,M,28,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20131157,BBN_19214,BBN_19214,IGF122159,MTG,,20131157,20131157-MTG,
116,2.0,Newcastle,,20141901,BBN_24279,,,,,"EC,MTEMP,SOM ",80.0,,,F,25,5.0,2,Control,Ndgen.BandBII,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20141901,BBN_24279,BBN_24279,IGF122126,EC,,20141901,20141901-EC,
117,2.0,Newcastle,,20141901,BBN_24279,,,,,"EC,MTEMP,SOM ",80.0,,,F,25,5.0,2,Control,Ndgen.BandBII,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20141901,BBN_24279,BBN_24279,IGF122183,SSC,,20141901,20141901-SSC,
118,2.0,Newcastle,,20141901,BBN_24279,,,,,"EC,MTEMP,SOM ",80.0,,,F,25,5.0,2,Control,Ndgen.BandBII,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20141901,BBN_24279,BBN_24279,IGF122220,MTG,,20141901,20141901-MTG,
119,2.0,Newcastle,,20150712,BBN003.26941,,,,,"EC,MTEMP,SOM ",74.0,,,M,26,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E2/E3,,Y,2.0,none,,,2.0,TREM2,,,,20150712,BBN003_26941,BBN003.26941,IGF122219,EC,,20150712,20150712-EC,
120,2.0,Newcastle,,20150712,BBN003.26941,,,,,"EC,MTEMP,SOM ",74.0,,,M,26,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E2/E3,,Y,2.0,none,,,2.0,TREM2,,,,20150712,BBN003_26941,BBN003.26941,IGF122245,SSC,,20150712,20150712-SSC,
121,2.0,Newcastle,,20150712,BBN003.26941,,,,,"EC,MTEMP,SOM ",74.0,,,M,26,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previously E2/E3,,Y,2.0,none,,,2.0,TREM2,,,,20150712,BBN003_26941,BBN003.26941,IGF117813,MTEMP,,20150712,20150712-MTEMP,
122,2.0,Newcastle,,20150975,BBN003.26951,,,,,"EC,MTEMP,SOM ",79.0,,,M,39,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20150975,BBN003_26951,BBN003.26951,IGF122153,EC,,20150975,20150975-EC,
123,2.0,Newcastle,,20150975,BBN003.26951,,,,,"EC,MTEMP,SOM ",79.0,,,M,39,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20150975,BBN003_26951,BBN003.26951,IGF122182,SSC,,20150975,20150975-SSC,
124,2.0,Newcastle,,20150975,BBN003.26951,,,,,"EC,MTEMP,SOM ",79.0,,,M,39,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20150975,BBN003_26951,BBN003.26951,IGF122191,MTG,,20150975,20150975-MTG,
125,2.0,Newcastle,,20152915,BBN003.28342,,,,,"EC,MTEMP,SOM ",84.0,,,M,45,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20152915,BBN003_28342,BBN003.28342,IGF122082,SSC,,20152915,20152915-SSC,
126,2.0,Newcastle,,20152915,BBN003.28342,,,,,"EC,MTEMP,SOM ",84.0,,,M,45,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20152915,BBN003_28342,BBN003.28342,IGF122109,MTG,,20152915,20152915-MTG,
127,2.0,Newcastle,,20152915,BBN003.28342,,,,,"EC,MTEMP,SOM ",84.0,,,M,45,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20152915,BBN003_28342,BBN003.28342,IGF122160,EC,,20152915,20152915-EC,
128,2.0,Newcastle,,20174902,BBN003.29735,,,,,"EC,MTEMP,SOM ",94.0,,,F,31,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,20174902,BBN003_29735,BBN003.29735,IGF122168,MTG,,20174902,20174902-MTG,
129,2.0,Newcastle,,20174902,BBN003.29735,,,,,"EC,MTEMP,SOM ",94.0,,,F,31,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,20174902,BBN003_29735,BBN003.29735,IGF122187,EC,,20174902,20174902-EC,
130,2.0,Newcastle,,20174902,BBN003.29735,,,,,"EC,MTEMP,SOM ",94.0,,,F,31,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,20174902,BBN003_29735,BBN003.29735,IGF122194,SSC,,20174902,20174902-SSC,
131,2.0,Newcastle,,20185910,BBN003.32849,,,,,"EC,MTEMP,SOM ",71.0,,,F,43,3.0,1,Control,Ndgen.BandBI,Control,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20185910,BBN003_32849,BBN003.32849,IGF122115,EC,,20185910,20185910-EC,
132,2.0,Newcastle,,20185910,BBN003.32849,,,,,"EC,MTEMP,SOM ",71.0,,,F,43,3.0,1,Control,Ndgen.BandBI,Control,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20185910,BBN003_32849,BBN003.32849,IGF122210,SSC,,20185910,20185910-SSC,
133,2.0,Newcastle,,20185935,BBN003.33729,,,,,"EC,MTEMP,SOM ",70.0,,,M,16,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,20185935,BBN003_33729,BBN003.33729,IGF122175,EC,,20185935,20185935-EC,
134,2.0,Newcastle,,20185935,BBN003.33729,,,,,"EC,MTEMP,SOM ",70.0,,,M,16,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,20185935,BBN003_33729,BBN003.33729,IGF122243,SSC,,20185935,20185935-SSC,
135,2.0,Newcastle,,20185935,BBN003.33729,,,,,"EC,MTEMP,SOM ",70.0,,,M,16,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,Y,2.0,none,,,2.0,TREM2,,,,20185935,BBN003_33729,BBN003.33729,IGF117794,MTEMP,,20185935,20185935-MTEMP,
136,2.0,Newcastle,,20185945,BBN003.34161,,,,,"EC,MTEMP,SOM ",87.0,,,M,46,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20185945,BBN003_34161,BBN003.34161,IGF122081,SSC,,20185945,20185945-SSC,
137,2.0,Newcastle,,20185945,BBN003.34161,,,,,"EC,MTEMP,SOM ",87.0,,,M,46,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20185945,BBN003_34161,BBN003.34161,IGF122116,EC,,20185945,20185945-EC,
138,2.0,Newcastle,,20185945,BBN003.34161,,,,,"EC,MTEMP,SOM ",87.0,,,M,46,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,,,,,,,,,Additional 10 FFPE MTG and 10 FFPE SOM arrived on 25/10/22,,N,2.0,none,,,2.0,TREM2,,,,20185945,BBN003_34161,BBN003.34161,IGF122184,MTG,,20185945,20185945-MTG,
139,2.0,Newcastle,,20196909,BBN003.35390,,,,,"EC,MTEMP,SOM ",72.0,,,M,9,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,2.0,none,,,2.0,TREM2,,,,20196909,BBN003_35390,BBN003.35390,IGF122121,EC,,20196909,20196909-EC,
140,2.0,Newcastle,,20196909,BBN003.35390,,,,,"EC,MTEMP,SOM ",72.0,,,M,9,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,1.0,,Null,Not Assessed,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,2.0,none,,,2.0,TREM2,,,,20196909,BBN003_35390,BBN003.35390,IGF122209,SSC,,20196909,20196909-SSC,
141,2.0,Newcastle,,20196919,BBN003.35446,,,,,"EC,MTEMP,SOM ",82.0,,,F,42,5.0,2,Control,Ndgen.BandBII,Control,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,,,,,,,,,,,N,2.0,none,,,2.0,TREM2,,,,20196919,BBN003_35446,BBN003.35446,IGF122091,EC,,20196919,20196919-EC,
142,2.0,Newcastle,,20196919,BBN003.35446,,,,,"EC,MTEMP,SOM ",82.0,,,F,42,5.0,2,Control,Ndgen.BandBII,Control,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,,,,,,,,,,,N,2.0,none,,,2.0,TREM2,,,,20196919,BBN003_35446,BBN003.35446,IGF122167,SSC,,20196919,20196919-SSC,
143,2.0,Newcastle,,20196919,BBN003.35446,,,,,"EC,MTEMP,SOM ",82.0,,,F,42,5.0,2,Control,Ndgen.BandBII,Control,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,1.0,,,Not assesed,,,,,,,,,,,N,2.0,none,,,2.0,TREM2,,,,20196919,BBN003_35446,BBN003.35446,IGF122173,MTG,,20196919,20196919-MTG,
144,2.0,Newcastle,,20196928,BBN003.35519,,,,,"EC,MTEMP,SOM ",77.0,,,M,38,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,2.0,none,,,2.0,TREM2,,,,20196928,BBN003_35519,BBN003.35519,IGF122139,EC,,20196928,20196928-EC,
145,2.0,Newcastle,,20196928,BBN003.35519,,,,,"EC,MTEMP,SOM ",77.0,,,M,38,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,2.0,none,,,2.0,TREM2,,,,20196928,BBN003_35519,BBN003.35519,IGF122149,MTG,,20196928,20196928-MTG,
146,2.0,Newcastle,,20196928,BBN003.35519,,,,,"EC,MTEMP,SOM ",77.0,,,M,38,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,2.0,none,,,2.0,TREM2,,,,20196928,BBN003_35519,BBN003.35519,IGF122172,SSC,,20196928,20196928-SSC,
147,6.0,Kings,1/9/2020,A013/03,BBN_9727,,3.0,,3.0,"EC,MTEMP,SOM, ent, sensmot, mt",89.0,,,M,18,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,Nuclei enrichment,,,A013_03,BBN_9727,BBN_9727,IGF122111,EC,,A013_03,A013-03-EC,
148,6.0,Kings,1/9/2020,A013/03,BBN_9727,,3.0,,3.0,"EC,MTEMP,SOM, ent, sensmot, mt",89.0,,,M,18,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,Nuclei enrichment,,,A013_03,BBN_9727,BBN_9727,IGF122157,MTG,,A013_03,A013-03-MTG,
149,6.0,Kings,1/9/2020,A013/03,BBN_9727,,3.0,,3.0,"EC,MTEMP,SOM, ent, sensmot, mt",89.0,,,M,18,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,Nuclei enrichment,,,A013_03,BBN_9727,BBN_9727,IGF122246,SSC,,A013_03,A013-03-SSC,
150,6.0,Kings,1/9/2020,A013/03,BBN_9727,,3.0,,3.0,"EC,MTEMP,SOM, ent, sensmot, mt",89.0,,,M,18,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,Nuclei enrichment,,,A013_03,BBN_9727,BBN_9727,IGF120784,SSC,,A013_03,A013-03-SSC_1,
151,6.0,Kings,1/9/2020,A013/03,BBN_9727,,3.0,,3.0,"EC,MTEMP,SOM, ent, sensmot, mt",89.0,,,M,18,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,Nuclei enrichment,,,A013_03,BBN_9727,BBN_9727,IGF117766,SOM,,A013_03,A013-03-SOM,
152,6.0,Kings,1/9/2020,A013/03,BBN_9727,,3.0,,3.0,"EC,MTEMP,SOM, ent, sensmot, mt",89.0,,,M,18,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,Nuclei enrichment,,,A013_03,BBN_9727,BBN_9727,IGF117811,MTEMP,,A013_03,A013-03-MTEMP,
153,6.0,Kings,3/26/2019,A019/12,BBN_10611,,3.0,,3.0,"EC,MTEMP,SOM ",92.0,,,F,30,6.0,3,AD,Ndgen.BandBIII,Moderate,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,3/26/2019,frozen only,A019_12,BBN_10611,BBN_10611,IGF114164,EC,,A019_12,A019-12-EC,
154,6.0,Kings,3/26/2019,A019/12,BBN_10611,,3.0,,3.0,"EC,MTEMP,SOM ",92.0,,,F,30,6.0,3,AD,Ndgen.BandBIII,Moderate,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,3/26/2019,frozen only,A019_12,BBN_10611,BBN_10611,IGF114165,mTemp,,A019_12,A019-12-mTemp,
155,6.0,Kings,3/26/2019,A019/12,BBN_10611,,3.0,,3.0,"EC,MTEMP,SOM ",92.0,,,F,30,6.0,3,AD,Ndgen.BandBIII,Moderate,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,3/26/2019,frozen only,A019_12,BBN_10611,BBN_10611,IGF114166,SSC,,A019_12,A019-12-SSC,
156,6.0,Kings,3/26/2019,A019/12,BBN_10611,,3.0,,3.0,"EC,MTEMP,SOM ",92.0,,,F,30,6.0,3,AD,Ndgen.BandBIII,Moderate,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,3/26/2019,frozen only,A019_12,BBN_10611,BBN_10611,IGF113091,EC,,A019_12,A019-12-EC_1,
157,6.0,Kings,3/26/2019,A019/12,BBN_10611,,3.0,,3.0,"EC,MTEMP,SOM ",92.0,,,F,30,6.0,3,AD,Ndgen.BandBIII,Moderate,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,3/26/2019,frozen only,A019_12,BBN_10611,BBN_10611,IGF113100,SSC,,A019_12,A019-12-SSC_1,
158,6.0,Kings,3/26/2019,A019/12,BBN_10611,,3.0,,3.0,"EC,MTEMP,SOM ",92.0,,,F,30,6.0,3,AD,Ndgen.BandBIII,Moderate,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,3/26/2019,frozen only,A019_12,BBN_10611,BBN_10611,IGF117822,MTEMP,,A019_12,A019-12-MTEMP,
159,6.0,Kings,3/26/2019,A019/12,BBN_10611,,3.0,,3.0,"EC,MTEMP,SOM ",92.0,,,F,30,6.0,3,AD,Ndgen.BandBIII,Moderate,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,3/26/2019,frozen only,A019_12,BBN_10611,BBN_10611,IGF117773,SOM,,A019_12,A019-12-SOM,
160,6.0,Kings,1/9/2020,A023/03*,BBN_15755,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",93.0,,,F,18,1.0,,,,Missing,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,,,,,,,?,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A023_03,BBN_15755,BBN_15755,IGF122131,SSC,,A023_03,A023-03-SSC,
161,6.0,Kings,1/9/2020,A029/04,BBN_9760,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",88.0,,,F,70,1.0,,AD,,Missing,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A029_04,BBN_9760,BBN_9760,IGF122180,EC,,A029_04,A029-04-EC,
162,6.0,Kings,1/9/2020,A029/04,BBN_9760,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",88.0,,,F,70,1.0,,AD,,Missing,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A029_04,BBN_9760,BBN_9760,IGF122234,SSC,,A029_04,A029-04-SSC,
163,6.0,Kings,1/9/2020,A029/04,BBN_9760,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",88.0,,,F,70,1.0,,AD,,Missing,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A029_04,BBN_9760,BBN_9760,IGF122236,MTG,,A029_04,A029-04-MTG,
164,6.0,Kings,1/9/2020,A048/13,BBN_15196,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",94.0,,,F,63,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A048_13,BBN_15196,BBN_15196,IGF122212,SSC,,A048_13,A048-13-SSC,
165,6.0,Kings,1/9/2020,A048/13,BBN_15196,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",94.0,,,F,63,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A048_13,BBN_15196,BBN_15196,IGF122221,MTG,,A048_13,A048-13-MTG,
166,6.0,Kings,1/9/2020,A048/13,BBN_15196,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",94.0,,,F,63,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A048_13,BBN_15196,BBN_15196,IGF122232,EC,,A048_13,A048-13-EC,
167,6.0,Kings,3/26/2019,A051/14,BBN_21005,,,,,"EC,MTEMP,SOM ",76.0,,,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A051_14,BBN_21005,BBN_21005,IGF114167,EC,,A051_14,A051-14-EC,
168,6.0,Kings,3/26/2019,A051/14,BBN_21005,,,,,"EC,MTEMP,SOM ",76.0,,,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A051_14,BBN_21005,BBN_21005,IGF114168,SSC,,A051_14,A051-14-SSC,
169,6.0,Kings,3/26/2019,A051/14,BBN_21005,,,,,"EC,MTEMP,SOM ",76.0,,,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A051_14,BBN_21005,BBN_21005,IGF114169,mTemp,,A051_14,A051-14-mTemp,
170,6.0,Kings,3/26/2019,A051/14,BBN_21005,,,,,"EC,MTEMP,SOM ",76.0,,,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A051_14,BBN_21005,BBN_21005,IGF113092,EC,,A051_14,A051-14-EC_1,
171,6.0,Kings,3/26/2019,A051/14,BBN_21005,,,,,"EC,MTEMP,SOM ",76.0,,,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A051_14,BBN_21005,BBN_21005,IGF113101,SSC,,A051_14,A051-14-SSC_1,
172,6.0,Kings,3/26/2019,A051/14,BBN_21005,,,,,"EC,MTEMP,SOM ",76.0,,,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A051_14,BBN_21005,BBN_21005,IGF117823,MTEMP,,A051_14,A051-14-MTEMP,
173,6.0,Kings,3/26/2019,A051/14,BBN_21005,,,,,"EC,MTEMP,SOM ",76.0,,,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A051_14,BBN_21005,BBN_21005,IGF117802,SOM,,A051_14,A051-14-SOM,
174,6.0,Kings,3/26/2019,A053/11,BBN_18399,,,,3.0,"EC,MTEMP,SOM ",77.0,,,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A053_11,BBN_18399,BBN_18399,IGF114170,SSC,,A053_11,A053-11-SSC,
175,6.0,Kings,3/26/2019,A053/11,BBN_18399,,,,3.0,"EC,MTEMP,SOM ",77.0,,,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A053_11,BBN_18399,BBN_18399,IGF114171,EC,,A053_11,A053-11-EC,
176,6.0,Kings,3/26/2019,A053/11,BBN_18399,,,,3.0,"EC,MTEMP,SOM ",77.0,,,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A053_11,BBN_18399,BBN_18399,IGF114172,mTemp,,A053_11,A053-11-mTemp,
177,6.0,Kings,3/26/2019,A053/11,BBN_18399,,,,3.0,"EC,MTEMP,SOM ",77.0,,,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A053_11,BBN_18399,BBN_18399,IGF112634,SSC,,A053_11,A053-11SSC_1,
178,6.0,Kings,3/26/2019,A053/11,BBN_18399,,,,3.0,"EC,MTEMP,SOM ",77.0,,,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A053_11,BBN_18399,BBN_18399,IGF112644,EC,,A053_11,A053-11EC_1,
179,6.0,Kings,3/26/2019,A053/11,BBN_18399,,,,3.0,"EC,MTEMP,SOM ",77.0,,,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A053_11,BBN_18399,BBN_18399,IGF113056,SSC,,A053_11,A053-11-SSC_1,
180,6.0,Kings,3/26/2019,A053/11,BBN_18399,,,,3.0,"EC,MTEMP,SOM ",77.0,,,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A053_11,BBN_18399,BBN_18399,IGF113066,EC,,A053_11,A053-11-EC_1,
181,6.0,Kings,3/26/2019,A053/11,BBN_18399,,,,3.0,"EC,MTEMP,SOM ",77.0,,,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A053_11,BBN_18399,BBN_18399,IGF117824,MTEMP,,A053_11,A053-11-MTEMP,
182,6.0,Kings,3/26/2019,A053/11,BBN_18399,,,,3.0,"EC,MTEMP,SOM ",77.0,,,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A053_11,BBN_18399,BBN_18399,IGF117806,SOM,,A053_11,A053-11-SOM,
183,6.0,Kings,8/25/2022,A053/11,BBN_18399,3.0,,3.0,2.0,"MTEMP, SOM",77.0,2.0,Unknown,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,metastatic prostate cancer,,,,High blood pressure,,,,,,,ABCA7/BIN1,,,,A053_11,BBN_18399,BBN_18399,IGF114170,SSC,,A053_11,A053-11-SSC,
184,6.0,Kings,8/25/2022,A053/11,BBN_18399,3.0,,3.0,2.0,"MTEMP, SOM",77.0,2.0,Unknown,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,metastatic prostate cancer,,,,High blood pressure,,,,,,,ABCA7/BIN1,,,,A053_11,BBN_18399,BBN_18399,IGF114171,EC,,A053_11,A053-11-EC,
185,6.0,Kings,8/25/2022,A053/11,BBN_18399,3.0,,3.0,2.0,"MTEMP, SOM",77.0,2.0,Unknown,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,metastatic prostate cancer,,,,High blood pressure,,,,,,,ABCA7/BIN1,,,,A053_11,BBN_18399,BBN_18399,IGF114172,mTemp,,A053_11,A053-11-mTemp,
186,6.0,Kings,8/25/2022,A053/11,BBN_18399,3.0,,3.0,2.0,"MTEMP, SOM",77.0,2.0,Unknown,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,metastatic prostate cancer,,,,High blood pressure,,,,,,,ABCA7/BIN1,,,,A053_11,BBN_18399,BBN_18399,IGF112634,SSC,,A053_11,A053-11SSC_1,
187,6.0,Kings,8/25/2022,A053/11,BBN_18399,3.0,,3.0,2.0,"MTEMP, SOM",77.0,2.0,Unknown,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,metastatic prostate cancer,,,,High blood pressure,,,,,,,ABCA7/BIN1,,,,A053_11,BBN_18399,BBN_18399,IGF112644,EC,,A053_11,A053-11EC_1,
188,6.0,Kings,8/25/2022,A053/11,BBN_18399,3.0,,3.0,2.0,"MTEMP, SOM",77.0,2.0,Unknown,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,metastatic prostate cancer,,,,High blood pressure,,,,,,,ABCA7/BIN1,,,,A053_11,BBN_18399,BBN_18399,IGF113056,SSC,,A053_11,A053-11-SSC_1,
189,6.0,Kings,8/25/2022,A053/11,BBN_18399,3.0,,3.0,2.0,"MTEMP, SOM",77.0,2.0,Unknown,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,metastatic prostate cancer,,,,High blood pressure,,,,,,,ABCA7/BIN1,,,,A053_11,BBN_18399,BBN_18399,IGF113066,EC,,A053_11,A053-11-EC_1,
190,6.0,Kings,8/25/2022,A053/11,BBN_18399,3.0,,3.0,2.0,"MTEMP, SOM",77.0,2.0,Unknown,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,metastatic prostate cancer,,,,High blood pressure,,,,,,,ABCA7/BIN1,,,,A053_11,BBN_18399,BBN_18399,IGF117824,MTEMP,,A053_11,A053-11-MTEMP,
191,6.0,Kings,8/25/2022,A053/11,BBN_18399,3.0,,3.0,2.0,"MTEMP, SOM",77.0,2.0,Unknown,M,11,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,metastatic prostate cancer,,,,High blood pressure,,,,,,,ABCA7/BIN1,,,,A053_11,BBN_18399,BBN_18399,IGF117806,SOM,,A053_11,A053-11-SOM,
192,6.0,Kings,1/9/2020,A064/13,BBN_15201,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",70.0,,,F,14.5,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A064_13,BBN_15201,BBN_15201,IGF122163,EC,,A064_13,A064-13-EC,
193,6.0,Kings,1/9/2020,A064/13,BBN_15201,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",70.0,,,F,14.5,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A064_13,BBN_15201,BBN_15201,IGF120789,SSC,,A064_13,A064-13-SSC_1,
194,6.0,Kings,1/9/2020,A064/13,BBN_15201,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",70.0,,,F,14.5,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A064_13,BBN_15201,BBN_15201,IGF117790,MTEMP,,A064_13,A064-13-MTEMP,
195,6.0,Kings,1/9/2020,A064/13,BBN_15201,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",70.0,,,F,14.5,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A064_13,BBN_15201,BBN_15201,IGF117804,SOM,,A064_13,A064-13-SOM,
196,6.0,Kings,1/9/2020,A065/02*,BBN_9714,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",82.0,,,M,80,7.0,4,AD,Ndgen.BandBIV,Moderate,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A065_02,BBN_9714,BBN_9714,IGF122189,MTG,,A065_02,A065-02-MTG,
197,6.0,Kings,1/9/2020,A065/02*,BBN_9714,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",82.0,,,M,80,7.0,4,AD,Ndgen.BandBIV,Moderate,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A065_02,BBN_9714,BBN_9714,IGF122202,EC,,A065_02,A065-02-EC,
198,6.0,Kings,1/9/2020,A065/02*,BBN_9714,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",82.0,,,M,80,7.0,4,AD,Ndgen.BandBIV,Moderate,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A065_02,BBN_9714,BBN_9714,IGF122222,MTG,,A065_02,A065-02-MTG-2,
199,6.0,Kings,1/9/2020,A074/05*,BBN_9786,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",89.0,,,F,28,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A074_05,BBN_9786,BBN_9786,IGF122165,EC,,A074_05,A074-05-EC,
200,6.0,Kings,1/9/2020,A074/05*,BBN_9786,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",89.0,,,F,28,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A074_05,BBN_9786,BBN_9786,IGF120780,SSC,,A074_05,A074-05-SSC_1,
201,6.0,Kings,1/9/2020,A074/05*,BBN_9786,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",89.0,,,F,28,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A074_05,BBN_9786,BBN_9786,IGF117753,MTEMP,,A074_05,A074-05-MTEMP,
202,6.0,Kings,1/9/2020,A074/05*,BBN_9786,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",89.0,,,F,28,10.0,5TO6,AD,"Ndgen.BandBV, Ndgen.BandBVI",Severe,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A074_05,BBN_9786,BBN_9786,IGF117808,SOM,,A074_05,A074-05-SOM,
203,6.0,Kings,3/26/2019,A096/14,BBN_21792,,,,,"EC,MTEMP,SOM ",87.0,,,M,19,7.0,4,AD,Ndgen.BandBIV,Moderate,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A096_14,BBN_21792,BBN_21792,IGF114173,EC,,A096_14,A096-14-EC,
204,6.0,Kings,3/26/2019,A096/14,BBN_21792,,,,,"EC,MTEMP,SOM ",87.0,,,M,19,7.0,4,AD,Ndgen.BandBIV,Moderate,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A096_14,BBN_21792,BBN_21792,IGF114174,SSC,,A096_14,A096-14-SSC,
205,6.0,Kings,3/26/2019,A096/14,BBN_21792,,,,,"EC,MTEMP,SOM ",87.0,,,M,19,7.0,4,AD,Ndgen.BandBIV,Moderate,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A096_14,BBN_21792,BBN_21792,IGF114175,mTemp,,A096_14,A096-14-mTemp,
206,6.0,Kings,3/26/2019,A096/14,BBN_21792,,,,,"EC,MTEMP,SOM ",87.0,,,M,19,7.0,4,AD,Ndgen.BandBIV,Moderate,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A096_14,BBN_21792,BBN_21792,IGF112638,SSC,,A096_14,A096-14SSC_1,
207,6.0,Kings,3/26/2019,A096/14,BBN_21792,,,,,"EC,MTEMP,SOM ",87.0,,,M,19,7.0,4,AD,Ndgen.BandBIV,Moderate,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A096_14,BBN_21792,BBN_21792,IGF112640,EC,,A096_14,A096-14EC_1,
208,6.0,Kings,3/26/2019,A096/14,BBN_21792,,,,,"EC,MTEMP,SOM ",87.0,,,M,19,7.0,4,AD,Ndgen.BandBIV,Moderate,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A096_14,BBN_21792,BBN_21792,IGF113060,SSC,,A096_14,A096-14-SSC_1,
209,6.0,Kings,3/26/2019,A096/14,BBN_21792,,,,,"EC,MTEMP,SOM ",87.0,,,M,19,7.0,4,AD,Ndgen.BandBIV,Moderate,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A096_14,BBN_21792,BBN_21792,IGF113062,EC,,A096_14,A096-14-EC_1,
210,6.0,Kings,3/26/2019,A096/14,BBN_21792,,,,,"EC,MTEMP,SOM ",87.0,,,M,19,7.0,4,AD,Ndgen.BandBIV,Moderate,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A096_14,BBN_21792,BBN_21792,IGF117825,MTEMP,,A096_14,A096-14-MTEMP,
211,6.0,Kings,3/26/2019,A096/14,BBN_21792,,,,,"EC,MTEMP,SOM ",87.0,,,M,19,7.0,4,AD,Ndgen.BandBIV,Moderate,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A096_14,BBN_21792,BBN_21792,IGF117758,SOM,,A096_14,A096-14-SOM,
212,6.0,Kings,3/26/2019,A115/17,BBN002.30035,,,,3.0,"EC,MTEMP,SOM ",92.0,,,M,9,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A115_17,BBN002_30035,BBN002.30035,IGF114176,SSC,,A115_17,A115-17-SSC,
213,6.0,Kings,3/26/2019,A115/17,BBN002.30035,,,,3.0,"EC,MTEMP,SOM ",92.0,,,M,9,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A115_17,BBN002_30035,BBN002.30035,IGF114177,EC,,A115_17,A115-17-EC,
214,6.0,Kings,3/26/2019,A115/17,BBN002.30035,,,,3.0,"EC,MTEMP,SOM ",92.0,,,M,9,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A115_17,BBN002_30035,BBN002.30035,IGF114178,mTemp,,A115_17,A115-17-mTemp,
215,6.0,Kings,3/26/2019,A115/17,BBN002.30035,,,,3.0,"EC,MTEMP,SOM ",92.0,,,M,9,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A115_17,BBN002_30035,BBN002.30035,IGF113093,EC,,A115_17,A115-17-EC_1,
216,6.0,Kings,3/26/2019,A115/17,BBN002.30035,,,,3.0,"EC,MTEMP,SOM ",92.0,,,M,9,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A115_17,BBN002_30035,BBN002.30035,IGF113102,SSC,,A115_17,A115-17-SSC_1,
217,6.0,Kings,3/26/2019,A115/17,BBN002.30035,,,,3.0,"EC,MTEMP,SOM ",92.0,,,M,9,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A115_17,BBN002_30035,BBN002.30035,IGF117826,MTEMP,,A115_17,A115-17-MTEMP,
218,6.0,Kings,3/26/2019,A115/17,BBN002.30035,,,,3.0,"EC,MTEMP,SOM ",92.0,,,M,9,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A115_17,BBN002_30035,BBN002.30035,IGF117745,SOM,,A115_17,A115-17-SOM,
219,6.0,Kings,3/26/2019,A127/11,BBN_16213,,,,3.0,"EC,MTEMP,SOM ",73.0,,,M,23,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A127_11,BBN_16213,BBN_16213,IGF114179,EC,,A127_11,A127-11-EC,
220,6.0,Kings,3/26/2019,A127/11,BBN_16213,,,,3.0,"EC,MTEMP,SOM ",73.0,,,M,23,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A127_11,BBN_16213,BBN_16213,IGF114180,mTemp,,A127_11,A127-11-mTemp,
221,6.0,Kings,3/26/2019,A127/11,BBN_16213,,,,3.0,"EC,MTEMP,SOM ",73.0,,,M,23,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A127_11,BBN_16213,BBN_16213,IGF114181,SSC,,A127_11,A127-11-SSC,
222,6.0,Kings,3/26/2019,A127/11,BBN_16213,,,,3.0,"EC,MTEMP,SOM ",73.0,,,M,23,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A127_11,BBN_16213,BBN_16213,IGF112633,SSC,,A127_11,A127-11SSC_1,
223,6.0,Kings,3/26/2019,A127/11,BBN_16213,,,,3.0,"EC,MTEMP,SOM ",73.0,,,M,23,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A127_11,BBN_16213,BBN_16213,IGF112636,EC,,A127_11,A127-11EC_1,
224,6.0,Kings,3/26/2019,A127/11,BBN_16213,,,,3.0,"EC,MTEMP,SOM ",73.0,,,M,23,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A127_11,BBN_16213,BBN_16213,IGF113055,SSC,,A127_11,A127-11-SSC_1,
225,6.0,Kings,3/26/2019,A127/11,BBN_16213,,,,3.0,"EC,MTEMP,SOM ",73.0,,,M,23,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A127_11,BBN_16213,BBN_16213,IGF113058,EC,,A127_11,A127-11-EC_1,
226,6.0,Kings,3/26/2019,A127/11,BBN_16213,,,,3.0,"EC,MTEMP,SOM ",73.0,,,M,23,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A127_11,BBN_16213,BBN_16213,IGF117764,MTEMP,,A127_11,A127-11-MTEMP,
227,6.0,Kings,3/26/2019,A127/11,BBN_16213,,,,3.0,"EC,MTEMP,SOM ",73.0,,,M,23,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 10 FFPE MTEMP arrived on 18/05/22; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A127_11,BBN_16213,BBN_16213,IGF117809,SOM,,A127_11,A127-11-SOM,
228,6.0,Kings,1/9/2020,A138/12,BBN_4575,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",74.0,,,F,16,11.0,6,AD,Ndgen.BandBVI,Severe,,,,,,,,,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A138_12,BBN_4575,BBN_4575,IGF122086,EC,,A138_12,A138-12-EC,
229,6.0,Kings,1/9/2020,A138/12,BBN_4575,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",74.0,,,F,16,11.0,6,AD,Ndgen.BandBVI,Severe,,,,,,,,,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A138_12,BBN_4575,BBN_4575,IGF120778,MTG,,A138_12,A138-12-MTG_1,
230,6.0,Kings,1/9/2020,A138/12,BBN_4575,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",74.0,,,F,16,11.0,6,AD,Ndgen.BandBVI,Severe,,,,,,,,,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A138_12,BBN_4575,BBN_4575,IGF117750,MTEMP,,A138_12,A138-12-MTEMP,
231,6.0,Kings,1/9/2020,A138/12,BBN_4575,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",74.0,,,F,16,11.0,6,AD,Ndgen.BandBVI,Severe,,,,,,,,,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A138_12,BBN_4575,BBN_4575,IGF117812,SOM,,A138_12,A138-12-SOM,
232,6.0,Kings,1/9/2020,A153/12,BBN_4250,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",80.0,,,F,72,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A153_12,BBN_4250,BBN_4250,IGF122117,SSC,,A153_12,A153-12-SSC,
233,6.0,Kings,1/9/2020,A153/12,BBN_4250,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",80.0,,,F,72,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A153_12,BBN_4250,BBN_4250,IGF122150,MTG,,A153_12,A153-12-MTG,
234,6.0,Kings,1/9/2020,A153/12,BBN_4250,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",80.0,,,F,72,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A153_12,BBN_4250,BBN_4250,IGF122190,EC,,A153_12,A153-12-EC,
235,6.0,Kings,3/26/2019,A163/17,BBN002.30127,,,,,"EC,MTEMP,SOM ",83.0,,,M,19.5,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A163_17,BBN002_30127,BBN002.30127,IGF114182,EC,,A163_17,A163-17-EC,
236,6.0,Kings,3/26/2019,A163/17,BBN002.30127,,,,,"EC,MTEMP,SOM ",83.0,,,M,19.5,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A163_17,BBN002_30127,BBN002.30127,IGF114183,SSC,,A163_17,A163-17-SSC,
237,6.0,Kings,3/26/2019,A163/17,BBN002.30127,,,,,"EC,MTEMP,SOM ",83.0,,,M,19.5,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A163_17,BBN002_30127,BBN002.30127,IGF114184,mTemp,,A163_17,A163-17-mTemp,
238,6.0,Kings,3/26/2019,A163/17,BBN002.30127,,,,,"EC,MTEMP,SOM ",83.0,,,M,19.5,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A163_17,BBN002_30127,BBN002.30127,IGF112639,SSC,,A163_17,A163-17SSC_1,
239,6.0,Kings,3/26/2019,A163/17,BBN002.30127,,,,,"EC,MTEMP,SOM ",83.0,,,M,19.5,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A163_17,BBN002_30127,BBN002.30127,IGF112641,EC,,A163_17,A163-17EC_1,
240,6.0,Kings,3/26/2019,A163/17,BBN002.30127,,,,,"EC,MTEMP,SOM ",83.0,,,M,19.5,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A163_17,BBN002_30127,BBN002.30127,IGF113061,SSC,,A163_17,A163-17-SSC_1,
241,6.0,Kings,3/26/2019,A163/17,BBN002.30127,,,,,"EC,MTEMP,SOM ",83.0,,,M,19.5,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A163_17,BBN002_30127,BBN002.30127,IGF113063,EC,,A163_17,A163-17-EC_1,
242,6.0,Kings,3/26/2019,A163/17,BBN002.30127,,,,,"EC,MTEMP,SOM ",83.0,,,M,19.5,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A163_17,BBN002_30127,BBN002.30127,IGF117827,MTEMP,,A163_17,A163-17-MTEMP,
243,6.0,Kings,3/26/2019,A163/17,BBN002.30127,,,,,"EC,MTEMP,SOM ",83.0,,,M,19.5,9.0,5,AD,Ndgen.BandBV,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A163_17,BBN002_30127,BBN002.30127,IGF117783,SOM,,A163_17,A163-17-SOM,
244,6.0,Kings,1/9/2020,A166/04,BBN_9779,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",43.0,,,M,27,1.0,,AD,,Missing,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,Nuclei enrichment,,,A166_04,BBN_9779,BBN_9779,IGF122176,EC,,A166_04,A166-04-EC,
245,6.0,Kings,1/9/2020,A166/04,BBN_9779,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",43.0,,,M,27,1.0,,AD,,Missing,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,Nuclei enrichment,,,A166_04,BBN_9779,BBN_9779,IGF120770,MTG,,A166_04,A166-04-MTG_1,
246,6.0,Kings,1/9/2020,A166/04,BBN_9779,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",43.0,,,M,27,1.0,,AD,,Missing,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,Nuclei enrichment,,,A166_04,BBN_9779,BBN_9779,IGF117775,SOM,,A166_04,A166-04-SOM,
247,6.0,Kings,1/9/2020,A166/04,BBN_9779,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",43.0,,,M,27,1.0,,AD,,Missing,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,Nuclei enrichment,,,A166_04,BBN_9779,BBN_9779,IGF117816,MTEMP,,A166_04,A166-04-MTEMP,
248,6.0,Kings,3/26/2019,A169/10,BBN_9939,,,,2.0,"EC,SOM",85.0,,,F,10,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 2 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A169_10,BBN_9939,BBN_9939,IGF114185,EC,,A169_10,A169-10-EC,
249,6.0,Kings,3/26/2019,A169/10,BBN_9939,,,,2.0,"EC,SOM",85.0,,,F,10,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 2 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A169_10,BBN_9939,BBN_9939,IGF114186,SSC,,A169_10,A169-10-SSC,
250,6.0,Kings,3/26/2019,A169/10,BBN_9939,,,,2.0,"EC,SOM",85.0,,,F,10,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 2 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A169_10,BBN_9939,BBN_9939,IGF112643,SSC,,A169_10,A169-10SSC_1,
251,6.0,Kings,3/26/2019,A169/10,BBN_9939,,,,2.0,"EC,SOM",85.0,,,F,10,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 2 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A169_10,BBN_9939,BBN_9939,IGF112646,EC,,A169_10,A169-10EC_1,
252,6.0,Kings,3/26/2019,A169/10,BBN_9939,,,,2.0,"EC,SOM",85.0,,,F,10,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 2 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A169_10,BBN_9939,BBN_9939,IGF113065,SSC,,A169_10,A169-10-SSC_1,
253,6.0,Kings,3/26/2019,A169/10,BBN_9939,,,,2.0,"EC,SOM",85.0,,,F,10,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 2 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A169_10,BBN_9939,BBN_9939,IGF113067,EC,,A169_10,A169-10-EC_1,
254,6.0,Kings,3/26/2019,A169/10,BBN_9939,,,,2.0,"EC,SOM",85.0,,,F,10,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 2 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A169_10,BBN_9939,BBN_9939,IGF117786,SOM,,A169_10,A169-10-SOM,
255,6.0,Kings,3/26/2019,A170/13,BBN_18813,,,,3.0,"EC,MTEMP,SOM ",85.0,,,F,23,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A170_13,BBN_18813,BBN_18813,IGF114187,EC,,A170_13,A170-13-EC,
256,6.0,Kings,3/26/2019,A170/13,BBN_18813,,,,3.0,"EC,MTEMP,SOM ",85.0,,,F,23,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A170_13,BBN_18813,BBN_18813,IGF114188,SSC,,A170_13,A170-13-SSC,
257,6.0,Kings,3/26/2019,A170/13,BBN_18813,,,,3.0,"EC,MTEMP,SOM ",85.0,,,F,23,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A170_13,BBN_18813,BBN_18813,IGF114189,mTemp,,A170_13,A170-13-mTemp,
258,6.0,Kings,3/26/2019,A170/13,BBN_18813,,,,3.0,"EC,MTEMP,SOM ",85.0,,,F,23,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A170_13,BBN_18813,BBN_18813,IGF113094,EC,,A170_13,A170-13-EC_1,
259,6.0,Kings,3/26/2019,A170/13,BBN_18813,,,,3.0,"EC,MTEMP,SOM ",85.0,,,F,23,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A170_13,BBN_18813,BBN_18813,IGF113103,SSC,,A170_13,A170-13-SSC_1,
260,6.0,Kings,3/26/2019,A170/13,BBN_18813,,,,3.0,"EC,MTEMP,SOM ",85.0,,,F,23,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A170_13,BBN_18813,BBN_18813,IGF117828,MTEMP,,A170_13,A170-13-MTEMP,
261,6.0,Kings,3/26/2019,A170/13,BBN_18813,,,,3.0,"EC,MTEMP,SOM ",85.0,,,F,23,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A170_13,BBN_18813,BBN_18813,IGF117780,SOM,,A170_13,A170-13-SOM,
262,6.0,Kings,1/9/2020,A187/96*,BBN_9601,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",82.0,,,M,72,1.0,,AD,,Missing,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A187_96,BBN_9601,BBN_9601,IGF122145,SSC,,A187_96,A187-96-SSC,
263,6.0,Kings,1/9/2020,A187/96*,BBN_9601,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",82.0,,,M,72,1.0,,AD,,Missing,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A187_96,BBN_9601,BBN_9601,IGF122162,EC,,A187_96,A187-96-EC,
264,6.0,Kings,1/9/2020,A187/96*,BBN_9601,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",82.0,,,M,72,1.0,,AD,,Missing,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A187_96,BBN_9601,BBN_9601,IGF122231,MTG,,A187_96,A187-96-MTG,
265,6.0,Kings,1/9/2020,A210/05*,BBN_9796,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",84.0,,,F,24,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A210_05,BBN_9796,BBN_9796,IGF122228,EC,,A210_05,A210-05-EC,
266,6.0,Kings,1/9/2020,A210/05*,BBN_9796,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",84.0,,,F,24,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A210_05,BBN_9796,BBN_9796,IGF120785,SSC,,A210_05,A210-05-SSC_1,
267,6.0,Kings,1/9/2020,A210/05*,BBN_9796,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",84.0,,,F,24,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A210_05,BBN_9796,BBN_9796,IGF117747,MTEMP,,A210_05,A210-05-MTEMP,
268,6.0,Kings,1/9/2020,A210/05*,BBN_9796,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",84.0,,,F,24,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A210_05,BBN_9796,BBN_9796,IGF117817,SOM,,A210_05,A210-05-SOM,
269,6.0,Kings,1/9/2020,A220/11,BBN_9953,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",71.0,,,F,18,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previouslyE3/E3,,Y,7.0,R47H,rs75932628,,2.0,TREM2,Nuclei enrichment,,,A220_11,BBN_9953,BBN_9953,IGF122174,EC,,A220_11,A220-11-EC,
270,6.0,Kings,1/9/2020,A220/11,BBN_9953,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",71.0,,,F,18,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previouslyE3/E3,,Y,7.0,R47H,rs75932628,,2.0,TREM2,Nuclei enrichment,,,A220_11,BBN_9953,BBN_9953,IGF120783,MTG,,A220_11,A220-11-MTG_1,
271,6.0,Kings,1/9/2020,A220/11,BBN_9953,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",71.0,,,F,18,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previouslyE3/E3,,Y,7.0,R47H,rs75932628,,2.0,TREM2,Nuclei enrichment,,,A220_11,BBN_9953,BBN_9953,IGF117770,MTEMP,,A220_11,A220-11-MTEMP,
272,6.0,Kings,1/9/2020,A220/11,BBN_9953,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",71.0,,,F,18,9.0,5,AD,Ndgen.BandBV,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,previouslyE3/E3,,Y,7.0,R47H,rs75932628,,2.0,TREM2,Nuclei enrichment,,,A220_11,BBN_9953,BBN_9953,IGF117793,SOM,,A220_11,A220-11-SOM,
273,6.0,Kings,1/9/2020,A248/10,BBN_4186,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",94.0,,,F,50,11.0,6,AD,Ndgen.BandBVI,Severe,,,,,,,,,1.0,,,Not assesed,,,,,,,,,,,?,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A248_10,BBN_4186,BBN_4186,IGF122170,MTG,,A248_10,A248-10-MTG,
274,6.0,Kings,1/9/2020,A248/10,BBN_4186,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",94.0,,,F,50,11.0,6,AD,Ndgen.BandBVI,Severe,,,,,,,,,1.0,,,Not assesed,,,,,,,,,,,?,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A248_10,BBN_4186,BBN_4186,IGF122201,SSC,,A248_10,A248-10-SSC,
275,6.0,Kings,1/9/2020,A248/10,BBN_4186,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",94.0,,,F,50,11.0,6,AD,Ndgen.BandBVI,Severe,,,,,,,,,1.0,,,Not assesed,,,,,,,,,,,?,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A248_10,BBN_4186,BBN_4186,IGF122239,EC,,A248_10,A248-10-EC,
276,6.0,Kings,1/9/2020,A253/12,BBN_9980,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",83.0,,,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,"MAP tissue in E166, ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22",,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A253_12,BBN_9980,BBN_9980,IGF122118,MTG,,A253_12,A253-12-MTG,
277,6.0,Kings,1/9/2020,A253/12,BBN_9980,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",83.0,,,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,"MAP tissue in E166, ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22",,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A253_12,BBN_9980,BBN_9980,IGF122164,EC,,A253_12,A253-12-EC,
278,6.0,Kings,1/9/2020,A253/12,BBN_9980,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",83.0,,,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,"MAP tissue in E166, ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22",,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A253_12,BBN_9980,BBN_9980,IGF122186,EC,,A253_12,A253-12-EC,
279,6.0,Kings,1/9/2020,A253/12,BBN_9980,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",83.0,,,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,"MAP tissue in E166, ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22",,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,ABCA7BIN1,,A253_12,BBN_9980,BBN_9980,IGF122199,SSC,,A253_12,A253-12-SSC-,
280,6.0,Kings,10/21/2021,A253/12,BBN_9980,2.0,2.0,10.0,8.0,"FROZEN: Frontal, Cingulate, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",83.0,2.0,Unknown,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Alzheimer's Disease,,,,TREM2 tissue in E81,,N,,,,,3.0,MAP,TREM2,,,A253_12,BBN_9980,BBN_9980,IGF122118,MTG,,A253_12,A253-12-MTG,
281,6.0,Kings,10/21/2021,A253/12,BBN_9980,2.0,2.0,10.0,8.0,"FROZEN: Frontal, Cingulate, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",83.0,2.0,Unknown,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Alzheimer's Disease,,,,TREM2 tissue in E81,,N,,,,,3.0,MAP,TREM2,,,A253_12,BBN_9980,BBN_9980,IGF122164,EC,,A253_12,A253-12-EC,
282,6.0,Kings,10/21/2021,A253/12,BBN_9980,2.0,2.0,10.0,8.0,"FROZEN: Frontal, Cingulate, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",83.0,2.0,Unknown,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Alzheimer's Disease,,,,TREM2 tissue in E81,,N,,,,,3.0,MAP,TREM2,,,A253_12,BBN_9980,BBN_9980,IGF122186,EC,,A253_12,A253-12-EC,
283,6.0,Kings,10/21/2021,A253/12,BBN_9980,2.0,2.0,10.0,8.0,"FROZEN: Frontal, Cingulate, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",83.0,2.0,Unknown,F,58,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Alzheimer's Disease,,,,TREM2 tissue in E81,,N,,,,,3.0,MAP,TREM2,,,A253_12,BBN_9980,BBN_9980,IGF122199,SSC,,A253_12,A253-12-SSC-,
284,6.0,Kings,3/26/2019,A272/15,BBN002.26094,,,,,"EC,MTEMP,SOM ",90.0,,,F,10,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A272_15,BBN002_26094,BBN002.26094,IGF114190,EC,,A272_15,A272-15-EC,
285,6.0,Kings,3/26/2019,A272/15,BBN002.26094,,,,,"EC,MTEMP,SOM ",90.0,,,F,10,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A272_15,BBN002_26094,BBN002.26094,IGF114191,SSC,,A272_15,A272-15-SSC,
286,6.0,Kings,3/26/2019,A272/15,BBN002.26094,,,,,"EC,MTEMP,SOM ",90.0,,,F,10,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A272_15,BBN002_26094,BBN002.26094,IGF114192,mTemp,,A272_15,A272-15-mTemp,
287,6.0,Kings,3/26/2019,A272/15,BBN002.26094,,,,,"EC,MTEMP,SOM ",90.0,,,F,10,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A272_15,BBN002_26094,BBN002.26094,IGF113104,EC,,A272_15,A272-15-EC_1,
288,6.0,Kings,3/26/2019,A272/15,BBN002.26094,,,,,"EC,MTEMP,SOM ",90.0,,,F,10,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A272_15,BBN002_26094,BBN002.26094,IGF113107,SSC,,A272_15,A272-15-SSC_1,
289,6.0,Kings,3/26/2019,A272/15,BBN002.26094,,,,,"EC,MTEMP,SOM ",90.0,,,F,10,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A272_15,BBN002_26094,BBN002.26094,IGF117829,MTEMP,,A272_15,A272-15-MTEMP,
290,6.0,Kings,3/26/2019,A272/15,BBN002.26094,,,,,"EC,MTEMP,SOM ",90.0,,,F,10,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A272_15,BBN002_26094,BBN002.26094,IGF117776,SOM,,A272_15,A272-15-SOM,
291,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF114193,SSC,,A277_12,A277-12-SSC,
292,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF114194,mTemp,,A277_12,A277-12-mTemp,
293,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF114214,EC,,A277_12,A277-12-EC,
294,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF112650,SSC,,A277_12,A277-12SSC_1,
295,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF112651,EC,,A277_12,A277-12EC_1,
296,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF113072,SSC,,A277_12,A277-12-SSC_1,
297,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF113073,EC,,A277_12,A277-12-EC_1,
298,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF117760,SOM,,A277_12,A277-12-SOM,
299,6.0,Kings,3/26/2019,A277/12,BBN_9984,,,,,"EC,MTEMP,SOM ",79.0,,,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,MAP tissue in E167; Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A277_12,BBN_9984,BBN_9984,IGF117830,MTEMP,,A277_12,A277-12-MTEMP,
300,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF114193,SSC,,A277_12,A277-12-SSC,
301,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF114194,mTemp,,A277_12,A277-12-mTemp,
302,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF114214,EC,,A277_12,A277-12-EC,
303,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF112650,SSC,,A277_12,A277-12SSC_1,
304,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF112651,EC,,A277_12,A277-12EC_1,
305,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF113072,SSC,,A277_12,A277-12-SSC_1,
306,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF113073,EC,,A277_12,A277-12-EC_1,
307,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF117760,SOM,,A277_12,A277-12-SOM,
308,6.0,Kings,10/21/2021,A277/12,BBN_9984,2.0,2.0,10.0,9.0,"FROZEN: Frontal, Cingulate, EC, Trigone, Temporal, Putamen, Parietal, Calcarine, Cerebellum. FFPE: Frontal, Temporal, 30slides/region (15/Sep/22)",79.0,2.0,Unknown,F,20,11.0,6,AD,Ndgen.BandBVI,Severe,4.0,2.0,Ndgen.Thal2,Amyloid in allocortex/limbic,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,1.0,,1.0,,Moderate arteriolar amyloid-beta CAA,Pneumonia. Pulmonary oedema,,,TREM2 tissue in E83,,N,,,,,3.0,MAP,TREM2,,,A277_12,BBN_9984,BBN_9984,IGF117830,MTEMP,,A277_12,A277-12-MTEMP,
309,6.0,Kings,3/26/2019,A282/14,BBN_24370,,3.0,,3.0,"EC,MTEMP,SOM ",68.0,,,F,53,6.0,3,AD,Ndgen.BandBIII,Moderate,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A282_14,BBN_24370,BBN_24370,IGF114195,SSC,,A282_14,A282-14-SSC,
310,6.0,Kings,3/26/2019,A282/14,BBN_24370,,3.0,,3.0,"EC,MTEMP,SOM ",68.0,,,F,53,6.0,3,AD,Ndgen.BandBIII,Moderate,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A282_14,BBN_24370,BBN_24370,IGF114196,EC,,A282_14,A282-14-EC,
311,6.0,Kings,3/26/2019,A282/14,BBN_24370,,3.0,,3.0,"EC,MTEMP,SOM ",68.0,,,F,53,6.0,3,AD,Ndgen.BandBIII,Moderate,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A282_14,BBN_24370,BBN_24370,IGF114197,mTemp,,A282_14,A282-14-mTemp,
312,6.0,Kings,3/26/2019,A282/14,BBN_24370,,3.0,,3.0,"EC,MTEMP,SOM ",68.0,,,F,53,6.0,3,AD,Ndgen.BandBIII,Moderate,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A282_14,BBN_24370,BBN_24370,IGF112635,SSC,,A282_14,A282-14SSC_1,
313,6.0,Kings,3/26/2019,A282/14,BBN_24370,,3.0,,3.0,"EC,MTEMP,SOM ",68.0,,,F,53,6.0,3,AD,Ndgen.BandBIII,Moderate,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A282_14,BBN_24370,BBN_24370,IGF112637,EC,,A282_14,A282-14EC_1,
314,6.0,Kings,3/26/2019,A282/14,BBN_24370,,3.0,,3.0,"EC,MTEMP,SOM ",68.0,,,F,53,6.0,3,AD,Ndgen.BandBIII,Moderate,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A282_14,BBN_24370,BBN_24370,IGF113057,SSC,,A282_14,A282-14-SSC_1,
315,6.0,Kings,3/26/2019,A282/14,BBN_24370,,3.0,,3.0,"EC,MTEMP,SOM ",68.0,,,F,53,6.0,3,AD,Ndgen.BandBIII,Moderate,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A282_14,BBN_24370,BBN_24370,IGF113059,EC,,A282_14,A282-14-EC_1,
316,6.0,Kings,3/26/2019,A282/14,BBN_24370,,3.0,,3.0,"EC,MTEMP,SOM ",68.0,,,F,53,6.0,3,AD,Ndgen.BandBIII,Moderate,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A282_14,BBN_24370,BBN_24370,IGF117831,MTEMP,,A282_14,A282-14-MTEMP,
317,6.0,Kings,3/26/2019,A282/14,BBN_24370,,3.0,,3.0,"EC,MTEMP,SOM ",68.0,,,F,53,6.0,3,AD,Ndgen.BandBIII,Moderate,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A282_14,BBN_24370,BBN_24370,IGF117798,SOM,,A282_14,A282-14-SOM,
318,6.0,Kings,3/26/2019,A297/16,BBN002.29089,,,,3.0,"EC,MTEMP,SOM ",81.0,,,M,10,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A297_16,BBN002_29089,BBN002.29089,IGF114198,EC,,A297_16,A297-16-EC,
319,6.0,Kings,3/26/2019,A297/16,BBN002.29089,,,,3.0,"EC,MTEMP,SOM ",81.0,,,M,10,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A297_16,BBN002_29089,BBN002.29089,IGF114199,mTemp,,A297_16,A297-16-mTemp,
320,6.0,Kings,3/26/2019,A297/16,BBN002.29089,,,,3.0,"EC,MTEMP,SOM ",81.0,,,M,10,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A297_16,BBN002_29089,BBN002.29089,IGF114200,SSC,,A297_16,A297-16-SSC,
321,6.0,Kings,3/26/2019,A297/16,BBN002.29089,,,,3.0,"EC,MTEMP,SOM ",81.0,,,M,10,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A297_16,BBN002_29089,BBN002.29089,IGF112647,SSC,,A297_16,A297-16SSC_1,
322,6.0,Kings,3/26/2019,A297/16,BBN002.29089,,,,3.0,"EC,MTEMP,SOM ",81.0,,,M,10,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A297_16,BBN002_29089,BBN002.29089,IGF112648,EC,,A297_16,A297-16EC_1,
323,6.0,Kings,3/26/2019,A297/16,BBN002.29089,,,,3.0,"EC,MTEMP,SOM ",81.0,,,M,10,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A297_16,BBN002_29089,BBN002.29089,IGF113069,SSC,,A297_16,A297-16-SSC_1,
324,6.0,Kings,3/26/2019,A297/16,BBN002.29089,,,,3.0,"EC,MTEMP,SOM ",81.0,,,M,10,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A297_16,BBN002_29089,BBN002.29089,IGF113070,EC,,A297_16,A297-16-EC_1,
325,6.0,Kings,3/26/2019,A297/16,BBN002.29089,,,,3.0,"EC,MTEMP,SOM ",81.0,,,M,10,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A297_16,BBN002_29089,BBN002.29089,IGF117832,MTEMP,,A297_16,A297-16-MTEMP,
326,6.0,Kings,3/26/2019,A297/16,BBN002.29089,,,,3.0,"EC,MTEMP,SOM ",81.0,,,M,10,3.0,1,Control,Ndgen.BandBI,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 13/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A297_16,BBN002_29089,BBN002.29089,IGF117814,SOM,,A297_16,A297-16-SOM,
327,6.0,Kings,1/9/2020,A301/10,BBN_15304,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",80.0,,,M,45,4.0,1TO2,Control,"Ndgen.BandBI, Ndgen.BandBII",Control,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A301_10,BBN_15304,BBN_15304,IGF122132,MTG,,A301_10,A301-10-MTG,
328,6.0,Kings,1/9/2020,A301/10,BBN_15304,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",80.0,,,M,45,4.0,1TO2,Control,"Ndgen.BandBI, Ndgen.BandBII",Control,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A301_10,BBN_15304,BBN_15304,IGF122169,EC,,A301_10,A301-10-EC,
329,6.0,Kings,1/9/2020,A301/10,BBN_15304,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",80.0,,,M,45,4.0,1TO2,Control,"Ndgen.BandBI, Ndgen.BandBII",Control,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A301_10,BBN_15304,BBN_15304,IGF122193,SSC,,A301_10,A301-10-SSC,
330,6.0,Kings,1/9/2020,A319/11,BBN_13802,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",74.0,,,M,24,3.0,1,Control,Ndgen.BandBI,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A319_11,BBN_13802,BBN_13802,IGF122217,EC,,A319_11,A319-11-EC,
331,6.0,Kings,1/9/2020,A319/11,BBN_13802,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",74.0,,,M,24,3.0,1,Control,Ndgen.BandBI,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A319_11,BBN_13802,BBN_13802,IGF120768,MTG,,A319_11,A319-11-MTG_1,
332,6.0,Kings,1/9/2020,A319/11,BBN_13802,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",74.0,,,M,24,3.0,1,Control,Ndgen.BandBI,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A319_11,BBN_13802,BBN_13802,IGF114201,SSC,,A319_11,A319-11-SSC,
333,6.0,Kings,1/9/2020,A319/11,BBN_13802,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",74.0,,,M,24,3.0,1,Control,Ndgen.BandBI,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A319_11,BBN_13802,BBN_13802,IGF114202,EC,,A319_11,A319-11-EC,
334,6.0,Kings,1/9/2020,A319/11,BBN_13802,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",74.0,,,M,24,3.0,1,Control,Ndgen.BandBI,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A319_11,BBN_13802,BBN_13802,IGF114203,mTemp,,A319_11,A319-11-mTemp,
335,6.0,Kings,1/9/2020,A319/11,BBN_13802,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",74.0,,,M,24,3.0,1,Control,Ndgen.BandBI,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A319_11,BBN_13802,BBN_13802,IGF112649,EC,,A319_11,A319-11EC_1,
336,6.0,Kings,1/9/2020,A319/11,BBN_13802,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",74.0,,,M,24,3.0,1,Control,Ndgen.BandBI,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A319_11,BBN_13802,BBN_13802,IGF112652,SSC,,A319_11,A319-11SSC_1,
337,6.0,Kings,1/9/2020,A319/11,BBN_13802,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",74.0,,,M,24,3.0,1,Control,Ndgen.BandBI,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A319_11,BBN_13802,BBN_13802,IGF113071,EC,,A319_11,A319-11-EC_1,
338,6.0,Kings,1/9/2020,A319/11,BBN_13802,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",74.0,,,M,24,3.0,1,Control,Ndgen.BandBI,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A319_11,BBN_13802,BBN_13802,IGF113074,SSC,,A319_11,A319-11-SSC_1,
339,6.0,Kings,1/9/2020,A319/11,BBN_13802,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",74.0,,,M,24,3.0,1,Control,Ndgen.BandBI,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A319_11,BBN_13802,BBN_13802,IGF117833,MTEMP,,A319_11,A319-11-MTEMP,
340,6.0,Kings,1/9/2020,A319/11,BBN_13802,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",74.0,,,M,24,3.0,1,Control,Ndgen.BandBI,Control,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A319_11,BBN_13802,BBN_13802,IGF117751,SOM,,A319_11,A319-11-SOM,
341,6.0,Kings,1/9/2020,A329/10,BBN_9944,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",83.0,,,F,53,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A329_10,BBN_9944,BBN_9944,IGF122166,SSC,,A329_10,A329-10-SSC,
342,6.0,Kings,1/9/2020,A329/10,BBN_9944,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",83.0,,,F,53,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A329_10,BBN_9944,BBN_9944,IGF122235,EC,,A329_10,A329-10-EC,
343,6.0,Kings,1/9/2020,A329/10,BBN_9944,,3.0,,3.0,"EC,MTEMP,SOM ent, sensmot, mt",83.0,,,F,53,9.0,5,AD,Ndgen.BandBV,Severe,,,,,,,,,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,Nuclei enrichment,,,A329_10,BBN_9944,BBN_9944,IGF122240,MTG,,A329_10,A329-10-MTG,
344,6.0,Kings,3/26/2019,A354/16,BBN002.29170,,,,3.0,"EC,MTEMP,SOM ",92.0,,,F,12,5.0,2,Control,Ndgen.BandBII,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A354_16,BBN002_29170,BBN002.29170,IGF122197,MTG,,A354_16,A354-16-MTG,
345,6.0,Kings,3/26/2019,A354/16,BBN002.29170,,,,3.0,"EC,MTEMP,SOM ",92.0,,,F,12,5.0,2,Control,Ndgen.BandBII,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A354_16,BBN002_29170,BBN002.29170,IGF114204,mtemp,,A354_16,A354-16-mtemp,
346,6.0,Kings,3/26/2019,A354/16,BBN002.29170,,,,3.0,"EC,MTEMP,SOM ",92.0,,,F,12,5.0,2,Control,Ndgen.BandBII,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A354_16,BBN002_29170,BBN002.29170,IGF114205,EC,,A354_16,A354-16-EC,
347,6.0,Kings,3/26/2019,A354/16,BBN002.29170,,,,3.0,"EC,MTEMP,SOM ",92.0,,,F,12,5.0,2,Control,Ndgen.BandBII,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A354_16,BBN002_29170,BBN002.29170,IGF114206,SSC,,A354_16,A354-16-SSC,
348,6.0,Kings,3/26/2019,A354/16,BBN002.29170,,,,3.0,"EC,MTEMP,SOM ",92.0,,,F,12,5.0,2,Control,Ndgen.BandBII,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A354_16,BBN002_29170,BBN002.29170,IGF113105,EC,,A354_16,A354-16-EC_1,
349,6.0,Kings,3/26/2019,A354/16,BBN002.29170,,,,3.0,"EC,MTEMP,SOM ",92.0,,,F,12,5.0,2,Control,Ndgen.BandBII,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A354_16,BBN002_29170,BBN002.29170,IGF113106,SSC,,A354_16,A354-16-SSC_1,
350,6.0,Kings,3/26/2019,A354/16,BBN002.29170,,,,3.0,"EC,MTEMP,SOM ",92.0,,,F,12,5.0,2,Control,Ndgen.BandBII,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A354_16,BBN002_29170,BBN002.29170,IGF117834,MTEMP,,A354_16,A354-16-MTEMP,
351,6.0,Kings,3/26/2019,A354/16,BBN002.29170,,,,3.0,"EC,MTEMP,SOM ",92.0,,,F,12,5.0,2,Control,Ndgen.BandBII,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions arrived on 25/08/22,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A354_16,BBN002_29170,BBN002.29170,IGF117799,SOM,,A354_16,A354-16-SOM,
352,6.0,Kings,3/26/2019,A402/14,BBN_24578,,3.0,,3.0,"EC,MTEMP,SOM ",83.0,,,M,10,6.0,3,AD,Ndgen.BandBIII,Moderate,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,4.0,2.0,Ndgen.CERAD2,Moderate,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A402_14,BBN_24578,BBN_24578,IGF114207,SSC,,A402_14,A402-14-SSC,
353,6.0,Kings,3/26/2019,A402/14,BBN_24578,,3.0,,3.0,"EC,MTEMP,SOM ",83.0,,,M,10,6.0,3,AD,Ndgen.BandBIII,Moderate,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,4.0,2.0,Ndgen.CERAD2,Moderate,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A402_14,BBN_24578,BBN_24578,IGF114208,EC,,A402_14,A402-14-EC,
354,6.0,Kings,3/26/2019,A402/14,BBN_24578,,3.0,,3.0,"EC,MTEMP,SOM ",83.0,,,M,10,6.0,3,AD,Ndgen.BandBIII,Moderate,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,4.0,2.0,Ndgen.CERAD2,Moderate,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A402_14,BBN_24578,BBN_24578,IGF114209,mTemp,,A402_14,A402-14-mTemp,
355,6.0,Kings,3/26/2019,A402/14,BBN_24578,,3.0,,3.0,"EC,MTEMP,SOM ",83.0,,,M,10,6.0,3,AD,Ndgen.BandBIII,Moderate,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,4.0,2.0,Ndgen.CERAD2,Moderate,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A402_14,BBN_24578,BBN_24578,IGF112642,SSC,,A402_14,A402-14SSC_1,
356,6.0,Kings,3/26/2019,A402/14,BBN_24578,,3.0,,3.0,"EC,MTEMP,SOM ",83.0,,,M,10,6.0,3,AD,Ndgen.BandBIII,Moderate,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,4.0,2.0,Ndgen.CERAD2,Moderate,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A402_14,BBN_24578,BBN_24578,IGF112645,EC,,A402_14,A402-14EC_1,
357,6.0,Kings,3/26/2019,A402/14,BBN_24578,,3.0,,3.0,"EC,MTEMP,SOM ",83.0,,,M,10,6.0,3,AD,Ndgen.BandBIII,Moderate,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,4.0,2.0,Ndgen.CERAD2,Moderate,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A402_14,BBN_24578,BBN_24578,IGF113064,SSC,,A402_14,A402-14-SSC_1,
358,6.0,Kings,3/26/2019,A402/14,BBN_24578,,3.0,,3.0,"EC,MTEMP,SOM ",83.0,,,M,10,6.0,3,AD,Ndgen.BandBIII,Moderate,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,4.0,2.0,Ndgen.CERAD2,Moderate,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A402_14,BBN_24578,BBN_24578,IGF113068,EC,,A402_14,A402-14-EC_1,
359,6.0,Kings,3/26/2019,A402/14,BBN_24578,,3.0,,3.0,"EC,MTEMP,SOM ",83.0,,,M,10,6.0,3,AD,Ndgen.BandBIII,Moderate,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,4.0,2.0,Ndgen.CERAD2,Moderate,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A402_14,BBN_24578,BBN_24578,IGF117835,MTEMP,,A402_14,A402-14-MTEMP,
360,6.0,Kings,3/26/2019,A402/14,BBN_24578,,3.0,,3.0,"EC,MTEMP,SOM ",83.0,,,M,10,6.0,3,AD,Ndgen.BandBIII,Moderate,3.0,1.0,Ndgen.Thal1,Amyloid in neocortex,4.0,2.0,Ndgen.CERAD2,Moderate,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,Additional 5 FFPE SSC arrived on 23/03/23,,Y,2.0,none,,,2.0,TREM2,Nuclei enrichment,,,A402_14,BBN_24578,BBN_24578,IGF117788,SOM,,A402_14,A402-14-SOM,
361,7.0,Bristol,,B509/962,BBN_24330,,,,,"EC,MTEMP,SOM ent, sensmot, mt",80.0,,,F,14.5,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,4.0,2.0,Ndgen.CERAD2,Moderate,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,B509_962,BBN_24330,BBN_24330,IGF122179,EC,,B509_962,B509-962-EC,
362,7.0,Bristol,,B509/962,BBN_24330,,,,,"EC,MTEMP,SOM ent, sensmot, mt",80.0,,,F,14.5,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,4.0,2.0,Ndgen.CERAD2,Moderate,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,B509_962,BBN_24330,BBN_24330,IGF117763,SOM,,B509_962,B509-962-SOM,
363,7.0,Bristol,,B509/962,BBN_24330,,,,,"EC,MTEMP,SOM ent, sensmot, mt",80.0,,,F,14.5,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,4.0,2.0,Ndgen.CERAD2,Moderate,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,B509_962,BBN_24330,BBN_24330,IGF117767,MTEMP,,B509_962,B509-962-MTEMP,
364,7.0,Bristol,,BC454/945,BBN_24308,,,,,"EC,MTEMP,SOM ent, sensmot, mt",80.0,,,M,50,6.0,3,AD,Ndgen.BandBIII,Moderate,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,?,8.0,R62H,rs143332484,,2.0,TREM2,,,,BC454_945,BBN_24308,BBN_24308,IGF122122,MTG,,BC454_945,BC454-945-MTG,
365,7.0,Bristol,,BC454/945,BBN_24308,,,,,"EC,MTEMP,SOM ent, sensmot, mt",80.0,,,M,50,6.0,3,AD,Ndgen.BandBIII,Moderate,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,?,8.0,R62H,rs143332484,,2.0,TREM2,,,,BC454_945,BBN_24308,BBN_24308,IGF122215,SSC,,BC454_945,BC454-945-SSC,
366,7.0,Bristol,,BC454/945,BBN_24308,,,,,"EC,MTEMP,SOM ent, sensmot, mt",80.0,,,M,50,6.0,3,AD,Ndgen.BandBIII,Moderate,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,?,8.0,R62H,rs143332484,,2.0,TREM2,,,,BC454_945,BBN_24308,BBN_24308,IGF122224,EC,,BC454_945,BC454-945-EC,
367,3.0,QSBB (UCL),,C19/93,BBN_11449,,,,,"MTEMP Hippo, mid temp, motor",82.0,,,M,33,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,C19_93,BBN_11449,BBN_11449,IGF117782,MTEMP,,C19_93,C19-93-MTEMP,
368,8.0,Manchester,,DPM13/19,BBN_14157,,,,,"EC,MTEMP,SOM ent, sensmot, mt",78.0,,,M,84,9.0,5,AD,Ndgen.BandBV,Severe,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,4.0,2.0,Ndgen.CERAD2,Moderate,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,N,7.0,R47H,rs75932628,,2.0,TREM2,,,,DPM13_19,BBN_14157,BBN_14157,IGF122093,EC,,DPM13_19,DPM13-19-EC,
369,8.0,Manchester,,DPM13/19,BBN_14157,,,,,"EC,MTEMP,SOM ent, sensmot, mt",78.0,,,M,84,9.0,5,AD,Ndgen.BandBV,Severe,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,4.0,2.0,Ndgen.CERAD2,Moderate,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,N,7.0,R47H,rs75932628,,2.0,TREM2,,,,DPM13_19,BBN_14157,BBN_14157,IGF122103,MTG,,DPM13_19,DPM13-19-MTG,
370,8.0,Manchester,,DPM13/19,BBN_14157,,,,,"EC,MTEMP,SOM ent, sensmot, mt",78.0,,,M,84,9.0,5,AD,Ndgen.BandBV,Severe,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,4.0,2.0,Ndgen.CERAD2,Moderate,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,N,7.0,R47H,rs75932628,,2.0,TREM2,,,,DPM13_19,BBN_14157,BBN_14157,IGF122120,SSC,,DPM13_19,DPM13-19-SSC,
371,8.0,Manchester,,DPM13/42,BBN_18791,,,,,"EC,MTEMP,SOM ent, sensmot, mt",89.0,,,F,88,3.0,1,Control,Ndgen.BandBI,Control,,,,,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,DPM13_42,BBN_18791,BBN_18791,IGF122113,MTG,,DPM13_42,DPM13-42-MTG,
372,8.0,Manchester,,DPM13/42,BBN_18791,,,,,"EC,MTEMP,SOM ent, sensmot, mt",89.0,,,F,88,3.0,1,Control,Ndgen.BandBI,Control,,,,,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,DPM13_42,BBN_18791,BBN_18791,IGF122130,EC,,DPM13_42,DPM13-42-EC,
373,8.0,Manchester,,DPM13/42,BBN_18791,,,,,"EC,MTEMP,SOM ent, sensmot, mt",89.0,,,F,88,3.0,1,Control,Ndgen.BandBI,Control,,,,,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,DPM13_42,BBN_18791,BBN_18791,IGF122156,SSC,,DPM13_42,DPM13-42-SSC,
374,8.0,Manchester,,DPM16/44,BBN005.29520,3.0,3.0,3.0,3.0,"EC,MTEMP,SOM ent, sensmot, mt",94.0,3.0,White,M,36.5,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions and 30 FFPE slides/region arrived on 25/08/22.,,Y,8.0,R62H,rs143332484,,2.0,TREM2,ABCA7/BIN1,,,DPM16_44,BBN005_29520,BBN005.29520,IGF122227,EC,,DPM16_44,DPM16-44-EC,
375,8.0,Manchester,,DPM16/44,BBN005.29520,3.0,3.0,3.0,3.0,"EC,MTEMP,SOM ent, sensmot, mt",94.0,3.0,White,M,36.5,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions and 30 FFPE slides/region arrived on 25/08/22.,,Y,8.0,R62H,rs143332484,,2.0,TREM2,ABCA7/BIN1,,,DPM16_44,BBN005_29520,BBN005.29520,IGF120774,MTG,,DPM16_44,DPM16-44-MTG_1,
376,8.0,Manchester,,DPM16/44,BBN005.29520,3.0,3.0,3.0,3.0,"EC,MTEMP,SOM ent, sensmot, mt",94.0,3.0,White,M,36.5,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions and 30 FFPE slides/region arrived on 25/08/22.,,Y,8.0,R62H,rs143332484,,2.0,TREM2,ABCA7/BIN1,,,DPM16_44,BBN005_29520,BBN005.29520,IGF117754,SOM,,DPM16_44,DPM16-44-SOM,
377,8.0,Manchester,,DPM16/44,BBN005.29520,3.0,3.0,3.0,3.0,"EC,MTEMP,SOM ent, sensmot, mt",94.0,3.0,White,M,36.5,5.0,2,Control,Ndgen.BandBII,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,3.0,1.0,Ndgen.CERAD1,Sparse Neruitic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,ABCA7BIN1 study: 3 frozen regions and 30 FFPE slides/region arrived on 25/08/22.,,Y,8.0,R62H,rs143332484,,2.0,TREM2,ABCA7/BIN1,,,DPM16_44,BBN005_29520,BBN005.29520,IGF117779,MTEMP,,DPM16_44,DPM16-44-MTEMP,
378,4.0,Oxford ,,NP08/166 , BBN004.28979,,,,,MTEMP 2,82.0,,,M,70,5.0,2,Control,Ndgen.BandBII,Control,,,,,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,NP08_166,BBN004_28979, BBN004.28979,IGF122095,MTG,,NP08_166,NP08-166-MTG,
379,4.0,Oxford ,,NP11/114 , BBN_5650,,,,,MTEMP 5,57.0,,,M,48,3.0,1,Control,Ndgen.BandBI,Control,,,,,,,,,1.0,,,Not assesed,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,NP11_114,BBN_5650, BBN_5650,IGF122196,MTG,,NP11_114,NP11-114-MTG,
380,4.0,Oxford ,,NP12/098 , BBN_11055,,,,,MTEMP 11,68.0,,,M,33,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,1.0,,,Not assesed,,,,,,,,,,,N,7.0,R47H,rs75932628,,2.0,TREM2,,,,NP12_098,BBN_11055, BBN_11055,IGF122213,MTG,,NP12_098,NP12-098-MTG,
381,4.0,Oxford ,,NP12/134 , BBN_11066,,,,,X 2,80.0,,,M,24,9.0,5,AD,Ndgen.BandBV,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,4.0,2.0,Ndgen.CERAD2,Moderate,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,8.0,R62H,rs143332484,,2.0,TREM2,,,,NP12_134,BBN_11066, BBN_11066,IGF122178,MTG,,NP12_134,NP12-134-MTG,
382,4.0,Oxford ,,NP12/162 , BBN_11097,,,,,MTEMP 2,83.0,,,M,48,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,NP12_162,BBN_11097, BBN_11097,IGF120794,MTG,,NP12_162,NP12-162-MTG_1,
383,4.0,Oxford ,,NP12/162 , BBN_11097,,,,,MTEMP 2,83.0,,,M,48,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,NP12_162,BBN_11097, BBN_11097,IGF117796,MTEMP,,NP12_162,NP12-162-MTEMP,
384,4.0,Oxford ,,NP13/012 , BBN_15230,,,,,MTEMP 12,60.0,,,F,48,3.0,1,Control,Ndgen.BandBI,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,NP13_012,BBN_15230, BBN_15230,IGF120793,MTG,,NP13_012,NP13-012-MTG_1,
385,4.0,Oxford ,,NP13/012 , BBN_15230,,,,,MTEMP 12,60.0,,,F,48,3.0,1,Control,Ndgen.BandBI,Control,5.0,3.0,Ndgen.Thal3,Amyloid in diencephalon/basal ganglia,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,NP13_012,BBN_15230, BBN_15230,IGF117757,MTEMP,,NP13_012,NP13-012-MTEMP,
386,4.0,Oxford ,,NP14/128 , BBN_24659,,,,,MTEMP 13,61.0,,,F,23,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E3/E4,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,NP14_128,BBN_24659, BBN_24659,IGF122214,MTG,,NP14_128,NP14-128-MTG,
387,4.0,Oxford ,,NP14/128 , BBN_24659,,,,,MTEMP 13,61.0,,,F,23,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,previously E3/E4,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,NP14_128,BBN_24659, BBN_24659,IGF117761,MTEMP,,NP14_128,NP14-128-MTEMP,
388,4.0,Oxford ,,NP16/088 , BBN004.29074,,,,,MTEMP 14,75.0,,,F,46,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,NP16_088,BBN004_29074, BBN004.29074,IGF122207,MTG,,NP16_088,NP16-088-MTG,
389,4.0,Oxford ,,NP16/088 , BBN004.29074,,,,,MTEMP 14,75.0,,,F,46,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,NP16_088,BBN004_29074, BBN004.29074,IGF117765,MTEMP,,NP16_088,NP16-088-MTEMP,
390,4.0,Oxford ,,NP17/023 , BBN004.29828,,,,,MTEMP 14,86.0,,,M,27,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,4.0,2.0,Ndgen.CERAD2,Moderate,4.0,E2/E4,Ndgen.GeneAPOE24,High AD risk,,,,,,,,,,,Y,8.0,R62H,rs143332484,,2.0,TREM2,,,,NP17_023,BBN004_29828, BBN004.29828,IGF117792,MTEMP,,NP17_023,NP17-023-MTEMP,
391,3.0,QSBB (UCL),,P19/06,BBN_11727,,,,,"MTEMP Hippo, mid temp, motor",71.0,,,M,40.2,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,3.0,D87N,rs142232675,,2.0,TREM2,,,,P19_06,BBN_11727,BBN_11727,IGF122206,MTG,,P19_06,P19-06-MTG,
392,3.0,QSBB (UCL),,P23/07,BBN_11804,,,,,"MTEMP Hippo, mid temp, motor",76.0,,,M,39.5,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,2.0,E2/E2,Ndgen.GeneAPOE22,Very low AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,P23_07,BBN_11804,BBN_11804,IGF120781,MTG,,P23_07,P23-07-MTG_1,
393,3.0,QSBB (UCL),,P23/07,BBN_11804,,,,,"MTEMP Hippo, mid temp, motor",76.0,,,M,39.5,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,2.0,0.0,Ndgen.CERAD0,No Neuritic Plaques,2.0,E2/E2,Ndgen.GeneAPOE22,Very low AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,P23_07,BBN_11804,BBN_11804,IGF117787,MTEMP,,P23_07,P23-07-MTEMP,
394,3.0,QSBB (UCL),,P3/09,BBN_8051,,,,,"MTEMP Hippo, mid temp, motor",64.0,,,M,36.15,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,P3_09,BBN_8051,BBN_8051,IGF122138,MTG,,P3_09,P3-09-MTG,
395,3.0,QSBB (UCL),,P3/09,BBN_8051,,,,,"MTEMP Hippo, mid temp, motor",64.0,,,M,36.15,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,Y,7.0,R47H,rs75932628,,2.0,TREM2,,,,P3_09,BBN_8051,BBN_8051,IGF117771,MTEMP,,P3_09,P3-09-MTEMP,
396,3.0,QSBB (UCL),,P59/03,BBN_12407,,,,," Hippo, mid temp, motor",41.0,,,F,75.5,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,,,,,,,N,7.0,R47H,rs75932628,,2.0,TREM2,,,,P59_03,BBN_12407,BBN_12407,IGF122102,MTG,,P59_03,P59-03-MTG,
397,3.0,QSBB (UCL),,P7/09,BBN_12556,,,,," Hippo, mid temp, motor",66.0,,,F,51.2,11.0,6,AD,Ndgen.BandBVI,Severe,7.0,5.0,Ndgen.Thal5,Amyloid in cerebellum,5.0,3.0,Ndgen.CERAD3,High Density,6.0,E3/E4,Ndgen.GeneAPOE34,High AD risk,,,,,,,,,,,N,7.0,R47H,rs75932628,,2.0,TREM2,,,,P7_09,BBN_12556,BBN_12556,IGF122084,MTG,,P7_09,P7-09-MTG,
398,9.0,Imperial,,PDC016,BBN_10099,,,,,"EC,MTEMP,SOM ",93.0,2.0,Unknown,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,"Ageing related changes. This case shows substantial calcification of the pallidus, internal capsule and anterior commissure involving both the vessel wall and parenchyma",Bronchial neumonia,,,,,Y,2.0,none,,,2.0,TREM2,,,,PDC016,BBN_10099,BBN_10099,IGF114210,EC,,PDC016,PDC016-EC,
399,9.0,Imperial,,PDC016,BBN_10099,,,,,"EC,MTEMP,SOM ",93.0,2.0,Unknown,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,"Ageing related changes. This case shows substantial calcification of the pallidus, internal capsule and anterior commissure involving both the vessel wall and parenchyma",Bronchial neumonia,,,,,Y,2.0,none,,,2.0,TREM2,,,,PDC016,BBN_10099,BBN_10099,IGF114211,mTemp,,PDC016,PDC016-mTemp,
400,9.0,Imperial,,PDC016,BBN_10099,,,,,"EC,MTEMP,SOM ",93.0,2.0,Unknown,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,"Ageing related changes. This case shows substantial calcification of the pallidus, internal capsule and anterior commissure involving both the vessel wall and parenchyma",Bronchial neumonia,,,,,Y,2.0,none,,,2.0,TREM2,,,,PDC016,BBN_10099,BBN_10099,IGF114215,SSC,,PDC016,PDC016-SSC,
401,9.0,Imperial,,PDC016,BBN_10099,,,,,"EC,MTEMP,SOM ",93.0,2.0,Unknown,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,"Ageing related changes. This case shows substantial calcification of the pallidus, internal capsule and anterior commissure involving both the vessel wall and parenchyma",Bronchial neumonia,,,,,Y,2.0,none,,,2.0,TREM2,,,,PDC016,BBN_10099,BBN_10099,IGF112653,EC,,PDC016,PDC016EC_1,
402,9.0,Imperial,,PDC016,BBN_10099,,,,,"EC,MTEMP,SOM ",93.0,2.0,Unknown,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,"Ageing related changes. This case shows substantial calcification of the pallidus, internal capsule and anterior commissure involving both the vessel wall and parenchyma",Bronchial neumonia,,,,,Y,2.0,none,,,2.0,TREM2,,,,PDC016,BBN_10099,BBN_10099,IGF112654,SSC,,PDC016,PDC016SSC_1,
403,9.0,Imperial,,PDC016,BBN_10099,,,,,"EC,MTEMP,SOM ",93.0,2.0,Unknown,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,"Ageing related changes. This case shows substantial calcification of the pallidus, internal capsule and anterior commissure involving both the vessel wall and parenchyma",Bronchial neumonia,,,,,Y,2.0,none,,,2.0,TREM2,,,,PDC016,BBN_10099,BBN_10099,IGF113075,EC,,PDC016,PDC016-EC_1,
404,9.0,Imperial,,PDC016,BBN_10099,,,,,"EC,MTEMP,SOM ",93.0,2.0,Unknown,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,"Ageing related changes. This case shows substantial calcification of the pallidus, internal capsule and anterior commissure involving both the vessel wall and parenchyma",Bronchial neumonia,,,,,Y,2.0,none,,,2.0,TREM2,,,,PDC016,BBN_10099,BBN_10099,IGF113076,SSC,,PDC016,PDC016-SSC_1,
405,9.0,Imperial,,PDC016,BBN_10099,,,,,"EC,MTEMP,SOM ",93.0,2.0,Unknown,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,"Ageing related changes. This case shows substantial calcification of the pallidus, internal capsule and anterior commissure involving both the vessel wall and parenchyma",Bronchial neumonia,,,,,Y,2.0,none,,,2.0,TREM2,,,,PDC016,BBN_10099,BBN_10099,IGF117791,SOM,,PDC016,PDC016-SOM,
406,9.0,Imperial,,PDC016,BBN_10099,,,,,"EC,MTEMP,SOM ",93.0,2.0,Unknown,F,22,5.0,2,Control,Ndgen.BandBII,Control,,,,,,,,,5.0,E3/E3,Ndgen.GeneAPOE33,Moderate AD risk,,,,,"Ageing related changes. This case shows substantial calcification of the pallidus, internal capsule and anterior commissure involving both the vessel wall and parenchyma",Bronchial neumonia,,,,,Y,2.0,none,,,2.0,TREM2,,,,PDC016,BBN_10099,BBN_10099,IGF117836,MTEMP,,PDC016,PDC016-MTEMP,
407,9.0,Imperial,,PDC026,BBN_10109,,,,,"EC,MTEMP,SOM ",80.0,2.0,Unknown,F,23,4.0,1TO2,Control,"Ndgen.BandBI, Ndgen.BandBII",Control,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,Mild age-related Alzheimer-type changes,Breast carcinoma with spinal metastasis; carcinosarcoma uterus,Y,,,,Y,2.0,none,,,2.0,TREM2,,,,PDC026,BBN_10109,BBN_10109,IGF112655,EC,,PDC026,PDC026EC_1,
408,9.0,Imperial,,PDC026,BBN_10109,,,,,"EC,MTEMP,SOM ",80.0,2.0,Unknown,F,23,4.0,1TO2,Control,"Ndgen.BandBI, Ndgen.BandBII",Control,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,Mild age-related Alzheimer-type changes,Breast carcinoma with spinal metastasis; carcinosarcoma uterus,Y,,,,Y,2.0,none,,,2.0,TREM2,,,,PDC026,BBN_10109,BBN_10109,IGF112656,SSC,,PDC026,PDC026SSC_1,
409,9.0,Imperial,,PDC026,BBN_10109,,,,,"EC,MTEMP,SOM ",80.0,2.0,Unknown,F,23,4.0,1TO2,Control,"Ndgen.BandBI, Ndgen.BandBII",Control,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,Mild age-related Alzheimer-type changes,Breast carcinoma with spinal metastasis; carcinosarcoma uterus,Y,,,,Y,2.0,none,,,2.0,TREM2,,,,PDC026,BBN_10109,BBN_10109,IGF113077,EC,,PDC026,PDC026-EC_1,
410,9.0,Imperial,,PDC026,BBN_10109,,,,,"EC,MTEMP,SOM ",80.0,2.0,Unknown,F,23,4.0,1TO2,Control,"Ndgen.BandBI, Ndgen.BandBII",Control,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,Mild age-related Alzheimer-type changes,Breast carcinoma with spinal metastasis; carcinosarcoma uterus,Y,,,,Y,2.0,none,,,2.0,TREM2,,,,PDC026,BBN_10109,BBN_10109,IGF113078,SSC,,PDC026,PDC026-SSC_1,
411,9.0,Imperial,,PDC026,BBN_10109,,,,,"EC,MTEMP,SOM ",80.0,2.0,Unknown,F,23,4.0,1TO2,Control,"Ndgen.BandBI, Ndgen.BandBII",Control,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,Mild age-related Alzheimer-type changes,Breast carcinoma with spinal metastasis; carcinosarcoma uterus,Y,,,,Y,2.0,none,,,2.0,TREM2,,,,PDC026,BBN_10109,BBN_10109,IGF117837,MTEMP,,PDC026,PDC026-MTEMP,
412,9.0,Imperial,,PDC026,BBN_10109,,,,,"EC,MTEMP,SOM ",80.0,2.0,Unknown,F,23,4.0,1TO2,Control,"Ndgen.BandBI, Ndgen.BandBII",Control,,,,,,,,,3.0,E2/E3,Ndgen.GeneAPOE23,Low AD risk,,,,,Mild age-related Alzheimer-type changes,Breast carcinoma with spinal metastasis; carcinosarcoma uterus,Y,,,,Y,2.0,none,,,2.0,TREM2,,,,PDC026,BBN_10109,BBN_10109,IGF117795,SOM,,PDC026,PDC026-SOM,
413,12.0,McGill,6/17/2021,RSMG1,RSMG1,,,1.0,1.0,Cortex,39.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG1,RSMG1,RSMG1,IGF119489,,,RSMG1,RSMG1-2,
414,12.0,McGill,6/17/2021,RSMG1,RSMG1,,,1.0,1.0,Cortex,39.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG1,RSMG1,RSMG1,IGF119490,,,RSMG1,RSMG1-3,
415,12.0,McGill,6/17/2021,RSMG1,RSMG1,,,1.0,1.0,Cortex,39.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG1,RSMG1,RSMG1,IGF119491,,,RSMG1,RSMG1-5,
416,12.0,McGill,6/17/2021,RSMG1,RSMG1,,,1.0,1.0,Cortex,39.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG1,RSMG1,RSMG1,IGF119494,,,RSMG1,RSMG1-6,
417,12.0,McGill,6/17/2021,RSMG1,RSMG1,,,1.0,1.0,Cortex,39.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG1,RSMG1,RSMG1,IGF119492,,,RSMG1,RSMG1-1,
418,12.0,McGill,6/17/2021,RSMG1,RSMG1,,,1.0,1.0,Cortex,39.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG1,RSMG1,RSMG1,IGF119493,,,RSMG1,RSMG1-4,
419,12.0,McGill,6/17/2021,RSMG10,RSMG10,,,1.0,1.0,Parietal-occipital cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG10,RSMG10,RSMG10,IGF119544,,,RSMG10,RSMG10-2,
420,12.0,McGill,6/17/2021,RSMG10,RSMG10,,,1.0,1.0,Parietal-occipital cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG10,RSMG10,RSMG10,IGF119545,,,RSMG10,RSMG10-5,
421,12.0,McGill,6/17/2021,RSMG10,RSMG10,,,1.0,1.0,Parietal-occipital cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG10,RSMG10,RSMG10,IGF119546,,,RSMG10,RSMG10-1,
422,12.0,McGill,6/17/2021,RSMG10,RSMG10,,,1.0,1.0,Parietal-occipital cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG10,RSMG10,RSMG10,IGF119547,,,RSMG10,RSMG10-3,
423,12.0,McGill,6/17/2021,RSMG10,RSMG10,,,1.0,1.0,Parietal-occipital cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG10,RSMG10,RSMG10,IGF119548,,,RSMG10,RSMG10-4,
424,12.0,McGill,6/17/2021,RSMG10,RSMG10,,,1.0,1.0,Parietal-occipital cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG10,RSMG10,RSMG10,IGF119549,,,RSMG10,RSMG10-6,
425,12.0,McGill,6/17/2021,RSMG11,RSMG11,,,1.0,1.0,Frontal cortex,54.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG11,RSMG11,RSMG11,IGF119550,,,RSMG11,RSMG11-2,
426,12.0,McGill,6/17/2021,RSMG11,RSMG11,,,1.0,1.0,Frontal cortex,54.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG11,RSMG11,RSMG11,IGF119551,,,RSMG11,RSMG11-5,
427,12.0,McGill,6/17/2021,RSMG11,RSMG11,,,1.0,1.0,Frontal cortex,54.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG11,RSMG11,RSMG11,IGF119552,,,RSMG11,RSMG11-1,
428,12.0,McGill,6/17/2021,RSMG11,RSMG11,,,1.0,1.0,Frontal cortex,54.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG11,RSMG11,RSMG11,IGF119553,,,RSMG11,RSMG11-3,
429,12.0,McGill,6/17/2021,RSMG11,RSMG11,,,1.0,1.0,Frontal cortex,54.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG11,RSMG11,RSMG11,IGF119554,,,RSMG11,RSMG11-4,
430,12.0,McGill,6/17/2021,RSMG11,RSMG11,,,1.0,1.0,Frontal cortex,54.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG11,RSMG11,RSMG11,IGF119555,,,RSMG11,RSMG11-6,
431,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF128418,,,RSMG12,RSMG12-4,RNAseq
432,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF119556,,,RSMG12,RSMG12-2,
433,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF119557,,,RSMG12,RSMG12-4,
434,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF119559,,,RSMG12,RSMG12-3,
435,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF119560,,,RSMG12,RSMG12-5,
436,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF119561,,,RSMG12,RSMG12-6,
437,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF119562,,,RSMG12,RSMG12-7,
438,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF119563,,,RSMG12,RSMG12-8,
439,12.0,McGill,6/17/2021,RSMG12,RSMG12,,,1.0,1.0,Frontal-temporal cortex,72.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG12,RSMG12,RSMG12,IGF119566,,,RSMG12,RSMG12-1,
440,12.0,McGill,6/17/2021,RSMG13,RSMG13,,,1.0,1.0,Frontal-temporal cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG13,RSMG13,RSMG13,IGF119558,,,RSMG13,RSMG13-5,
441,12.0,McGill,6/17/2021,RSMG13,RSMG13,,,1.0,1.0,Frontal-temporal cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG13,RSMG13,RSMG13,IGF119564,,,RSMG13,RSMG13-2,
442,12.0,McGill,6/17/2021,RSMG13,RSMG13,,,1.0,1.0,Frontal-temporal cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG13,RSMG13,RSMG13,IGF119565,,,RSMG13,RSMG13-3,
443,12.0,McGill,6/17/2021,RSMG13,RSMG13,,,1.0,1.0,Frontal-temporal cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG13,RSMG13,RSMG13,IGF119567,,,RSMG13,RSMG13-1,
444,12.0,McGill,6/17/2021,RSMG13,RSMG13,,,1.0,1.0,Frontal-temporal cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG13,RSMG13,RSMG13,IGF119568,,,RSMG13,RSMG13-4,
445,12.0,McGill,6/17/2021,RSMG13,RSMG13,,,1.0,1.0,Frontal-temporal cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG13,RSMG13,RSMG13,IGF119569,,,RSMG13,RSMG13-6,
446,12.0,McGill,6/17/2021,RSMG14,RSMG14,,,1.0,1.0,Frontal-temporal cortex,42.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG14,RSMG14,RSMG14,IGF119575,,,RSMG14,RSMG14-5,
447,12.0,McGill,6/17/2021,RSMG14,RSMG14,,,1.0,1.0,Frontal-temporal cortex,42.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG14,RSMG14,RSMG14,IGF119570,,,RSMG14,RSMG14-2,
448,12.0,McGill,6/17/2021,RSMG14,RSMG14,,,1.0,1.0,Frontal-temporal cortex,42.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG14,RSMG14,RSMG14,IGF119571,,,RSMG14,RSMG14-4,
449,12.0,McGill,6/17/2021,RSMG14,RSMG14,,,1.0,1.0,Frontal-temporal cortex,42.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG14,RSMG14,RSMG14,IGF119572,,,RSMG14,RSMG14-6,
450,12.0,McGill,6/17/2021,RSMG14,RSMG14,,,1.0,1.0,Frontal-temporal cortex,42.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG14,RSMG14,RSMG14,IGF119573,,,RSMG14,RSMG14-1,
451,12.0,McGill,6/17/2021,RSMG14,RSMG14,,,1.0,1.0,Frontal-temporal cortex,42.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG14,RSMG14,RSMG14,IGF119574,,,RSMG14,RSMG14-3,
452,12.0,McGill,6/17/2021,RSMG14,RSMG14,,,1.0,1.0,Frontal-temporal cortex,42.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG14,RSMG14,RSMG14,IGF119576,,,RSMG14,RSMG14-7,
453,12.0,McGill,6/17/2021,RSMG14,RSMG14,,,1.0,1.0,Frontal-temporal cortex,42.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG14,RSMG14,RSMG14,IGF119577,,,RSMG14,RSMG14-8,
454,12.0,McGill,6/17/2021,RSMG15,RSMG15,,,1.0,1.0,Frontal-parietal cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG15,RSMG15,RSMG15,IGF119585,,,RSMG15,RSMG15-4,
455,12.0,McGill,6/17/2021,RSMG15,RSMG15,,,1.0,1.0,Frontal-parietal cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG15,RSMG15,RSMG15,IGF119579,,,RSMG15,RSMG15-6,
456,12.0,McGill,6/17/2021,RSMG15,RSMG15,,,1.0,1.0,Frontal-parietal cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG15,RSMG15,RSMG15,IGF119578,,,RSMG15,RSMG15-2,
457,12.0,McGill,6/17/2021,RSMG15,RSMG15,,,1.0,1.0,Frontal-parietal cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG15,RSMG15,RSMG15,IGF119580,,,RSMG15,RSMG15-1,
458,12.0,McGill,6/17/2021,RSMG15,RSMG15,,,1.0,1.0,Frontal-parietal cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG15,RSMG15,RSMG15,IGF119581,,,RSMG15,RSMG15-3,
459,12.0,McGill,6/17/2021,RSMG15,RSMG15,,,1.0,1.0,Frontal-parietal cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG15,RSMG15,RSMG15,IGF119582,,,RSMG15,RSMG15-5,
460,12.0,McGill,6/17/2021,RSMG15,RSMG15,,,1.0,1.0,Frontal-parietal cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG15,RSMG15,RSMG15,IGF119583,,,RSMG15,RSMG15-7,
461,12.0,McGill,6/17/2021,RSMG16,RSMG16,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG16,RSMG16,RSMG16,IGF119586,,,RSMG16,RSMG16-4,
462,12.0,McGill,6/17/2021,RSMG16,RSMG16,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG16,RSMG16,RSMG16,IGF119587,,,RSMG16,RSMG16-6,
463,12.0,McGill,6/17/2021,RSMG16,RSMG16,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG16,RSMG16,RSMG16,IGF119588,,,RSMG16,RSMG16-1,
464,12.0,McGill,6/17/2021,RSMG16,RSMG16,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG16,RSMG16,RSMG16,IGF119589,,,RSMG16,RSMG16-3,
465,12.0,McGill,6/17/2021,RSMG16,RSMG16,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG16,RSMG16,RSMG16,IGF119590,,,RSMG16,RSMG16-5,
466,12.0,McGill,6/17/2021,RSMG16,RSMG16,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG16,RSMG16,RSMG16,IGF119591,,,RSMG16,RSMG16-7,
467,12.0,McGill,6/17/2021,RSMG16,RSMG16,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG16,RSMG16,RSMG16,IGF119584,,,RSMG16,RSMG16-2,
468,12.0,McGill,6/17/2021,RSMG17,RSMG17,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG17,RSMG17,RSMG17,IGF119592,,,RSMG17,RSMG17-2,
469,12.0,McGill,6/17/2021,RSMG17,RSMG17,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG17,RSMG17,RSMG17,IGF119593,,,RSMG17,RSMG17-4,
470,12.0,McGill,6/17/2021,RSMG17,RSMG17,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG17,RSMG17,RSMG17,IGF119594,,,RSMG17,RSMG17-6,
471,12.0,McGill,6/17/2021,RSMG17,RSMG17,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG17,RSMG17,RSMG17,IGF119595,,,RSMG17,RSMG17-1,
472,12.0,McGill,6/17/2021,RSMG17,RSMG17,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG17,RSMG17,RSMG17,IGF119596,,,RSMG17,RSMG17-3,
473,12.0,McGill,6/17/2021,RSMG17,RSMG17,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG17,RSMG17,RSMG17,IGF119597,,,RSMG17,RSMG17-5,
474,12.0,McGill,6/17/2021,RSMG17,RSMG17,,,1.0,1.0,Frontal-temporal cortex,63.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG17,RSMG17,RSMG17,IGF119598,,,RSMG17,RSMG17-7,
475,12.0,McGill,6/17/2021,RSMG2,RSMG2,,,1.0,1.0,Cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG2,RSMG2,RSMG2,IGF119496,,,RSMG2,RSMG2-3,
476,12.0,McGill,6/17/2021,RSMG2,RSMG2,,,1.0,1.0,Cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG2,RSMG2,RSMG2,IGF119495,,,RSMG2,RSMG2-2,
477,12.0,McGill,6/17/2021,RSMG2,RSMG2,,,1.0,1.0,Cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG2,RSMG2,RSMG2,IGF119497,,,RSMG2,RSMG2-5,
478,12.0,McGill,6/17/2021,RSMG2,RSMG2,,,1.0,1.0,Cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG2,RSMG2,RSMG2,IGF119498,,,RSMG2,RSMG2-1,
479,12.0,McGill,6/17/2021,RSMG2,RSMG2,,,1.0,1.0,Cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG2,RSMG2,RSMG2,IGF119499,,,RSMG2,RSMG2-4,
480,12.0,McGill,6/17/2021,RSMG2,RSMG2,,,1.0,1.0,Cortex,57.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG2,RSMG2,RSMG2,IGF119500,,,RSMG2,RSMG2-6,
481,12.0,McGill,6/17/2021,RSMG3,RSMG3,,,1.0,1.0,Occipital cortex,55.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG3,RSMG3,RSMG3,IGF119504,,,RSMG3,RSMG3-1,
482,12.0,McGill,6/17/2021,RSMG3,RSMG3,,,1.0,1.0,Occipital cortex,55.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG3,RSMG3,RSMG3,IGF119501,,,RSMG3,RSMG3-2,
483,12.0,McGill,6/17/2021,RSMG3,RSMG3,,,1.0,1.0,Occipital cortex,55.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG3,RSMG3,RSMG3,IGF119502,,,RSMG3,RSMG3-3,
484,12.0,McGill,6/17/2021,RSMG3,RSMG3,,,1.0,1.0,Occipital cortex,55.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG3,RSMG3,RSMG3,IGF119503,,,RSMG3,RSMG3-5,
485,12.0,McGill,6/17/2021,RSMG3,RSMG3,,,1.0,1.0,Occipital cortex,55.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG3,RSMG3,RSMG3,IGF119505,,,RSMG3,RSMG3-4,
486,12.0,McGill,6/17/2021,RSMG3,RSMG3,,,1.0,1.0,Occipital cortex,55.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG3,RSMG3,RSMG3,IGF119506,,,RSMG3,RSMG3-6,
487,12.0,McGill,6/17/2021,RSMG4,RSMG4,,,1.0,1.0,Parietal-occipital cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG4,RSMG4,RSMG4,IGF119512,,,RSMG4,RSMG4-5,
488,12.0,McGill,6/17/2021,RSMG4,RSMG4,,,1.0,1.0,Parietal-occipital cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG4,RSMG4,RSMG4,IGF119507,,,RSMG4,RSMG4-2,
489,12.0,McGill,6/17/2021,RSMG4,RSMG4,,,1.0,1.0,Parietal-occipital cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG4,RSMG4,RSMG4,IGF119508,,,RSMG4,RSMG4-4,
490,12.0,McGill,6/17/2021,RSMG4,RSMG4,,,1.0,1.0,Parietal-occipital cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG4,RSMG4,RSMG4,IGF119509,,,RSMG4,RSMG4-6,
491,12.0,McGill,6/17/2021,RSMG4,RSMG4,,,1.0,1.0,Parietal-occipital cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG4,RSMG4,RSMG4,IGF119510,,,RSMG4,RSMG4-1,
492,12.0,McGill,6/17/2021,RSMG4,RSMG4,,,1.0,1.0,Parietal-occipital cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG4,RSMG4,RSMG4,IGF119513,,,RSMG4,RSMG4-7,
493,12.0,McGill,6/17/2021,RSMG4,RSMG4,,,1.0,1.0,Parietal-occipital cortex,50.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG4,RSMG4,RSMG4,IGF119511,,,RSMG4,RSMG4-3,
494,12.0,McGill,6/17/2021,RSMG5,RSMG5,,,1.0,1.0,Occipital cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG5,RSMG5,RSMG5,IGF119514,,,RSMG5,RSMG5-2,
495,12.0,McGill,6/17/2021,RSMG5,RSMG5,,,1.0,1.0,Occipital cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG5,RSMG5,RSMG5,IGF119515,,,RSMG5,RSMG5-4,
496,12.0,McGill,6/17/2021,RSMG5,RSMG5,,,1.0,1.0,Occipital cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG5,RSMG5,RSMG5,IGF119516,,,RSMG5,RSMG5-6,
497,12.0,McGill,6/17/2021,RSMG5,RSMG5,,,1.0,1.0,Occipital cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG5,RSMG5,RSMG5,IGF119517,,,RSMG5,RSMG5-1,
498,12.0,McGill,6/17/2021,RSMG5,RSMG5,,,1.0,1.0,Occipital cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG5,RSMG5,RSMG5,IGF119518,,,RSMG5,RSMG5-3,
499,12.0,McGill,6/17/2021,RSMG5,RSMG5,,,1.0,1.0,Occipital cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG5,RSMG5,RSMG5,IGF119519,,,RSMG5,RSMG5-5,
500,12.0,McGill,6/17/2021,RSMG5,RSMG5,,,1.0,1.0,Occipital cortex,52.0,,,F,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG5,RSMG5,RSMG5,IGF119520,,,RSMG5,RSMG5-7,
501,12.0,McGill,6/17/2021,RSMG6,RSMG6,,,1.0,1.0,Parietal-occipital cortex,64.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG6,RSMG6,RSMG6,IGF119521,,,RSMG6,RSMG6-1,
502,12.0,McGill,6/17/2021,RSMG6,RSMG6,,,1.0,1.0,Parietal-occipital cortex,64.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG6,RSMG6,RSMG6,IGF119522,,,RSMG6,RSMG6-2,
503,12.0,McGill,6/17/2021,RSMG6,RSMG6,,,1.0,1.0,Parietal-occipital cortex,64.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG6,RSMG6,RSMG6,IGF119523,,,RSMG6,RSMG6-3,
504,12.0,McGill,6/17/2021,RSMG6,RSMG6,,,1.0,1.0,Parietal-occipital cortex,64.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG6,RSMG6,RSMG6,IGF119524,,,RSMG6,RSMG6-4,
505,12.0,McGill,6/17/2021,RSMG7,RSMG7,,,1.0,1.0,Frontal-Temporal-Occipital cortex,76.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG7,RSMG7,RSMG7,IGF119525,,,RSMG7,RSMG7-1,
506,12.0,McGill,6/17/2021,RSMG7,RSMG7,,,1.0,1.0,Frontal-Temporal-Occipital cortex,76.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG7,RSMG7,RSMG7,IGF119526,,,RSMG7,RSMG7-2,
507,12.0,McGill,6/17/2021,RSMG7,RSMG7,,,1.0,1.0,Frontal-Temporal-Occipital cortex,76.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG7,RSMG7,RSMG7,IGF119527,,,RSMG7,RSMG7-3,
508,12.0,McGill,6/17/2021,RSMG7,RSMG7,,,1.0,1.0,Frontal-Temporal-Occipital cortex,76.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG7,RSMG7,RSMG7,IGF119528,,,RSMG7,RSMG7-4,
509,12.0,McGill,6/17/2021,RSMG7,RSMG7,,,1.0,1.0,Frontal-Temporal-Occipital cortex,76.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG7,RSMG7,RSMG7,IGF119529,,,RSMG7,RSMG7-5,
510,12.0,McGill,6/17/2021,RSMG7,RSMG7,,,1.0,1.0,Frontal-Temporal-Occipital cortex,76.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG7,RSMG7,RSMG7,IGF119530,,,RSMG7,RSMG7-6,
511,12.0,McGill,6/17/2021,RSMG7,RSMG7,,,1.0,1.0,Frontal-Temporal-Occipital cortex,76.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG7,RSMG7,RSMG7,IGF119531,,,RSMG7,RSMG7-7,
512,12.0,McGill,6/17/2021,RSMG8,RSMG8,,,1.0,1.0,Parietal-occipital cortex,60.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG8,RSMG8,RSMG8,IGF119532,,,RSMG8,RSMG8-2,
513,12.0,McGill,6/17/2021,RSMG8,RSMG8,,,1.0,1.0,Parietal-occipital cortex,60.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG8,RSMG8,RSMG8,IGF119533,,,RSMG8,RSMG8-4,
514,12.0,McGill,6/17/2021,RSMG8,RSMG8,,,1.0,1.0,Parietal-occipital cortex,60.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG8,RSMG8,RSMG8,IGF119534,,,RSMG8,RSMG8-1,
515,12.0,McGill,6/17/2021,RSMG8,RSMG8,,,1.0,1.0,Parietal-occipital cortex,60.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG8,RSMG8,RSMG8,IGF119535,,,RSMG8,RSMG8-3,
516,12.0,McGill,6/17/2021,RSMG8,RSMG8,,,1.0,1.0,Parietal-occipital cortex,60.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG8,RSMG8,RSMG8,IGF119536,,,RSMG8,RSMG8-5,
517,12.0,McGill,6/17/2021,RSMG9,RSMG9,,,1.0,1.0,Frontal-temporal cortex,66.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG9,RSMG9,RSMG9,IGF119537,,,RSMG9,RSMG9-2,
518,12.0,McGill,6/17/2021,RSMG9,RSMG9,,,1.0,1.0,Frontal-temporal cortex,66.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG9,RSMG9,RSMG9,IGF119541,,,RSMG9,RSMG9-3,
519,12.0,McGill,6/17/2021,RSMG9,RSMG9,,,1.0,1.0,Frontal-temporal cortex,66.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG9,RSMG9,RSMG9,IGF119538,,,RSMG9,RSMG9-4,
520,12.0,McGill,6/17/2021,RSMG9,RSMG9,,,1.0,1.0,Frontal-temporal cortex,66.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG9,RSMG9,RSMG9,IGF119539,,,RSMG9,RSMG9-6,
521,12.0,McGill,6/17/2021,RSMG9,RSMG9,,,1.0,1.0,Frontal-temporal cortex,66.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG9,RSMG9,RSMG9,IGF119540,,,RSMG9,RSMG9-1,
522,12.0,McGill,6/17/2021,RSMG9,RSMG9,,,1.0,1.0,Frontal-temporal cortex,66.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG9,RSMG9,RSMG9,IGF119542,,,RSMG9,RSMG9-5,
523,12.0,McGill,6/17/2021,RSMG9,RSMG9,,,1.0,1.0,Frontal-temporal cortex,66.0,,,M,,1.0,,,,Missing,1.0,,,Not assesed,1.0,,Null,Not Assessed,1.0,,,Not assesed,1.0,,1.0,,,,,,,,N,1.0,,,,4.0,Tissue Quality Control,,,,RSMG9,RSMG9,RSMG9,IGF119543,,,RSMG9,RSMG9-7,
524,5.0,Edinburgh,,SD030/07,BBN_2414,,,,,MTEMP sup  temp,39.0,,,M,71,2.0,0,Control,Ndgen.BandB0,Control,2.0,0.0,Ndgen.Thal0,No amyloid deposition,,,,,,,,,,,,,,,,,,,N,7.0,R47H,rs75932628,,2.0,TREM2,,,,SD030_07,BBN_2414,BBN_2414,IGF122097,MTG,,SD030_07,SD030-07-MTG,
525,6.0,Kings,,A163/15,BBN_25890,,,3.0,3.0,,76.0,3.0,White,F,4,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,1.0,,Null,Not Assessed,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,1.0,,1.0,,"CAA, Hippocampal sclerosis",,,,,,,,,,,1.0,Glia Enrichment,,,,A163_15,BBN_25890,BBN_25890,IGF122123,SSC,,A163_15,A163-15-SSC,
526,6.0,Kings,,A163/15,BBN_25890,,,3.0,3.0,,76.0,3.0,White,F,4,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,1.0,,Null,Not Assessed,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,1.0,,1.0,,"CAA, Hippocampal sclerosis",,,,,,,,,,,1.0,Glia Enrichment,,,,A163_15,BBN_25890,BBN_25890,IGF122147,EC,,A163_15,A163-15-EC,
527,6.0,Kings,,A163/15,BBN_25890,,,3.0,3.0,,76.0,3.0,White,F,4,11.0,6,AD,Ndgen.BandBVI,Severe,6.0,4.0,Ndgen.Thal4,Amyloid in brainstem/midbrain,1.0,,Null,Not Assessed,7.0,E4/E4,Ndgen.GeneAPOE44,Very high AD risk,1.0,,1.0,,"CAA, Hippocampal sclerosis",,,,,,,,,,,1.0,Glia Enrichment,,,,A163_15,BBN_25890,BBN_25890,IGF122155,MTG,,A163_15,A163-15MTG,
